
<html lang="en"     class="pb-page"  data-request-id="08209b78-7fae-4e8e-8c99-7c04d47f5b3e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2021.64.issue-6;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01836;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist" /></meta><meta name="dc.Creator" content="Yasutaka  Hoashi" /></meta><meta name="dc.Creator" content="Takafumi  Takai" /></meta><meta name="dc.Creator" content="Yohei  Kosugi" /></meta><meta name="dc.Creator" content="Masato  Nakashima" /></meta><meta name="dc.Creator" content="Masaharu  Nakayama" /></meta><meta name="dc.Creator" content="Keisuke  Hirai" /></meta><meta name="dc.Creator" content="Osamu  Uchikawa" /></meta><meta name="dc.Creator" content="Tatsuki  Koike" /></meta><meta name="dc.Description" content="To develop potent and orally bioavailable melatonin receptor (MT1 and MT2) agonists, a novel series of 5–6–5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5..." /></meta><meta name="Description" content="To develop potent and orally bioavailable melatonin receptor (MT1 and MT2) agonists, a novel series of 5–6–5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 8, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01836" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01836" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01836" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01836" /></link>
        
    
    

<title>Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01836" /></meta><meta property="og:title" content="Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0014.jpeg" /></meta><meta property="og:description" content="To develop potent and orally bioavailable melatonin receptor (MT1 and MT2) agonists, a novel series of 5–6–5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5,4-d][1,3]oxazole, cyclopenta[c]pyrazolo[1,5-a]pyridine, indeno[5,4-d][1,3]thiazole, and cyclopenta[e]indazole derivatives showed potent binding affinities for MT1/MT2 receptors. Further optimization of these derivatives based on their metabolic stability in human hepatic microsomes revealed that (S)-3b ((S)-N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]oxazol-8-yl)ethyl]acetamide) was a potent MT1 and MT2 ligand (MT1, Ki = 0.031 nM; MT2, Ki = 0.070 nM) with good metabolic stability in human hepatic microsomes. Moreover, compound (S)-3b showed good BBB permeability in rats, and its in vivo pharmacological effects were confirmed by its sleep-promotion ability in cats." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01836"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01836">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01836&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01836&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01836&amp;href=/doi/10.1021/acs.jmedchem.0c01836" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 3059-3074</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01804" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01858" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yasutaka Hoashi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasutaka Hoashi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takeda Pharmaceutical Company, Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#750c14060001141e145b1d1a14061d1c3501141e1011145b161a18"><span class="__cf_email__" data-cfemail="5e273f2d2b2a3f353f7036313f2d36371e2a3f353b3a3f703d3133">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasutaka++Hoashi">Yasutaka Hoashi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0863-1304" title="Orcid link">http://orcid.org/0000-0002-0863-1304</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Takafumi Takai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takafumi Takai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takeda Pharmaceutical Company, Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takafumi++Takai">Takafumi Takai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yohei Kosugi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yohei Kosugi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takeda Pharmaceutical Company, Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yohei++Kosugi">Yohei Kosugi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9318-4723" title="Orcid link">http://orcid.org/0000-0001-9318-4723</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Masato Nakashima</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Masato Nakashima</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takeda Pharmaceutical Company, Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Masato++Nakashima">Masato Nakashima</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Masaharu Nakayama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Masaharu Nakayama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takeda Pharmaceutical Company, Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Masaharu++Nakayama">Masaharu Nakayama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Keisuke Hirai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Keisuke Hirai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takeda Pharmaceutical Company, Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Keisuke++Hirai">Keisuke Hirai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Osamu Uchikawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Osamu Uchikawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takeda Pharmaceutical Company, Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Osamu++Uchikawa">Osamu Uchikawa</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Tatsuki Koike</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tatsuki Koike</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Takeda Pharmaceutical Company, Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tatsuki++Koike">Tatsuki Koike</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3264-1406" title="Orcid link">http://orcid.org/0000-0002-3264-1406</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01836&amp;href=/doi/10.1021%2Facs.jmedchem.0c01836" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 3059–3074</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 7, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 October 2020</li><li><span class="item_label"><b>Published</b> online</span>8 March 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 March 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01836" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01836</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3059%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYasutaka%2BHoashi%252C%2BTakafumi%2BTakai%252C%2BYohei%2BKosugi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D6%26contentID%3Dacs.jmedchem.0c01836%26title%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BOrally%2BBioavailable%2BMelatonin%2BReceptor%2BAgonist%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3074%26publicationDate%3DMarch%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01836"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1156</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01836" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yasutaka&quot;,&quot;last_name&quot;:&quot;Hoashi&quot;},{&quot;first_name&quot;:&quot;Takafumi&quot;,&quot;last_name&quot;:&quot;Takai&quot;},{&quot;first_name&quot;:&quot;Yohei&quot;,&quot;last_name&quot;:&quot;Kosugi&quot;},{&quot;first_name&quot;:&quot;Masato&quot;,&quot;last_name&quot;:&quot;Nakashima&quot;},{&quot;first_name&quot;:&quot;Masaharu&quot;,&quot;last_name&quot;:&quot;Nakayama&quot;},{&quot;first_name&quot;:&quot;Keisuke&quot;,&quot;last_name&quot;:&quot;Hirai&quot;},{&quot;first_name&quot;:&quot;Osamu&quot;,&quot;last_name&quot;:&quot;Uchikawa&quot;},{&quot;first_name&quot;:&quot;Tatsuki&quot;,&quot;last_name&quot;:&quot;Koike&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;3059-3074&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01836&quot;},&quot;abstract&quot;:&quot;To develop potent and orally bioavailable melatonin receptor (MT1 and MT2) agonists, a novel series of 5–6–5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5,4-d][1,3]oxazole, cyclopenta[c]pyrazolo[1,5-a]pyridine, indeno[5,4-d][1,3]thiazole, and cyclopenta[e]indazole derivatives showed potent binding affinities for MT1/MT2 receptors. Further optimization of these derivatives based on their metabolic stability in human hepatic microsomes revealed that (S)-3b ((S)-N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]oxazol-8-yl)ethyl]acetamide) was a potent MT1 and MT2 ligand (MT1, Ki = 0.031 nM; MT2, Ki = 0.070 nM) with good metabolic stability in human hepatic microsomes. Moreover, compound (S)-3b showed good BBB permeability in rats, and its in vivo pharmacological effects were confirmed by its sleep-promotion ability in cats.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01836&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01836" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01836&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01836" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01836&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01836" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01836&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01836&amp;href=/doi/10.1021/acs.jmedchem.0c01836" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01836" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01836" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01836%26sid%3Dliteratum%253Aachs%26pmid%3D33682410%26genre%3Darticle%26aulast%3DHoashi%26date%3D2021%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BOrally%2BBioavailable%2BMelatonin%2BReceptor%2BAgonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D6%26spage%3D3059%26epage%3D3074%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292588" title="Partition coefficient">Partition coefficient</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/jmcmar.2021.64.issue-6/20210325/jmcmar.2021.64.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To develop potent and orally bioavailable melatonin receptor (MT<sub>1</sub> and MT<sub>2</sub>) agonists, a novel series of 5–6–5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5,4-<i>d</i>][1,3]oxazole, cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridine, indeno[5,4-<i>d</i>][1,3]thiazole, and cyclopenta[<i>e</i>]indazole derivatives showed potent binding affinities for MT<sub>1</sub>/MT<sub>2</sub> receptors. Further optimization of these derivatives based on their metabolic stability in human hepatic microsomes revealed that (<i>S</i>)-<b>3b</b> ((<i>S</i>)-<i>N</i>-[2-(2-methyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide) was a potent MT<sub>1</sub> and MT<sub>2</sub> ligand (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.031 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.070 nM) with good metabolic stability in human hepatic microsomes. Moreover, compound (<i>S</i>)-<b>3b</b> showed good BBB permeability in rats, and its in vivo pharmacological effects were confirmed by its sleep-promotion ability in cats.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Melatonin, <i>N</i>-acetyl-5-methoxytryptamine (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), is a neurohormone primarily released from the pineal gland at nights in both diurnal and nocturnal species.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Its production is regulated by the suprachiasmatic nucleus, which is located in the hypothalamus and contains the master clock that programs circadian rhythms.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Melatonin works through the activation of GPCRs, MT<sub>1</sub> and MT<sub>2</sub>,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> expressed primarily in the brain, retina, pituitary, and blood vessels.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Some reports indicate that MT<sub>1</sub> and MT<sub>2</sub> receptors mediate sleep-promotion effects and circadian rhythms.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> It has been suggested that melatonin administration in humans could ameliorate the symptoms of insomnia,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> jet lag,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and shift work disturbances.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Moreover, based on its chronobiotic effects, melatonin has also been proposed to have a potential for ameliorating mood disorders,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> depression,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> anxiety,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> cancer,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> and Parkinson’s disease.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, the therapeutic use of melatonin is limited by its poor pharmacokinetic profile.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> These pharmacological and pharmacokinetic aspects of melatonin have encouraged us to develop potent and orally bioavailable MT<sub>1</sub>/MT<sub>2</sub> receptor agonists.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of melatonin, ramelteon, and dihydrofuran-fused tricyclic derivatives (<b>1a</b>, <b>1b</b>, <b>2a</b>, <b>2b</b>, and <b>2c</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During the past two decades, several structurally different MT<sub>1</sub>/MT<sub>2</sub> receptor ligands have been reported in the literature.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Ramelteon (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which was designed and synthesized in our laboratory,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> possesses an angularly fused 5–6–5 tricyclic chemical scaffold, whereas most of the MT<sub>1</sub>/MT<sub>2</sub> receptor ligands are characterized by mono- or bicyclic ring systems. Ramelteon showed potent binding affinity for MT<sub>1</sub> (<i>K</i><sub>i</sub> = 0.014 nM) and MT<sub>2</sub> (<i>K</i><sub>i</sub> = 0.112 nM) and has been marketed for the treatment of insomnia.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The discovery of this unique tricyclic ring system has opened the possibility of MT<sub>1</sub>/MT<sub>2</sub> receptor agonists for human use. To enhance the therapeutic value of melatonin receptor agonists, further exploration of the tricyclic ring is desired.</div><div class="NLM_p">In a clinical study of ramelteon, its mean bioavailability was found to be less than 2%, and the main cause was possibly first-pass oxidative metabolism.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Our next focus is to develop potent MT<sub>1</sub>/MT<sub>2</sub> receptor agonists with higher oral bioavailability by reducing the oxidative metabolism.</div><div class="NLM_p">The strategies for enhancing metabolic stability can be generally divided into two major groups. One is the modification of metabolically unstable sites, and the other is the reduction of compound lipophilicity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> While the modification of metabolically unstable sites is a powerful and direct approach to prevent metabolism, it would be inefficient when compounds are metabolized at multiple sites. We focused on reducing the lipophilicity because ramelteon has been reported to be metabolized at multiple sites such as the dihydrofuran ring, cyclopentane ring, and amide chain.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Our initial trial to reduce the lipophilicity involved incorporating nitrogen atom into the indan ring (<b>1a</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><b>1b</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <b>2a–c</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>), resulting in a decreased MT<sub>1</sub>/MT<sub>2</sub> receptor binding affinity. This result suggested that the binding pocket occupied by the indan ring was hydrophobic. We therefore aimed to reduce the lipophilicity by changing the dihydrofuran ring moiety to more polar heterocycles. Very recently, X-ray crystal structures of MT<sub>1</sub>/MT<sub>2</sub> in complex with ramelteon revealed that the oxygen atom of the dihydrofuran ring acts as a hydrogen bond acceptor,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> suggesting that oxygen atom at this position might be essential for the high MT<sub>1</sub>/MT<sub>2</sub> affinity. On the other hand, some of the previous papers suggested that the nitrogen atom of oxazole ring might also serve as a surrogate hydrogen bond acceptor.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> In this paper, we designed a novel series of 5-6-5 tricyclic derivatives by converting the dihydrofuran moiety of ramelteon to more polar nitrogen-containing heterocycles (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), which are expected to achieve not only reduced lipophilicity but also potent binding affinity.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of novel tricyclic derivatives and cLogP values of representative compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, we report the SAR of tricyclic derivatives with azole rings such as oxazole (<b>3</b>), thiazole (<b>4</b>), and pyrazole (<b>5</b> and <b>6</b>) and a subsequent optimization to identify a potent and orally bioavailable MT<sub>1</sub>/MT<sub>2</sub> receptor agonist. The lipophilicities of the designed derivatives that correspond to ramelteon (R<sup>1</sup> = H, R<sup>2</sup> = H, R<sup>3</sup> = Et) were calculated to be lower (cLogP = 1.7–2.4) than that of ramelteon (cLogP = 2.5).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The installation of these azoles can therefore enhance metabolic stability and oral bioavailability. Moreover, the designed tricycles enabled us to explore the R<sup>1</sup> and R<sup>2</sup> substituents, which will provide new findings on the SAR of MT<sub>1</sub>/MT<sub>2</sub> receptor ligands.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The indeno[5,4-<i>d</i>][1,3]oxazole derivatives <b>3a</b>, <b>3b</b>, and <b>3j</b> were synthesized as demonstrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The selective nitration of the position-6 of 4-bromo-7-hydroxyindan-1-one <b>7</b><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> using fuming HNO<sub>3</sub> afforded the nitro form <b>8</b>. Both the nitro and bromo groups of <b>8</b> were simultaneously reduced by hydrogenation to provide the aniline <b>9</b> as a hydrobromide salt. The oxazole ring of compound <b>10a</b> was constructed by refluxing <b>9</b> in the presence of triethyl orthoformate. The methyloxazole derivative <b>10b</b> was prepared by the acetylation of <b>9</b> with acetic anhydride followed by cyclization in the presence of catalytic pyridinium <i>p</i>-toluenesulfonate. Moreover, <b>10a</b> and <b>10b</b> were converted to the target compounds <b>3a</b>, <b>3b</b>, and <b>3j</b> by a previously reported procedure, with some modification.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The Horner–Wadsworth–Emmons reaction of <b>10a</b> and <b>10b</b> with diethyl cyanomethylphosphonate gave the nitriles <b>11a</b> and <b>11b</b>, respectively. The hydrogenation of their nitrile group over Raney cobalt followed by acylation and hydrogenation over Pd/C afforded the target compounds <b>3a</b>, <b>3b</b>, and <b>3j</b>. Chiral column chromatography was employed to prepare optically active isomers of <b>3b</b>, namely, (<i>S</i>)-<b>3b</b> and (<i>R</i>)-<b>3b</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indeno[5,4-<i>d</i>][1,3]oxazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) fuming HNO<sub>3</sub>, Ac<sub>2</sub>O, AcOH, room temp; (b) Pd/C, H<sub>2</sub>, MeOH, room temp; (c) triethyl orthoformate, THF, reflux; (d) (1) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, room temp, (2) pyridinium <i>p</i>-toluenesulfonate, xylene, reflux; (e) NaH, diethyl cyanomethylphosphonate, THF, 0 °C; (f) (1) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, EtOH, room temp, (2) (R<sup>3</sup>CO)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C, (3) Pd/C, H<sub>2</sub>, MeOH, room temp; and (g) HPLC resolution (CHIRALPAK AD).</p></p></figure><div class="NLM_p">The indeno[5,4-<i>d</i>][1,3]oxazole derivatives <b>3c</b>–<b>3g</b> and <b>3i</b> with various R<sup>1</sup> groups were prepared by diversity-oriented synthesis (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). To cyclize the oxazole ring at the last steps, we first constructed the amide side chain. The hydroxy group of compound <b>8</b> was protected by the methyl group. The methoxy form <b>12</b> was transformed into the amide <b>16</b> by a procedure similar to that in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and by the reduction of the nitro and bromo groups. The removal of the methyl group with boron tribromide provided the key intermediate <b>17</b>. The oxazole ring for compounds <b>3c</b>–<b>f</b> and <b>3h</b> was formed by acylation and subsequent cyclization using a certain amount of catalytic pyridinium <i>p</i>-toluenesulfonate. The methoxy derivative <b>3g</b> was prepared by refluxing <b>17</b> in the presence of tetramethoxymethane in THF. The debenzylation of compound <b>3h</b> with palladium on carbon yielded the hydroxymethyl derivative <b>3i</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Diversity-Oriented Synthesis of Indeno[5,4-<i>d</i>][1,3]oxazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeI, 1,8-diazabicyclo[5.4.0]undec-7-ene, DMF, room temp; (b) NaH, diethyl cyanomethylphosphonate, THF, 0 °C; (c) Pd/C, H<sub>2</sub>, Et<sub>3</sub>N, AcOEt, room temp; (d) (1) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, EtOH, room temp, (2) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; (e) Pd/C, H<sub>2</sub>, MeOH, room temp; (f) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (g) (1) (R<sup>1</sup>CO)<sub>2</sub>O or R<sup>1</sup>COCl, pyridine, 0 °C; (2) pyridinium p-toluenesulfonate, xylene, reflux; (h) tetramethyl orthocarbonate, THF, reflux; and (i) Pd/C, H<sub>2</sub>, MeOH, room temp.</p></p></figure><div class="NLM_p">The synthetic route for the indeno[5,4-<i>d</i>][1,3]thiazole derivatives <b>4a</b> and <b>4b</b> is illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The known aminoindan derivative <b>18</b><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> was regioselectively halogenated at position-7 by iodine(I) chloride to provide compound <b>19</b>. The thiazole ring was constructed by a palladium(0)-catalyzed thiation of <b>19</b> with thioacetamide.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The obtained indenothiazole derivative <b>20</b> was converted into the desired compounds <b>4a</b> and <b>4b</b> in a manner similar to that in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Indeno[5,4-<i>d</i>][1,3]thiazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodine(I) chloride, CaCO<sub>3</sub>, MeOH, H2O, room temp; (b) thioacetamide, tris(dibenzylideneacetone)dipalladium(0), 1,1′-bis(diphenylphosphino)ferrocene, CaO, DMF, 60 °C; (c) NaH, diethyl cyanomethylphosphonate, THF, 0 °C; (d) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, MeOH, room temp; (e) Pd/C, H<sub>2</sub>, MeOH, room temp; and (f) (R<sup>3</sup>CO)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C.</p></p></figure><div class="NLM_p">The cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridine derivatives <b>5a</b>–<b>c</b> were synthesized using the known pyridine derivative <b>24</b> as the starting precursor<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The cyclopentane ring was constructed via the Dieckmann condensation of <b>24</b> and subsequent decarboxylation to form the ketone <b>25</b>. The Horner–Wadsworth–Emmons reaction followed by hydrogenation provided the nitrile <b>26</b>. The angular tricyclic compound <b>27a</b> was obtained by the 1,3-dipolar cycloaddition reaction<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> of the <i>N</i>-aminopyridinium salt prepared by the amination of <b>26</b> with 1-(aminooxy)-2,4-dinitrobenzene.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The linear tricyclic compound <b>27b</b> was also obtained (<b>27a</b>:<b>27b</b> = 2.5:1) due to the poor selectivity of this cycloaddition reaction. The nitrile moiety of <b>27a</b> was reduced over Raney cobalt to provide the amine <b>28</b>. The hydrolysis and decarboxylation of the ester moiety of <b>28</b> under acidic conditions followed by acylation furnished the monomethyl derivatives <b>5a</b> and <b>5d</b>. The dimethyl derivative <b>5b</b> was prepared by reduction with diisobutylaluminum hydride before acetylation, and the ester derivative <b>5c</b> was formed by the acetylation of <b>28</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, MeOH, THF, reflux, then hydrochloric acid, reflux; (b) (1) diethyl cyanomethylphosphonate, NaH, THF, 0 °C, (2) Pd/C, H<sub>2</sub>, MeOH, room temp; (c) 1-(aminooxy)-2,4-dinitrobenzene, MeCN, 40 °C; (d) ethyl 2-butynoate, K<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (e) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, EtOH, room temp; (f) (1) hydrochloric acid, 100 °C, (2) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; (g) (1) diisobutylaluminum hydride in toluene, THF, (2) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; (h) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; and (i) (1) 40% sulfuric acid, 100 °C, (2) (EtCO)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C.</p></p></figure><div class="NLM_p">The synthesis of the cyclopenta[<i>e</i>]indazole derivative <b>6a</b> is illustrated in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. The position-6 of commercially available methyl 3-amino-2-methylbenzoate <b>29</b> was regioselectively brominated with <i>N</i>-bromosuccimide to form compound <b>30</b>. Compound <b>30</b> was then treated with sodium nitrite in acetic acid to provide the indazole <b>31</b> via diazonium salt formation. Trimethyloxonium tetrafluoroborate regioselectively methylated the nitrogen atom at the position-2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> of <b>31</b> to prepare compound <b>32</b>. To construct the cyclopentane ring, methyl acrylate was introduced via Heck reaction to afford the cinnamic acid derivative <b>33</b> followed by hydrogenation to yield the propanoic acid derivative <b>34</b>. Dieckmann condensation and subsequent decarboxylation under acidic conditions resulted in the construction of cyclopenta[<i>e</i>]indazole to yield the ketone <b>35</b>. The target compound <b>6a</b> was obtained by following the same procedure as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Cyclopenta[<i>e</i>]indazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-bromosuccimide, MeOH, 0 °C; (b) NaNO<sub>2</sub>, H<sub>2</sub>O, acetic acid, room temp; (c) trimethyloxonium tetrafluoroborate, AcOEt, room temp; (d) Pd(OAc)<sub>2</sub>, triphenylphosphine, K<sub>2</sub>CO<sub>3</sub>, methyl acrylate, DMF, 100 °C; (e) Pd/C, H<sub>2</sub>, MeOH, room temp; (f) NaH, MeOH, THF, then hydrochloric acid, reflux; (g) NaH, diethyl cyanomethylphosphonate, THF, 50 °C; (h) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, EtOH , room temp; (i) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; (j) (EtCO)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; and (k) Pd/C, H<sub>2</sub>, MeOH, room temp.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> SAR Studies on Central Core and R<sup>1</sup>/R<sup>2</sup>/R<sup>3</sup> Substituents</h3><div class="NLM_p">The binding affinities of the synthesized tricyclic derivatives were evaluated using 2-[<sup>125</sup>I]-iodomelatonin as a radioligand in Chinese hamster ovary (CHO) cells expressing human MT<sub>1</sub> and MT<sub>2</sub> receptors.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The results, together with the chemical structures, are presented in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities for Human MT<sub>1</sub> and MT<sub>2</sub> Receptors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0013.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>i</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">MT<sub>1</sub></th><th class="colsep0 rowsep0" align="center">MT<sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">melatonin</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.24 ± 0.06<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.21 ± 0.03<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.45 ± 0.17</td><td class="colsep0 rowsep0" align="left">0.073 ± 0.026</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.067 ± 0.014</td><td class="colsep0 rowsep0" align="left">0.13 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>3b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.031 ± 0.005</td><td class="colsep0 rowsep0" align="left">0.070 ± 0.014</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>3b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">23 ± 7.5</td><td class="colsep0 rowsep0" align="left">6.1 ± 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.22 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.16 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>Pr</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.39 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.15 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.4</td><td class="colsep0 rowsep0" align="left">0.23 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4.4 ± 0.5</td><td class="colsep0 rowsep0" align="left">0.12 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3g</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.45 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.15 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3i</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.5</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3j</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.067 ± 0.033</td><td class="colsep0 rowsep0" align="left">0.088 ± 0.046</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.037 ± 0.007</td><td class="colsep0 rowsep0" align="left">0.086 ± 0.014</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.027 ± 0.003</td><td class="colsep0 rowsep0" align="left">0.058 ± 0.010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.20 ± 0.02</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">9.3 ± 0.3</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.17 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.95 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.35 ± 0.08</td><td class="colsep0 rowsep0" align="left">0.75 ± 0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.30 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.35 ± 0.08</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data are presented as mean values with the standard deviation from a single experiment in triplicate.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Data are presented as mean values with the standard deviation from six independent experiments in more than triplicate.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Not determined; indicates <50% inhibition at a concentration of 100 nM.</p></div></div></div><div class="NLM_p">We initially focused on the SAR studies of the indeno[5,4-<i>d</i>][1,3]oxazole derivatives. The binding affinity of the unsubstituted form <b>3a</b> (R<sup>1</sup> = H; MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.45 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.073 nM) was comparable to that of melatonin (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.24 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.21 nM); this suggests that the nitrogen atom on the oxazole ring functioned as a hydrogen bond acceptor. The SARs of R<sup>1</sup> substituents in the indeno[5,4-<i>d</i>][1,3]oxazole series (<b>3b</b>–<b>3g</b> and <b>3i</b>) were explored. The introduction of a methyl group (<b>3b</b>) resulted in a sevenfold enhancement of the MT<sub>1</sub> receptor binding affinity (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.067 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.13 nM). The introduction of more bulky groups such as ethyl (<b>3c</b>), cyclopropyl (<b>3d</b>), phenyl (<b>3e</b>), or benzyl group (<b>3f</b>) resulted in decreased MT<sub>1</sub> receptor binding affinity. By contrast, the R<sup>1</sup> conversion had little impact on the MT<sub>2</sub> receptor binding affinity, leading to the identification of the MT<sub>2</sub> selective ligand <b>3f</b> (MT<sub>1</sub>/MT<sub>2</sub> = 37). This result is consistent with the reported SAR of the bicyclic benzoxazole derivatives.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compound <b>3g</b>, which possesses an electron-donating methoxy group, exhibited a binding affinity similar to that of the ethyl derivative <b>3c</b>. The electron density of the benzoxazole ring might not affect the MT<sub>1</sub> and MT<sub>2</sub> receptor binding affinities. The introduction of a hydrophilic hydroxymethyl group (<b>3i</b>) resulted in a decreased binding affinity for both MT<sub>1</sub> and MT<sub>2</sub> receptors (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 1.2 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 1.1 nM). The X-ray crystal structures of MT<sub>1</sub> and MT<sub>2</sub> revealed that the binding pocket around the R<sub>1</sub> position was hydrophobic.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> The SAR is consistent with the observation from the X-ray crystal structures. We conclude that the methyl group was the best R<sup>1</sup> substituent to achieve a potent binding affinity for both receptors.</div><div class="NLM_p">The indeno[5,4-<i>d</i>][1,3]thiazole derivative with methyl group on the R<sub>1</sub> substituent (<b>4a</b>) exhibited a slight enhancement in the MT<sub>1</sub>/MT<sub>2</sub> receptor binding affinity (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.037 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.086 nM) compared with the indeno[5,4-<i>d</i>][1,3]oxazole derivative <b>3b</b>. The thiazole ring also effectively worked to achieve a potent binding affinity for MT<sub>1</sub>/MT<sub>2</sub> receptors.</div><div class="NLM_p">The cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridine derivative <b>5a</b> (R<sup>1</sup> = Me, R<sup>2</sup> = H) showed a potent MT<sub>1</sub> receptor binding affinity comparable to that of melatonin but a lower binding affinity for MT<sub>2</sub> receptors (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.20 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 1.4 nM, MT<sub>1</sub>/MT<sub>2</sub> = 0.14). This result indicates the possibility of developing MT<sub>1</sub> selective ligands by exploring heteroaromatic rings. The tricyclic nucleus of the derivatives easily allows for the exploration of the R<sup>2</sup> substituent, whose SAR has not been reported in the literature. The introduction of a methyl group (<b>5b</b>) extremely decreased the binding affinity for both MT<sub>1</sub> and MT<sub>2</sub> (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 9.3 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 47 nM). Moreover, the ester derivative <b>5c</b>, even at a concentration of 100 nM, exhibited less than 50% binding for MT<sub>1</sub>/MT<sub>2</sub> receptors. The X-ray crystal structures of MT<sub>1</sub>/MT<sub>2</sub> in complex with ramelteon revealed that the valine residues (MT<sub>1</sub>: V191<sup>5.42</sup>, MT<sub>2</sub>: V204<sup>5.42</sup>) are located at the close position of the dihydrofuran ring.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> The introduction of R<sup>2</sup> substituents might cause the steric repulsion against these valine residues. The cyclopenta[<i>e</i>]indazole derivative with the optimal substituents (<b>6a</b>, R<sup>1</sup> = Me, R<sup>2</sup> = H) showed a binding affinity (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.35 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.75 nM) comparable to that of melatonin. The two types of pyrazole-fused tricyclic derivatives (<b>5</b> and <b>6</b>) indicated that the pyrazole ring was also a good hydrogen bond acceptor for MT<sub>1</sub>/MT<sub>2</sub> receptors.</div><div class="NLM_p last">Regarding the amide side chain, we have previously reported that the propanamide group exerted the most potent binding affinity.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The installation of the propanamide group slightly enhanced the MT<sub>1</sub> or MT<sub>2</sub> receptor binding affinity or both (<b>3j</b>, <b>4b</b>, <b>5d</b>, and <b>6b</b>) compared with the acetamide derivatives <b>3b</b>, <b>4a</b>, <b>5a</b>, and <b>6a</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Identification of Potent and Orally Bioavailable Melatonin Ligand (<i>S</i>)-<b>3b</b></h3><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> presents the cLogP values, metabolic stability, and rat oral bioavailability for representative compounds selected from each tricyclic scaffold (<b>3b</b>, <b>3j</b>, <b>4a</b>–<b>4b</b>, <b>5a</b>, <b>5d</b>, and <b>6a</b>–<b>6b</b>). The cLogP values were calculated using the software by Daylight Chemical Information Systems, Inc. The metabolic stability was evaluated by testing in vitro clearance in human and rat hepatic microsomes.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Values for cLogP, In Vitro Clearance in Human and Rat Hepatic Microsomes, and Oral Bioavailability in Rats of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">microsomal clearance (μL/min/mg)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center"><i>F</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ramelteon</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">126</td><td class="colsep0 rowsep0" align="left">8.5 ± 2.0<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">18.5 ± 5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3j</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">6.8 ± 2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">188</td><td class="colsep0 rowsep0" align="left">4.8 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">379</td><td class="colsep0 rowsep0" align="left">3.2 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">14.3 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">20.9 ± 9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">13.7 ± 5.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Oral bioavailability after cassette dosing at 0.1 mg/kg (iv) and 1 mg/kg (po).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Test compound was administered discretely at 1 mg/kg (iv) and 1 mg/kg (po).</p></div></div></div><div class="NLM_p">The propanamide derivatives (R<sup>3</sup> = Et) with less lipophilicity (<b>3j</b>, cLogP = 2.0; <b>5d</b>, cLogP = 2.0; and <b>6b</b>, cLogP = 1.9) than ramelteon (cLogP = 2.5) showed enhanced metabolic stability in human hepatic microsomes (<b>3j</b>, 29 μL/min/mg; <b>5d</b>, 20 μL/min/mg; and <b>6b</b>, 23 μL/min/mg) compared with ramelteon (51 μL/min/mg). Moreover, the more lipophilic indeno[5,4-<i>d</i>][1,3]thiazole derivative <b>4b</b> (cLogP = 2.9) showed a stability (41 μL/min/mg) comparable to that of ramelteon. Less lipophilic acetamide derivatives <b>3b</b>, <b>5a</b>, and <b>6a</b> were more stable (<b>3b</b>, 0 μL/min/mg; <b>5a</b>, 14 μL/min/mg; and <b>6a</b>, 5 μL/min/mg) than the corresponding propanamide derivatives <b>3j</b>, <b>5d</b>, and <b>6b</b>. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a demonstrates a clear correlation between the metabolic clearance in human hepatic microsomes and the cLogP values, strongly suggesting the effectiveness of our metabolic stability enhancement strategy.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of clearance in human (a) or rat (b) hepatic microsomes against cLogP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar results were obtained for the metabolic stability in rat hepatic microsomes. A definite correlation also existed between the metabolic clearance in rat hepatic microsomes and the cLogP values (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b). Compounds with good metabolic stability in rat hepatic microsomes showed a better rat oral bioavailability (<b>3b</b>, <i>F</i> = 18.5%; <b>5a</b>, <i>F</i> = 14.3%; and <b>6a</b>, <i>F</i> = 20.9%) than ramelteon (<i>F</i> = 8.5%). <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows that the rat oral bioavailability highly correlates with the metabolic stability in rat hepatic microsomes. This correlation suggests that an improved first-pass metabolism contributes to the oral bioavailability of these derivatives. Hence, compounds with superior metabolic stability in human hepatic microsomes have the potential to show good oral bioavailability in humans. We selected the oxazole derivative <b>3b</b> owing to the good metabolic stability against human hepatic microsomes (0 μL/min/mg) and the highly potent binding affinity (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.067 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.13 nM).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of rat oral bioavailability against clearance in rat hepatic microsomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The binding affinity for the optically active isomers of <b>3b</b> was evaluated (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The <i>S</i>-isomer (<i>S</i>)-<b>3b</b> showed much higher MT<sub>1</sub> and MT<sub>2</sub> receptor binding affinities (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.031 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.070 nM) than (<i>R</i>)-<b>3b</b> (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 23 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 6.1 nM). Compound (<i>S</i>)-<b>3b</b> was determined to be a eutomer. The eutomer demonstrated a binding affinity comparable to that of ramelteon<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.014 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.11 nM). The metabolic clearance in human hepatic microsomes (0 μL/min/mg) and rat oral bioavailability (<i>F</i> = 27.0%) were confirmed to be similar to those of the racemate <b>3b</b>. Compound (<i>S</i>)-<b>3b</b> was subjected to further pharmacokinetic and pharmacological evaluation.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> BBB Permeability and Pharmacological Evaluation of (<i>S</i>)-<b>3b</b></h3><div class="NLM_p">The BBB permeability of compound (<i>S</i>)-<b>3b</b> was evaluated by calculating the brain-to-plasma concentration ratio (B/P ratio) in rats after oral administration (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The brain concentration was found to be half the plasma concentration (B/P ratio = 0.48), indicating that compound (<i>S</i>)-<b>3b</b> exhibited good BBB permeability as is the case with ramelteon (B/P ratio = 1.1).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Brain-to-Plasma Concentration Ratio (B/P Ratio) 60 Min after Oral Administration of Ramelteon and (<i>S</i>)-<b>3b</b> to Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">brain (ng/g)</th><th class="colsep0 rowsep0" align="center">plasma (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">B/P ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ramelteon</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>3b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td></tr></tbody></table></div></div><div class="NLM_p">The functional activity of (<i>S</i>)-<b>3b</b> was evaluated using cAMP production in CHO cells expressing human MT<sub>1</sub> or MT<sub>2</sub> receptors (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Melatonin reduced forskolin-stimulated cAMP accumulation in a concentration-dependent manner (MT<sub>1</sub>, EC<sub>50</sub> = 0.022 nM; MT<sub>2</sub>, EC<sub>50</sub> = 0.85 nM). Compound (<i>S</i>)-<b>3b</b> also exhibited full agonism and superior MT<sub>1</sub> and MT<sub>2</sub> agonistic activities (MT<sub>1</sub>, EC<sub>50</sub> = 0.015 nM; MT<sub>2</sub>, EC<sub>50</sub> = 0.51 nM). The other tricyclic series also showed full agonism and superior MT<sub>1</sub> and MT<sub>2</sub> agonistic activities (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Functional analysis of melatonin and (<i>S</i>)-<b>3b</b> on forskolin-stimulated cAMP formation in CHO cells expressing either human MT<sub>1</sub> or human MT<sub>2</sub> receptor. The 100% value was the mean cAMP production with 2 μmol/L forskolin. The 0% value was that with 1 μmol/L melatonin and 2 μmol/L forskolin. Data were expressed as mean of percentage forskolin response at each receptor. The EC<sub>50</sub> values were estimated by a two-parameter nonlinear logistic regression analysis. The EC<sub>50</sub> values for melatonin are 0.022 nM (MT<sub>1</sub>, 95% confidence interval = 0.019–0.025 nM) and 0.85 nM (MT<sub>2</sub>, 95% confidence interval = 0.65–1.1 nM). Those for (<i>S</i>)-<b>3b</b> are 0.015 nM (MT<sub>1</sub>, 95% confidence interval = 0.012–0.023) and 0.51 nM (MT<sub>2</sub>, 95% confidence interval = 0.33–0.77).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The in vivo pharmacological effects of (<i>S</i>)-<b>3b</b> were evaluated using a previously reported cat model.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The oral administration of (<i>S</i>)-<b>3b</b> at 10 mg/kg significantly increased the total sleep time compared with the vehicle-treated control (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). We confirmed the sleep-promoting effect of compound (<i>S</i>)-<b>3b</b> in cats after oral administration.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of (<i>S</i>)-<b>3b</b> on total sleep time in freely moving cats. Seven cats were treated with (<i>S</i>)-<b>3b</b> (10 mg/kg, po) or vehicle. Data were expressed as the mean of total time sleep during 8 h following the oral administration with standard error of mean.*<i>p</i> < 0.05 (versus the vehicle-treated control by ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, novel 5–6–5 tricyclic derivatives were investigated for developing potent and orally bioavailable MT<sub>1</sub> and MT<sub>2</sub> receptor agonists. Among the synthesized compounds, the indeno[5,4-<i>d</i>][1,3]oxazole derivative (<i>S</i>)-<b>3b</b> was identified as a potent MT<sub>1</sub> and MT<sub>2</sub> receptor agonist (MT<sub>1</sub>, <i>K</i><sub>i</sub> = 0.031 nM; MT<sub>2</sub>, <i>K</i><sub>i</sub> = 0.070 nM) with good in vitro clearance in human hepatic microsomes (0 μL/min/mg). In this chemical series, a clear correlation existed between in vitro clearance in rat hepatic microsomes and oral bioavailability in rat, suggesting that compound (<i>S</i>)-<b>3b</b> could show good oral bioavailability in humans given its improved in vitro clearance compared to that of ramelteon (51 μL/min/mg). Moreover, compound (<i>S</i>)-<b>3b</b> showed good BBB permeability in rats, and its sleep-promoting effect was confirmed by oral administration in cats. These results support the therapeutic potential of compound (<i>S</i>)-<b>3b</b> as an orally available MT<sub>1</sub> and MT<sub>2</sub> receptor agonist. Further evaluation will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Information</h3><div class="NLM_p last">Melting points were determined on a Buchi melting point apparatus and were not corrected. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were recorded on Varian Gemini-200 (200 MHz), Varian Gemini-300 (300 MHz), or Bruker DPX300 (300 MHz) instruments. Chemical shifts are reported as δ values (ppm) downfield from internal tetramethylsilane of the indicated organic solution. Peak multiplicities and  their abbreviations are expressed as follows: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublet; ddd, doublet of doublet of doublets; dt, doublet of triplet; brs, broad singlet; and m, multiplet. Coupling constants (<i>J</i> values) are given in hertz (Hz). LCMS analysis (ESI<sup>+</sup>) was performed on a Waters 2795 Separations Module (L-column2 ODS (3.0 × 50 mm I.D., CERI, Japan); 0.05% TFA in ultrapure water/acetonitrile gradient; UV detection 220 nm or 254 nm), and MS spectra were recorded using a Waters ZQ2000 with electrospray ionization. Optical rotations were determined on a JASCO P-1030 polarimeter. The purities (>95%) of all compounds tested in biological systems were established by HPLC analyses (for <b>3f</b>) or elemental analyses (for the other compounds). HPLC was performed on a Shimadzu LC-VP instrument equipped with a CAPCELL PAK C18 UG120 S-3 μm, 2.0 × 50 mm column with a 4 min linear gradient from 90/10 to 5/95 and subsequently with a 1.5 min isocratic elution 5/95 A/B, where A = H<sub>2</sub>O<b>–</b>0.1% TFA and B = CH<sub>3</sub>CN<b>–</b>0.1% TFA, at a flow rate of 0.5 μL/min, with UV detection at 220 and 254 nm. Element analyses were carried out by Takeda Analytical Laboratories and Discovery Research Laboratories, and the results were within 0.4% of theoretical values unless otherwise noted. Chromatographic purification was carried out on thin layer chromatography (TLC silica gel 60 F<sub>254</sub>, Merck) or on silica gel columns (Merck Kieselgel 60, 70<b>–</b>230 mesh or 230<b>–</b>400 mesh, Merck, or Chromatorex NH-DM 1020, 100<b>–</b>200 mesh) or on Purif-Pack (SI 60 μM or NH 60 μM, Shoko Scientific Co., Ltd.). Reagents and solvents were obtained from commercial sources and used without further purification. All animal experiments in this paper were conducted in accordance with the principles and guidelines on animal experimentation of the Pharmaceutical Research Division of Takeda Pharmaceutical Company, Ltd.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>N</i>-[2-(7,8-Dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide (<b>3a</b>)</h3><div class="NLM_p last">A mixture of <b>11a</b> (210 mg, 1.07 mmol) and Raney cobalt (2 g, washed with water and ethanol before use) in 0.67 M ammonia ethanol solution (12 mL) was stirred at room temperature for 5 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. The residue was purified by NH silica gel column chromatography to afford 2-(6,7-dihydro-8<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-ylidene)ethanamine (60.2 mg, 28%). To a stirred solution of 2-(6,7-dihydro-8<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-ylidene)ethanamine (30.0 mg, 0.148 mmol) in tetrahydrofuran (1 mL) were added triethylamine (31.0 μL, 0.222 mmol) and acetic anhydride (16.8 μL, 0.178 mmol) at 0 °C, and the mixture was stirred for 15 min. Saturated aqueous sodium hydrogencarbonate was added, and the mixture was extracted with ethyl acetate, washed with brine, and concentrated in vacuo. The residue was purified by silica gel column chromatography. A mixture of the obtained compound and 10% palladium on carbon (10 mg, containing 50% water) in methanol (1 mL) was stirred at room temperature for 1 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by thin layer chromatography afforded <b>3a</b> (16.0 mg, 44%) as solid. Total of 12% from <b>3a</b>. Mp 101–103 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 245 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.74–1.97 (2H, m), 1.99 (3H, s), 2.21–2.36 (1H, m), 2.39–2.54 (1H, m), 2.93–3.18 (2H, m), 3.27–3.41 (1H, m), 3.42–3.61 (2H, m), 5.56 (1H, brs), 7.23 (1H, d, <i>J</i> = 8.0 Hz), 7.59 (1H, d, <i>J</i> = 8.0 Hz), 8.03 (1H, s). Anal. Calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>: C, 68.83; H, 6.60; N, 11.47. Found: C, 68.69; H, 6.60; N, 11.26.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-[2-(2-Methyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-Yl)ethyl]acetamide (<b>3b</b>)</h3><div class="NLM_p last">A mixture of <b>11b</b> (1.34 g, 6.37 mmol) and Raney cobalt (13 g, washed with water and ethanol before use) in 0.67 M ammonia ethanol solution (63 mL) was stirred at room temperature for 3 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. The residue was dissolved in tetrahydrofuran (64 mL), and triethylamine (1.33 mL, 9.56 mmol) and acetic anhydride (723 μL, 7.64 mmol) were added at 0 °C. After 15 min, saturated aqueous sodium hydrogencarbonate was added, and the mixture was extracted with ethyl acetate, washed with brine, and concentrated in vacuo. The residue was purified by silica gel column chromatography. A mixture of the obtained compound and 10% palladium on carbon (600 mg, containing 50% water) in methanol (60 mL) was stirred at room temperature for 12 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by silica gel column chromatography afforded <b>3b</b> (1.42 g, 86%) as solid. Mp 93–95 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 259 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.69–1.96 (2H, m), 1.99 (3H, s), 2.23–2.50 (2H, m), 2.63 (3H, s), 2.89–3.15 (2H, m), 3.28–3.56 (3H, m), 5.54 (1H, brs), 7.15 (1H, d, <i>J</i> = 8.0 Hz), 7.44 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>: C, 69.74; H, 7.02; N, 10.84. Found: C, 69.77; H, 6.97; N, 10.95.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chiral Resolution of <b>3b</b></h3><div class="NLM_p last">The racemic <b>3b</b> (768 mg, 3.00 mmol) was fractionated by high-performance liquid chromatography (instrument: Prep LC 2000 (manufactured by Nihon Waters K.K.), column: CHIRALPAK AD (50 mm ID × 500 mmL, manufactured by Daicel Chemical Industries, Ltd.), mobile phase: hexane/ethanol/diethylamine = 90/10/0.1, flow rate: 60 mL/min, column temperature: 30 °C, sample concentration: 1.02 mg/mL, injection weight: 31 mg) to afford (<i>S</i>)-<b>3b</b> (retention time: 21.1 min, 381 mg, 99.9%ee) and (<i>R</i>)-<b>3b</b> (retention time: 24.6 min, 381 mg, 99.7%ee). Enantiomer excess (ee) was measured by high-performance liquid chromatography (column: CHIRALPAK AD (4.6 mm ID × 250 mmL, manufactured by Daicel Chemical Industries, Ltd.), mobile phase: hexane/ethanol/diethylamine = 90/10/0.1, flow rate: 0.5 mL/min, column temperature: 30 °C, sample concentration: 0.65 mg/mL (hexane/ethanol), injection volume: 10 μL).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>S</i>)-<i>N</i>-[2-(2-Methyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide ((<i>S</i>)-<b>3b</b>)</h3><div class="NLM_p last">A solid. [α]<sub>D</sub><sup>20</sup>: −53.4° (c 0.50, methanol). Mp 111–113 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 259 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.69–1.96 (2H, m), 1.98 (3H, s), 2.23–2.50 (2H, m), 2.63 (3H, s), 2.89–3.15 (2H, m), 3.28–3.56 (3H, m), 5.56 (1H, brs), 7.15 (1H, d, <i>J</i> = 8.0 Hz), 7.44 (1H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 14.6, 23.4, 31.9, 32.4, 34.1, 38.2, 41.0, 117.6, 120.41, 128.15, 140.56, 141.55, 147.56, 162.84, 169.97. Anal. Calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>: C, 69.74; H, 7.02; N, 10.84. Found: C, 69.53; H, 7.01; N, 10.96.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>R</i>)-<i>N</i>-[2-(2-Methyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide ((<i>R</i>)-<b>3b</b>)</h3><div class="NLM_p last">A solid. [α]<sub>D</sub><sup>20</sup>: +50.7° (c 0.51, methanol). Mp 111–113 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 259 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.69–1.96 (2H, m), 1.99 (3H, s), 2.23–2.50 (2H, m), 2.63 (3H, s), 2.89–3.15 (2H, m), 3.28–3.56 (3H, m), 5.54 (1H, brs), 7.15 (1H, d, <i>J</i> = 8.0 Hz), 7.44 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>: C, 69.74; H, 7.02; N, 10.84. Found: C, 69.61; H, 7.01; N, 10.89.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-[2-(2-Ethyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide (<b>3c</b>)</h3><div class="NLM_p last">To a stirred solution of <b>17</b> (100 mg, 0.369 mmol) in pyridine (4 mL) was added propionic anhydride (52.1 μL, 0.406 mmol) at 0 °C, and the mixture was stirred for 15 min. Water was added, and the mixture was concentrated in vacuo. Purification by silica gel column chromatography afforded <i>N</i>-{3-[2-(acetylamino)ethyl]-4-hydroxy-2,3-dihydro-1<i>H</i>-inden-5-yl}propanamide (94.5 mg, 88%). A mixture of <i>N</i>-{3-[2-(acetylamino)ethyl]-4-hydroxy-2,3-dihydro-1<i>H</i>-inden-5-yl}propanamide (88.5 mg, 0.305 mmol) and pyridinium <i>p</i>-toluenesulfonate (15.3 mg, 0.061 mmol) in xylene (3.1 mL) was stirred at reflux for 2.5 h. The solvent was concentrated in vacuo, and the residue was purified by silica gel column chromatography to afford the title compound <b>3c</b> (69.8 mg, 84%) as solid. Total of 74% from <b>17</b>. Mp 76–78 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 273 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.46 (3H, t, <i>J</i> = 7.7 Hz), 1.71–1.96 (2H, m), 1.98 (3H, s), 2.20–2.34 (1H, m), 2.36–2.51 (1H, m), 2.96 (2H, q, <i>J</i> = 7.7 Hz), 2.98–3.15 (2H, m), 3.28–3.41 (1H, m), 3.42–3.57 (2H, m), 5.54 (1 H, brs), 7.15 (1H, d, <i>J</i> = 8.0 Hz), 7.46 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>: C, 70.56; H, 7.40; N, 10.29. Found: C, 70.25; H, 7.35; N, 10.33.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-[2-(2-Cyclopropyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide (<b>3d</b>)</h3><div class="NLM_p last">By a similar procedure to that used for <b>3c</b>, <b>3d</b> (70%) was prepared from <b>17</b> and cyclopropylcarbonyl chloride as solid. Mp 92–95 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 285 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.10–1.20 (2H, m), 1.21–1.29 (2H, m), 1.69–1.93 (2H, m), 1.98 (3H, s), 2.11–2.30 (2H, m), 2.31–2.49 (1H, m), 2.84–3.16 (2H, m), 3.25–3.57 (3H, m), 5.73 (1H, brs), 7.11 (1H, d, <i>J</i> = 8.0 Hz), 7.38 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>17</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>: C, 71.81; H, 7.09; N, 9.85. Found: C, 71.69; H, 7.11; N, 9.79.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-[2-(2-Phenyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide (<b>3e</b>)</h3><div class="NLM_p last">By a similar procedure to that used for <b>3c</b>, <b>3e</b> (73%) was prepared from <b>17</b> and benzoyl chloride as solid. Mp 124–126 °C (recrystallized from ethyl acetate/diisopropyl ether). MS (ESI): <i>m</i>/<i>z</i> 321 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.76–1.97 (2H, m), 1.99 (3H, s), 2.31–2.57 (2H, m), 2.92–3.18 (2H, m), 3.37–3.66 (3H, m), 5.59 (1H, brs), 7.21 (1H, d, <i>J</i> = 8.0 Hz), 7.50–7.60 (4H, m), 8.20–8.27 (2H, m). Anal. Calcd for C<sub>20</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>: C, 74.98; H, 6.29; N, 8.74. Found: C, 74.86; H, 6.26; N, 8.83.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-[2-(2-Benzyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide (<b>3f</b>)</h3><div class="NLM_p last">By a similar procedure to that used for <b>3c</b>, <b>3f</b> (7%) was prepared from <b>17</b> and phenylacetyl chloride as solid. MS (ESI): <i>m</i>/<i>z</i> 335 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.73–1.91 (2H, m), 1.93 (3H, s), 2.07–2.21 (1H, m), 2.35–2.49 (1H, m), 2.87–3.14 (2H, m), 3.14–3.30 (1H, m), 3.37–3.52 (2H, m), 4.27 (2H, s), 5.45 (1H, brs), 7.15 (1H, d, <i>J</i> = 8.0 Hz), 7.26–7.40 (5H, m), 7.47 (1H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-[2-(2-Methoxy-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]acetamide (<b>3g</b>)</h3><div class="NLM_p last">A mixture of <b>17</b> (100 mg, 0.369 mmol) and tetramethoxymethane (151 mg, 1.11 mmol) in tetrahydrofuran (3.7 mL) was stirred at reflux for 2 h. The reaction mixture was diluted with ethyl acetate and saturated aqueous sodium hydrogencarbonate. The mixture was washed with brine, dried over anhydrous sodium sulfate, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>3g</b> (58.4 mg, 58%) as a solid. Mp 126–128 °C (recrystallized from ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 275 (M + H) <sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.72–1.94 (2H, m), 1.98 (3H, s), 2.13–2.29 (1H, m), 2.31–2.48 (1H, m), 2.85–3.12 (2H, m), 3.23–3.37 (1H, m), 3.37–3.55 (2H, m), 4.21 (3H, s), 5.57 (1H, brs), 7.09 (1H, d, <i>J</i> = 8.0 Hz), 7.29 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>: C, 65.68; H, 6.61; N, 10.21. Found: C, 65.56; H, 6.48; N, 10.22.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(2-{2-[(Benzyloxy)methyl]-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl}ethyl)acetamide (<b>3h</b>)</h3><div class="NLM_p last">By a similar procedure to that used for <b>3c</b>, <b>3h</b> (18%) was prepared from <b>17</b> and (benzyloxy)acetyl chloride as solid. MS (ESI): <i>m</i>/<i>z</i> 365 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.75–1.94 (2H, m), 1.95 (3H, s), 2.20–2.34 (1H, m), 2.37–2.51 (1H, m), 2.93–3.15 (2H, m), 3.24–3.38 (1H, m), 3.41–3.58 (2H, m), 4.70 (2H, s), 4.78 (2H, s), 5.62 (1H, brs), 7.21 (1H, d, <i>J</i> = 8.0 Hz), 7.28–7.42 (5H, m), 7.54 (1H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-{2-[2-(Hydroxymethyl)-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl]ethyl}acetamide (<b>3i</b>)</h3><div class="NLM_p last">A mixture of <b>3h</b> (50.0 mg, 0.131 mmol) and 10% palladium on carbon (100 mg, containing 50% water) in methanol (1 mL) was stirred at 50 °C for 24 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by silica gel column chromatography and recrystallization (ethyl acetate/hexane) afforded <b>3i</b> (19.0 mg, 53%) as solid. Mp 132–134 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 275 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.80–1.97 (2H, m), 1.99 (3H, s), 2.08–2.25 (1H, m), 2.36–2.51 (1H, m), 2.91–3.16 (2H, m), 3.33–3.61 (4H, m), 4.90 (2H, d, <i>J</i> = 5.5 Hz), 5.57 (1H, brs), 7.19 (1H, d, <i>J</i> = 8.0 Hz), 7.50 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>: C, 65.68; H, 6.61; N, 10.21. Found: C, 65.54; H, 6.63; N, 10.11.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-[2-(2-Methyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-yl)ethyl]propionamide (<b>3j</b>)</h3><div class="NLM_p last">A mixture of <b>11b</b> (21.0 mg, 0.0999 mmol) and Raney cobalt (200 mg, washed with water and ethanol before use) in 0.6 M ammonia ethanol solution (1 mL) was stirred at room temperature for 3 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. The residue was dissolved in tetrahydrofuran (1 mL), and triethylamine (18.1 μL, 0.13 mmol) and propionic anhydride (15.4 μL, 0.12 mmol) were added at 0 °C. After 15 min, saturated aqueous sodium hydrogencarbonate was added, and the mixture was extracted with ethyl acetate, washed with brine, and concentrated in vacuo. The residue was purified by silica gel column chromatography. A mixture of the obtained compound and 10% palladium on carbon (4.0 mg, containing 50% water) in methanol (1 mL) was stirred at room temperature for 20 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by silica gel column chromatography afforded <b>3j</b> (17.5 mg, 64%) as solid. Mp 111–113 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 273 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.16 (3H, t, <i>J</i> = 7.6 Hz), 1.70–1.98 (2H, m), 2.15–2.51 (4H, m), 2.63 (3H, s), 2.88–3.15 (2H, m), 3.28–3.56 (3H, m), 5.54 (1H, brs), 7.14 (1H, d, <i>J</i> = 7.7 Hz), 7.44 (1H, d, <i>J</i> = 7.7 Hz). Anal. Calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>: C, 70.56; H, 7.39; N, 10.28. Found: C, 70.14; H, 7.28; N, 10.23.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-[2-(2-Methyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]thiazol-8-yl)ethyl]acetamide (<b>4a</b>)</h3><div class="NLM_p last">To a stirred solution of <b>23</b> (1.66 g, 7.14 mmol) in tetrahydrofuran (70 mL) were added triethylamine (2.00 mL, 14.3 mmol) and acetic anhydride (810 μL, 8.57 mmol) at 0 °C. After 1 h, the reaction mixture was concentrated in vacuo, and the residue was purified by silica gel column chromatography to afford <b>4a</b> (1.83 g, 93%) as solid. Mp 115–116 °C (recrystallized from ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 275 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.60–1.80 (1H, m), 1.84–2.06 (4H, m), 2.14–2.30 (1H, m), 2.34–2.51 (1H, m), 2.82 (3H, s), 2.88–3.18 (2H, m), 3.24–3.51 (3H, m), 5.62 (1H, brs), 7.30 (1H, d, <i>J</i> = 8.2 Hz), 7.76 (1H, d, <i>J</i> = 8.2 Hz). Anal. Calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>OS: C, 65.66; H, 6.61; N, 10.21. Found: C, 65.59; H, 6.62; N, 10.17.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-[2-(2-Methyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]thiazol-8-yl)ethyl]propionamide (<b>4b</b>)</h3><div class="NLM_p last">To a stirred solution of <b>23</b> (100 mg, 0.430 mmol) in tetrahydrofuran (4 mL) were added triethylamine (120 μL, 0.861 mmol) and propionic anhydride (66.2 μL, 0.516 mmol) at 0 °C. After 1 h, the reaction mixture was concentrated in vacuo, and the residue was purified by silica gel column chromatography to afford <b>4b</b> (110 mg, 89%) as solid. Mp 122–123 °C (recrystallized from ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 289 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.13 (3H, d, <i>J</i> = 7.6 Hz), 1.67–1.81 (1H, m), 1.88–2.06 (1H, m), 2.09–2.29 (3H, m), 2.33–2.52 (1H, m), 2.82 (3H, s), 2.90–3.19 (2H, m), 3.26–3.51 (3H, m), 5.42 (1H, brs), 7.30 (1H, d, <i>J</i> = 8.2 Hz), 7.76 (1H, d, <i>J</i> = 8.2 Hz). Anal. Calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>OS: C, 66.63; H, 6.99; N, 9.71. Found: C, 66.62; H, 7.02; N, 9.66.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-[2-(2-Methyl-8,9-dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridin-9-yl)ethyl]acetamide (<b>5a</b>)</h3><div class="NLM_p last">A mixture of <b>28</b> (140 mg, 0.487 mmol) and 12 M hydrochloric acid (5 mL) was stirred at 100 °C for 2 days, and the reaction mixture was concentrated in vacuo. The residue was dissolved in tetrahydrofuran (5 mL), and triethylamine (1.36 mL, 9.76 mmol) and acetic anhydride (115 μL, 1.22 mmol) were added at 0 °C. After 15 min, the reaction solution was diluted with saturated aqueous sodium hydrogen carbonate and extracted with ethyl acetate. The extract was dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography and recrystallization (ethyl acetate/diisopropyl ether) afforded <b>5a</b> (56.6 mg, 45%) as solid. Mp 106–107 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 258 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.63–1.78 (1H, m), 1.88–2.03 (4H, m), 2.11–2.26 (1H, m), 2.33–2.45 (1H, m), 2.47 (3H, s), 2.78–3.07 (2H, m), 3.24–3.50 (3H, m), 5.43 (1H, brs), 6.15 (1H, s), 6.57 (1H, d, <i>J</i> = 7.2 Hz), 8.21 (1H, d, <i>J</i> = 7.2 Hz). Anal. Calcd for C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O: C, 70.01; H, 7.44; N, 16.33. Found: C, 69.67; H, 7.43; N, 16.38.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-[2-(1,2-Dimethyl-8,9-dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridin-9-yl)ethyl]acetamide (<b>5b</b>)</h3><div class="NLM_p last">To a stirred solution of <b>28</b> (75.0 mg, 0.261 mmol) in tetrahydrofuran (2.6 mL) was added 1.5 M diisobutylaluminum hydride in toluene (2.1 mL, 3.2 mmol) at room temperature, and the mixture was stirred for 3 h. Sodium sulfate decahydrate (2.1 g) was added, the mixture was filtered, and the filtrate was concentrated in vacuo. To a stirred solution of the residue and triethylamine (54.6 μL, 0.392 mmol) in tetrahydrofuran (2.5 mL) was added acetic anhydride (37.0 μL, 0.391 mmol) at 0 °C, and the mixture was stirred at room temperature for 30 min. After adding water (70 μL), the mixture was concentrated in vacuo. Purification by silica gel column chromatography and recrystallization (ethyl acetate/diisopropyl ether) afforded <b>5b</b> (24.4 mg, yield 34%) as solid. Mp 134–135 °C (recrystallized from ethyl acetate/diisopropyl ether). MS (ESI): <i>m</i>/<i>z</i> 272 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.49–1.68 (1H, m), 1.82–1.97 (4H, m), 2.01–2.14 (1H, m), 2.21–2.34 (4H, m), 2.37 (3H, s), 2.73–2.85 (1H, m), 2.89–3.04 (1H, m), 3.26–3.50 (2H, m), 3.51–3.62 (1H, m), 5.41 (1H, brs), 6.48 (1H, d, <i>J</i> = 6.9 Hz), 8.12 (1H, d, <i>J</i> = 6.9 Hz). Anal. Calcd for C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O: C, 70.82; H, 7.80; N, 15.49. Found: C, 70.52; H, 7.92; N, 15.30.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Ethyl 9-[2-(Acetylamino)ethyl]-2-methyl-8,9-dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridine-1-carboxylate (<b>5c</b>)</h3><div class="NLM_p last">To a stirred solution of <b>28</b> (50.0 mg, 0.174 mmol) and triethylamine (36.4 μL, 0.261 mmol) in tetrahydrofuran (2 mL) was added acetic anhydride (24.7 μL) at 0 °C, and the mixture was stirred at room temperature for 30 min. After adding water (50 μL), the mixture was concentrated in vacuo. Purification by silica gel column chromatography and recrystallization (diisopropyl ether) afforded <b>5c</b> (32.1 mg, yield 56%) as solid. Mp 101–103 °C (recrystallized from diisopropyl ether). MS (ESI): <i>m</i>/<i>z</i> 330 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.38–1.55 (4H, m), 1.77–1.92 (1H, m), 1.96–2.10 (4H, m), 2.14–2.36 (1H, m), 2.63 (3H, s), 2.82–2.93 (1H, m), 2.97–3.13 (1H, m), 3.25–3.36 (1H, m), 3.36–3.50 (1H, m), 4.16–4.26 (1H, m), 4.29–4.41 (2H, m), 6.81 (1H, d, <i>J</i> = 6.9 Hz), 7.21 (1H, brs), 8.25 (1H, d, <i>J</i> = 6.9 Hz). Anal. Calcd for C<sub>18</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>: C, 65.63; H, 7.04; N, 12.76. Found: C, 65.63; H, 7.09; N, 12.41.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-[2-(2-Methyl-8,9-dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridin-9-yl)ethyl]propionamide (<b>5d</b>)</h3><div class="NLM_p last">A mixture of <b>28</b> (333 mg, 1.16 mmol) and 40% sulfuric acid (6 mL) was stirred at 100 °C for 2 h. The reaction mixture was cooled to 0 °C, diluted with water, and neutralized with saturated aqueous sodium hydrogen carbonate. The mixture was extracted with ethyl acetate. The extract was dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo to afford 2-(2-methyl-8,9-dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridin-9-yl)ethanamine (239 mg, 96%). To a stirred solution of 2-(2-methyl-8,9-dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridin-9-yl)ethanamine (69.7 mg, 0.324 mmol) and triethylamine (90.3 μL, 0.648 mmol) in tetrahydrofuran (3 mL) was added propionic anhydride (49.9 μL, 0.389 mmol) at 0 °C. After 15 min, the reaction solution was diluted with saturated aqueous sodium hydrogen carbonate and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>5d</b> (66.8 mg, 76%) as solid. Total of 73% from <b>28</b>. Mp 100–102 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 272 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.10 (3H, t, <i>J</i> = 7.6 Hz), 1.62–1.77 (1H, m), 1.88–2.02 (1H, m), 2.07–2.25 (3H, m), 2.32–2.44 (1H, m), 2.46 (3H, s), 2.78–3.05 (2H, m), 3.22–3.48 (3H, m), 5.38 (1H, brs), 6.14 (1H, s), 6.57 (1H, d, <i>J</i> = 7.0 Hz), 8.20 (1H, d, <i>J</i> = 7.0 Hz). Anal. Calcd for C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O: C, 70.82; H, 7.80; N, 15.49. Found: C, 70.99; H, 7.90; N, 15.61.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-[2-(2-Methyl-2,6,7,8-tetrahydrocyclopenta[<i>e</i>]indazol-8-yl)ethyl]acetamide (<b>6a</b>)</h3><div class="NLM_p last">A mixture of <b>38a</b> (311 mg, 1.22 mmol) and 10% palladium on carbon (31 mg, containing 50% water) in methanol (12 mL) was stirred at room temperature for 3 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by silica gel column chromatography afforded <b>6a</b> (229 mg, 73%) as solid. Mp 123–125 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 258 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.64–1.85 (2H, m), 1.90 (3H, s), 2.16–2.29 (1H, m), 2.32–2.46 (1H, m), 2.82–3.10 (2H, m), 3.24–3.52 (3H, m), 4.20 (3H, s), 5.48 (1H, brs), 7.17 (1H, d, <i>J</i> = 8.7 Hz), 7.52 (1H, d, <i>J</i> = 8.7 Hz), 7.88 (1H, s). Anal. Calcd for C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O: C, C, 70.01; H, 7.44; N, 16.33. Found: C, 69.73; H, 7.43; N, 16.27.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[2-(2-Methyl-2,6,7,8-tetrahydrocyclopenta[<i>e</i>]indazol-8-yl)ethyl]propionamide (<b>6b</b>)</h3><div class="NLM_p last">A mixture of <b>38b</b> (83.0 mg, 1.22 mmol) and 10% palladium on carbon (8 mg, containing 50% water) in methanol (2 mL) was stirred at room temperature for 3 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by thin layer chromatography afforded <b>6b</b> (45.1 mg, 74%) as solid. Mp 105–107 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 272 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.11 (3H, t, <i>J</i> = 7.4 Hz), 1.67–1.82 (1H, m), 1.82–1.97 (1H, m), 2.11 (2H, q, <i>J</i> = 7.4 Hz), 2.17–2.31 (1H, m), 2.33–2.48 (1H, m), 2.84–3.11 (2H, m), 3.28–3.53 (3H, m), 4.21 (3H, s), 5.38 (1H, brs), 7.17 (1H, d, <i>J</i> = 8.8 Hz), 7.52 (1H, d, <i>J</i> = 8.8 Hz), 7.88 (1H, s). Anal. Calcd for C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O: C, C, 70.82; H, 7.80; N, 15.49. Found: C, 70.54; H, 7.78; N, 15.52.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-Bromo-7-hydroxy-6-nitroindan-1-one (<b>8</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>7</b><sup>29</sup> (3.06 g, 13.5 mmol) in acetic acid (20 mL) was added a solution of acetic anhydride (1.66 mL, 17.6 mmol) and fuming nitric acid (838 μL, 20.2 mmol) in acetic acid (10 mL) at room temperature. After 3 h, the reaction mixture was evaporated in vacuo, and the resulting solid was collected by filtration to afford <b>8</b> (2.98 g, 79%) as solid. Mp 149–151 °C (recrystallized from methanol). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.83–2.92 (2H, m), 3.08–3.16 (2H, m), 8.50 (1H, s), 10.99 (1H, s). Anal. Calcd for C<sub>9</sub>H<sub>6</sub>BrNO<sub>4</sub>: C, 39.73; H, 2.22; N, 5.14. Found: C, 39.88; H, 2.40; N, 5.37.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-Amino-7-hydroxyindan-1-one hydrobromide (<b>9</b>)</h3><div class="NLM_p last">A mixture of <b>8</b> (2.90 g, 10.7 mmol) and 10% palladium on carbon (290 mg, containing 50% water) in methanol (53 mL) was stirred at room temperature for 6 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo to afford <b>9</b> (2.08 g, yield 80%) as solid. <sup>1</sup>H NMR (METHANOL-<i>d<sub>4</sub></i>) δ 2.69–2.82 (2H, m), 3.12–3.21 (2H, m), 7.13 (1H, d, <i>J</i> = 8.0 Hz), 7.57 (1H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6,7-Dihydro-8<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-one (<b>10a</b>)</h3><div class="NLM_p last">A mixture of <b>9</b> (50.0 mg, 0.205 mmol) and triethyl orthoformate (128 μL, 0.769 mmol) in tetrahydrofuran (2.5 mL) was stirred at reflux for 0.5 h. The reaction mixture was diluted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>10a</b> (21.9 mg, 62%) as solid. Mp 188–190 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 174 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.80–2.87 (2H, m), 3.29–3.36 (2H, m), 7.48 (1H, d, <i>J</i> = 8.2 Hz), 8.02 (1H, d, <i>J</i> = 8.2 Hz), 8.19 (1H, s). Anal. Calcd for C<sub>10</sub>H<sub>7</sub>NO<sub>2</sub>: C, 69.36; H, 4.07; N, 8.09. Found: C, 69.04; H, 4.02; N, 8.14.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-Methyl-6,7-dihydro-8<i>H-</i>indeno[5,4-<i>d</i>][1,3]oxazol-8-one (<b>10b</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>9</b> (800 mg, 3.28 mmol) in tetrahydrofuran (20 mL) were added triethylamine (571 μL, 4.10 mmol) and acetic anhydride (387 μL, 4.10 mmol) at room temperature. After 1.5 h, saturated aqueous sodium hydrogencarbonate was added. The mixture was extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <i>N</i>-(4-hydroxy-3-oxo-2,3-dihydro-1<i>H</i>-inden-5-yl)acetamide (481 mg, 71%). A mixture of <i>N</i>-(4-hydroxy-3-oxo-2,3-dihydro-1<i>H</i>-inden-5-yl)acetamide (469 mg, 2.29 mmol) and pyridinium <i>p</i>-toluenesulfonate (115 mg, 0.457 mmol) in xylene (23 mL) was stirred at reflux for 2.5 h. The reaction mixture was concentrated in vacuo, and the residue was purified by silica gel column chromatography to afford <b>10b</b> (363 mg, 85%) as solid. Mp 106–107 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 188 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.71 (3H, s), 2.78–2.85 (2H, m), 3.24–3.33 (2H, m), 7.38 (1H, d, <i>J</i> = 8.0 Hz), 7.86 (1H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>E</i>)-(6,7-Dihydro-8<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-ylidene)acetonitrile (<b>11a</b>)</h3><div class="NLM_p last">To a stirred suspension of 60% sodium hydride (in mineral oil, 73.4 mg, 1.84 mmol) in tetrahydrofuran (8 mL) was added diethyl cyanomethylphosphonate (322 μL, 1.99 mmol) at 0 °C, and the mixture was stirred for 15 min. A solution of <b>10a</b> (265 mg, 1.53 mmol) in tetrahydrofuran (8 mL) was added, and the mixture was stirred for 30 min. Saturated aqueous ammonium chloride was added, and the mixture was extracted with ethyl acetate. The extract was washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>11a</b> (220 mg, 73%) as solid. The Z form was removed by column chromatography. Mp 166–168 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 197 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.16–3.37 (4H, m), 6.07 (1H, t, <i>J</i> = 2.5 Hz), 7.36 (1H, d, <i>J</i> = 8.2 Hz), 7.81 (1H, d, <i>J</i> = 8.2 Hz), 8.15 (1H, s). Anal. Calcd for C<sub>12</sub>H<sub>8</sub>N<sub>2</sub>O: C, 73.46; H, 4.11; N, 14.28. Found: C, 73.44; H, 4.05; N, 14.49.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>E</i>)-(2-Methyl-6,7-dihydro-8<i>H</i>-indeno[5,4-<i>d</i>][1,3]oxazol-8-ylidene)acetonitrile (<b>11b</b>)</h3><div class="NLM_p last">To a stirred suspension of 60% sodium hydride (in mineral oil, 90.0 mg, 2.24 mmol) in tetrahydrofuran (9 mL) was added diethyl cyanomethylphosphonate (393 μL, 2.43 mmol) at 0 °C, and the mixture was stirred for 15 min. A solution of <b>10b</b> (350 mg, 1.87 mmol) in tetrahydrofuran (9 mL) was added, and the mixture was stirred for 1 h. Saturated aqueous ammonium chloride was added, and the mixture was extracted with ethyl acetate. The extract was washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>11b</b> (300 mg, 76%) as solid. The Z form was removed by column chromatography. Mp 180–182 °C (recrystallized from ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 211 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.70 (3H, s), 3.15–3.31 (4H, m), 6.04 (1H, t, <i>J</i> = 2.6 Hz), 7.28 (1H, d, <i>J</i> = 8.0 Hz), 7.67 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>13</sub>H<sub>10</sub>N<sub>2</sub>O: C, 74.27; H, 4.79; N, 13.33. Found: C, 74.22; H, 4.75; N, 13.16.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-Bromo-7-methoxy-6-nitroindan-1-one (<b>12</b>)</h3><div class="NLM_p last">To a stirred solution of <b>8</b> (8.07 g, 29.7 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (5.33 mL, 35.6 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (150 mL) was added iodomethane (18.5 mL, 297 mmol) at room temperature. After 40 h, saturated aqueous sodium hydrogencarbonate was added. The mixture was extracted with diethyl ether, washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>12</b> (6.70 g, 79%) as solid. Mp 138–139 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 286 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.78–2.86 (2H, m), 3.07–3.15 (2H, m), 4.13 (3H, s), 8.16 (1H, s). Anal. Calcd for C<sub>10</sub>H<sub>8</sub>NO<sub>4</sub>Br: C, 41.98; H, 2.82; N, 4.90. Found: C, 41.98; H, 2.76; N, 4.82.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>E</i>)-(4-Bromo-7-methoxy-6-nitro-2,3-dihydro-1<i>H</i>-inden-1-ylidene)acetonitrile (<b>13</b>)</h3><div class="NLM_p last">To a stirred suspension of 60% sodium hydride (in mineral oil, 1.03 g, 25.6 mmol) in tetrahydrofuran (100 mL) was added diethyl cyanomethylphosphonate (4.52 mL, 28.0 mmol) at 0 °C, and the mixture was stirred for 15 min. A solution of <b>12</b> (6.67 g, 23.3 mmol) in tetrahydrofuran (50 mL) was added, and the mixture was stirred for 30 min. Saturated aqueous ammonium chloride was added, and the mixture was extracted with ethyl acetate. The extract was washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>13</b> (5.54 g, 77%) as solid. Mp 156–158 °C (recrystallized from ethyl acetate/hexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.09–3.25 (4H, m), 3.94 (3H, s), 6.27 (1H, t, <i>J</i> = 2.6 Hz), 8.03 (1H, s). Anal. Calcd for C<sub>12</sub>H<sub>9</sub>N<sub>2</sub>O<sub>3</sub>Br: C, 46.63; H, 2.93; N, 9.06. Found: C, 46.66; H, 2.86; N, 9.09.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>E</i>)-(6-Amino-7-methoxy-2,3-dihydro-1<i>H</i>-inden-1-ylidene)acetonitrile (<b>14</b>)</h3><div class="NLM_p last">A mixture of <b>13</b> (47.0 mg, 0.152 mmol), triethylamine (22.3 μL, 0.160 mmol), and 10% palladium on carbon (10 mg, containing 50% water) in ethyl acetate (1.5 mL) was stirred at room temperature for 1.5 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo to afford <b>14</b> (30.4 mg, 100%) as solid. Mp 140–142 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 201 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.94–3.01 (2H, m), 3.04–3.11 (2H, m), 3.76 (3H, s), 3.78 (2H, brs), 6.11 (1H, t, <i>J</i> = 2.6 Hz), 6.81 (1H, d, <i>J</i> = 8.0 Hz), 6.91 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>O: C, 71.98; H, 6.04; N, 13.99. Found: C, 71.60; H, 6.14; N, 13.94.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>E</i>)-<i>N</i>-[2-(6-Amino-7-methoxy-2,3-dihydro-1<i>H</i>-inden-1-ylidene)ethyl]acetamide (<b>15</b>)</h3><div class="NLM_p last">A mixture of <b>14</b> (15.2 mg, 0.076 mmol) and Raney cobalt (150 mg, washed with water and ethanol before use) in 1 M ammonia ethanol solution (1 mL) was stirred at room temperature for 2 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. The residue and triethylamine (21.2 μL, 0.152 mmol) were dissolved in tetrahydrofuran (0.9 mL), and a solution of acetic anhydride (7.18 μL, 0.076 mmol) in tetrahydrofuran (0.1 mL) was added at 0 °C. After 15 min, saturated aqueous sodium hydrogencarbonate was added, and the mixture was extracted with ethyl acetate, washed with brine, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>15</b> (16.2 mg, 87%) as solid. Mp 105–107 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 247 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.01 (3H, s), 2.70–2.80 (2H, m), 2.85–2.96 (2H, m), 3.75 (3H, s), 4.01–4.09 (2H, m), 5.52 (1H, brs), 6.25–6.33 (1H, m), 6.65 (1H, d, <i>J</i> = 8.0 Hz), 6.82 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>: C, 68.27; H, 7.37; N, 11.37. Found: C, 67.93; H, 7.25; N, 11.10.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-[2-(6-Amino-7-methoxy-2,3-dihydro-1<i>H</i>-inden-1-yl)ethyl]acetamide (<b>16</b>)</h3><div class="NLM_p last">A mixture of <b>15</b> (2.62 g, 10.7 mmol) and 10% palladium on carbon (500 mg, containing 50% water) in methanol (50 mL) was stirred at room temperature for 5 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo to afford <b>16</b> (2.56 g, 96%) as solid. Mp 130–132 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 249 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.68–1.93 (3H, m), 1.95 (3H, s), 2.16–2.31 (1H, m), 2.65–2.79 (1H, m), 2.81–2.96 (1H, m), 3.09–3.24 (1H, m), 3.28–3.50 (2H, m), 3.79 (3H, s), 3.91 (2H, brs), 5.71 (1H, brs), 6.60 (1H, d, <i>J</i> = 8.0 Hz), 6.78 (1H, d, <i>J</i> = 8.0 Hz). Anal. Calcd for C<sub>14</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>: C, 67.71; H, 8.12; N, 11.28. Found: C, 67.56; H, 8.01; N, 11.27.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-[2-(6-Amino-7-hydroxy-2,3-dihydro-1<i>H</i>-inden-1-yl)ethyl]acetamide hydrochloride (<b>17</b>)</h3><div class="NLM_p last">To a stirred solution of <b>16</b> (2.56 g, 10.3 mmol) in dichloromethane (80 mL) was added a solution of boron tribromide in dichloromethane (1 M, 22.7 mL, 22.7 mmol) at 0 °C, and the mixture was stirred at room temperature for 1.5 h. Water was added, and the mixture was diluted with ethyl acetate. The extract was washed with saturated aqueous sodium hydrogencarbonate and brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. The residue was dissolved in dichloromethane (80 mL), and a solution of boron tribromide in dichloromethane (1 M, 22.7 mL, 22.7 mmol) was added at 0 °C. The mixture was stirred at room temperature for 1.5 h, and then water was added. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogencarbonate and brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. The residue was dissolved in ethyl acetate, and 4 M HCl ethyl acetate solution was added at room temperature. The solvent was removed in vacuo to afford <b>17</b> (2.51 g, 90%). MS (ESI): <i>m</i>/<i>z</i> 235 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>) δ 1.31–1.46 (1H, m), 1.68–1.86 (3H, m), 1.80 (3H, s), 1.99–2.14 (1H, m), 2.64–2.77 (1H, m), 2.80–2.95 (1H, m), 3.04–3.13 (1H, m), 3.37–3.50 (1H, m), 6.74 (1H, d, <i>J</i> = 8.0 Hz), 7.13 (1H, d, <i>J</i> = 8.0 Hz), 8.09 (1H, brs), 9.87 (3H, brs), 10.14 (1H, brs).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 6-Amino-7-iodoindan-1-one (<b>19</b>)</h3><div class="NLM_p last">To a stirred solution of <b>18</b><sup>34</sup> (5.00 g, 34.0 mmol) in methanol (200 mL) and water (50 mL) were added calcium carbonate (6.81 g, 68.0 mmol) and iodine(I) chloride (2.22 mL, 44.2 mmol), and the mixture was stirred at room temperature for 2 h. Saturated aqueous sodium thiosulfate was added and concentrated in vacuo. To the mixture was added saturated aqueous sodium hydrogencarbonate. The mixture was extracted with ethyl acetate, washed with brine, and concentrated in vacuo. The residue was washed with methanol and ethyl acetate to afford <b>19</b> (7.95 g, 86%) as solid. Mp 183–186 °C (recrystallized from ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 274 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>) δ 2.56–2.66 (2H, m), 2.78–2.87 (2H, m), 5.48 (2H, s), 7.08 (1H, d, <i>J</i> = 8.2 Hz), 7.25 (1H, d, <i>J</i> = 8.2 Hz). Anal. Calcd for C<sub>9</sub>H<sub>8</sub>NOI: C, 39.59; H, 2.95; N, 5.13. Found: C, 39.65; H, 2.87; N, 5.07.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-Methyl-6,7-dihydro-8<i>H</i>-indeno[5,4-<i>d</i>][1,3]thiazol-8-one (<b>20</b>)</h3><div class="NLM_p last">A mixture of <b>19</b> (1.00 g, 3.66 mmol), thioacetamide (413 mg, 5.49 mmol), 1,1′-bis(diphenylphosphino)ferrocene (383 mg, 1.46 mmol), calcium oxide (411 mg, 7.32 mmol), and tris(dibenzylideneacetone)dipalladium(0) (335 mg, 0.37 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (12 mL) was stirred at 60 °C for 1 h. After cooling to room temperature, water was added. The mixture was extracted with ethyl acetate, washed with brine, and concentrated in vacuo. Purification by silica gel column chromatography and NH silica gel column chromatography afforded <b>20</b> (340 mg, 46%) as solid. Mp 163–165 °C (recrystallized from ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 204 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.80–2.86 (2H, m), 2.90 (3H, s), 3.27–3.33 (2H, m), 7.54 (1H, d, <i>J</i> = 8.2 Hz), 8.15 (1H, d, <i>J</i> = 8.2 Hz). Anal. Calcd for C<sub>11</sub>H<sub>9</sub>NOS: C, 65.00; H, 4.46; N, 6.89. Found: C, 65.00; H, 4.29; N, 6.94.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>E</i>)-2-(2-Methyl-6,7-dihydro-8<i>H</i>-indeno[5,4-<i>d</i>][1,3]thiazol-8-ylidene)acetonitrile (<b>21</b>)</h3><div class="NLM_p last">To a stirred solution of diethyl cyanomethylphosphonate (348 μL, 2.22 mmol) in tetrahydrofuran (6 mL) was added 65% sodium hydride (in mineral oil, 66.0 mg, 1.79 mmol) at 0 °C. After 30 min, a solution of <b>20</b> (300 mg, 1.48 mmol) in tetrahydrofuran (6 mL) was added. After 2 h, 65% sodium hydride (in mineral oil, 16.0 mg, 0.43 mmol) and diethyl cyanomethylphosphonate (116 μL, 0.74 mmol) were added. After 30 min, saturated aqueous ammonium chloride was added, and the mixture was extracted with ethyl acetate. The extract was washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>21</b> (181 mg, 54%) as solid. Mp 194–195 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 227 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.91 (3H, s), 3.27 (4H, s), 5.60–5.63 (1H, m), 7.46 (1H, d, <i>J</i> = 8.2 Hz), 8.01 (1H, d, <i>J</i> = 8.2 Hz). Anal. Calcd for C<sub>13</sub>H<sub>10</sub>N<sub>2</sub>S: C, 69.00; H, 4.45; N, 12.38. Found: C, 68.76; H, 4.19; N, 12.40.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>E</i>)-2-(2-Methyl-6,7-dihydro-8<i>H</i>-indeno[5,4-<i>d</i>][1,3]thiazol-8-ylidene)ethanamine (<b>22</b>)</h3><div class="NLM_p last">A mixture of <b>21</b> (2.50 g, 11.0 mmol) and Raney cobalt (25 g, washed with water and ethanol before use) in 2 M ammonia ethanol solution (110 mL) was stirred at room temperature for 3 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo to afford <b>22</b> (2.47 g, 97%). Mp 145–147 °C (recrystallized from methanol/ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 231 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 2.79–2.94 (5H, m), 3.10–3.22 (2H, m), 3.57 (2H, d, <i>J</i> = 6.8 Hz), 5.89–6.04 (1H, m), 7.36 (1H, d, <i>J</i> = 8.0 Hz), 7.83 (1H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-(2-Methyl-7,8-dihydro-6<i>H</i>-indeno[5,4-<i>d</i>][1,3]thiazol-8-yl)ethanamine (<b>23</b>)</h3><div class="NLM_p last">A mixture of <b>22</b> (2.09 g, 9.07 mmol) and 10% palladium on carbon (100 mg, containing 50% water) in methanol (90 mL) was stirred at room temperature for 16 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by silica gel column chromatography afforded <b>23</b> (2.04 g, 97%). MS (ESI): <i>m</i>/<i>z</i> 233 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ:1.58–1.75 (1H, m), 1.84–2.00 (1H, m), 2.07–2.23 (1H, m), 2.30–2.47 (1H, m), 2.73–2.89 (2H, m), 2.83 (3H, s), 2.89–3.16 (2H, m), 3.33–3.47 (1H, m), 7.30 (1H, d, <i>J</i> = 8.2 Hz), 7.75 (1H, d, <i>J</i> = 8.3 Hz).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5,6-Dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyridin-7-one (<b>25</b>)</h3><div class="NLM_p last">To a stirred suspension of 60% sodium hydride (in mineral oil, 7.80 g, 200 mmol) in tetrahydrofuran (84 mL) was added a solution of <b>24</b><sup>36</sup> (10.0 g, 42.1 mmol) in tetrahydrofuran (84 mL) and methanol (84 μL) at room temperature, and the mixture was refluxed for 3 h. The reaction mixture was concentrated in vacuo after cooling, and the residue was added portionwise to 12 M hydrochloric acid (42 mL) at 0 °C. The mixture was refluxed for 30 min. After cooling, the reaction solution was alkalified with saturated aqueous sodium hydrogen carbonate. The resultant mixture was filtered and extracted with ethyl acetate. The extract was dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. The residue was washed with hexane to afford <b>25</b> (4.39 g, yield 78%) as solid. MS (ESI): <i>m</i>/<i>z</i> 134 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.66–2.76 (2H, m), 3.14–3.23 (2H, m), 7.42–7.50 (1H, m), 8.71 (1H, d, <i>J</i> = 5.2 Hz), 9.00 (1H, d, <i>J</i> = 0.8 Hz).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 6,7-Dihydro-5<i>H</i>-cyclopenta[<i>c</i>]pyridin-7-ylacetonitrile (<b>26</b>)</h3><div class="NLM_p last">To a stirred solution of diethyl cyanomethylphosphonate (306 μL, 1.95 mmol) in tetrahydrofuran (10 mL) was added 60% sodium hydride (in mineral oil, 54.0 mg, 1.35 mmol) at 0 °C, and the mixture was stirred for 30 min. The mixture was added to a solution of <b>25</b> (130 mg, 0.976 mmol) in tetrahydrofuran (5 mL) at 0 °C, and the mixture was stirred for 15 min. The reaction solution was diluted with saturated aqueous sodium hydrogen carbonate, and the mixture was extracted with ethyl acetate. The extract was dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. The residue was purified by silica gel column chromatography. A mixture of the purified compound and 10% palladium on carbon (30 mg, containing 50% water) in methanol (10 mL) was stirred at room temperature for 4 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by silica gel column chromatography afforded <b>26</b> (95.0 mg, 62%) as solid. MS (ESI): <i>m</i>/<i>z</i> 159 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.87–2.03 (1H, m), 2.42–3.14 (5H, m), 3.53–3.66 (1H, m), 7.22 (1H, dd, <i>J</i> = 4.9, 0.8 Hz), 8.46 (1H, d, <i>J</i> = 4.9 Hz), 8.55 (1H, s).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Ethyl 9-(Cyanomethyl)-2-methyl-8,9-dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridine-1-carboxylate (<b>27a</b>) and Ethyl 7-(Cyanomethyl)-2-methyl-6,7-dihydro-5H-cyclopenta[<i>d</i>]pyrazolo[1,5-<i>a</i>]pyridine-3-carboxylate (<b>27b</b>)</h3><div class="NLM_p last">To a solution of <b>26</b> (90.0 mg, 0.569 mmol) in acetonitrile (1.0 mL) was added 1-(aminooxy)-2,4-dinitrobenzene (113 mg, 0.567 mmol), and the mixture was stirred at 40 °C for 12 h. The solvent was concentrated in vacuo, and the residue was dissolved in <i>N</i>,<i>N</i>-dimethylformamide (1.0 mL). To the mixture, ethyl 2-butynoate (80.0 μL, 0.686 mmol) and potassium carbonate (94.4 mg, 0.683 mmol) were added, and the mixture was stirred at room temperature for 4 h. The reaction solution was diluted with water and extracted with ethyl acetate. The extract was dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded less polar <b>27a</b> (51.2 mg, 32%) as solid and polar <b>27b</b> (20.2 mg, 13%) as solid. <b>27a</b>: Mp 136–140 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 284 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.42 (3H, t, <i>J</i> = 7.2 Hz), 2.18–2.31 (1H, m), 2.42–2.66 (5H, m), 2.76–2.86 (1H, m), 2.90–3.02 (1H, m), 3.20–3.36 (1H, m), 4.36 (2H, q, <i>J</i> = 7.2 Hz), 4.44–4.56 (1H, m), 6.84 (1H, d, <i>J</i> = 6.8 Hz), 8.31 (1H, d, <i>J</i> = 6.8 Hz). Anal. Calcd for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>: C, 67.83; H, 6.05; N, 14.83. Found: C, 67.68; H, 6.01; N, 14.86. <b>27b</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.42 (3H, t, <i>J</i> = 7.1 Hz), 1.93–2.09 (1H, m), 2.47–2.79 (6H, m), 2.93–3.20 (2H, m), 3.56–3.66 (1H, m), 4.38 (2H, q, <i>J</i> = 7.1 Hz), 7.91–7.94 (1H, m), 8.36 (1H, s).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Ethyl 9-(2-Aminoethyl)-2-methyl-8,9-dihydro-7<i>H</i>-cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridine-1-carboxylate (<b>28</b>)</h3><div class="NLM_p last">A mixture of <b>27a</b> (145 mg, 0.512 mmol) and Raney cobalt (1.5 g, washed with water and ethanol before use) in 2.0 M ammonia ethanol solution (50 mL) was stirred at room temperature for 14 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo to afford <b>28</b> (145 mg, 99%) as oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.41 (3H, t, <i>J</i> = 7.0 Hz), 1.63–2.41 (6H, m), 2.63 (3H, s), 2.80–3.11 (2H, m), 4.14–4.42 (3H, m), 6.78 (1H, d, <i>J</i> = 6.6 Hz), 8.23 (1H, d, <i>J</i> = 6.6 Hz). MS (ESI+): 288 (M + H).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Methyl 3-Amino-6-bromo-2-methylbenzoate (<b>30</b>)</h3><div class="NLM_p last">To a stirred solution of <b>29</b> (10.0 g, 60.5 mmol) in acetonitrile (50 mL) was added <i>N</i>-bromosuccimide (10.8 g, 60.5 mmol) portionwise over 20 min at 0 °C. After the addition was completed, the reaction mixture was concentrated in vacuo and diisopropylether (50 mL) was added. The mixture was filtrated, and the filtrate was concentrated in vacuo. Purification by silica gel column chromatography afforded <b>30</b> as oil (14.4 g, 97%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.08 (3H, s), 3.70 (2H, brs), 3.94 (3H, s), 6.58 (1H, d, <i>J</i> = 8.5 Hz), 7.18 (1H, d, <i>J</i> = 8.5 Hz).</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Methyl 5-Bromo-1<i>H</i>-indazole-4-carboxylate (<b>31</b>)</h3><div class="NLM_p last">To a stirred solution of <b>30</b> (5.44 g, 22.3 mmol) in acetic acid (110 mL) was added a solution of sodium nitrite (1.69 g, 24.5 mmol) in water (11 mL) at room temperature. After 20 h, the organic solvent was concentrated in vacuo. The residual aqueous solution was diluted with saturated aqueous sodium hydrogen carbonate, and the mixture was extracted with ethyl acetate. The extract was washed with saturated brine, dried over anhydrous sodium sulfate, filtrated, and evaporated. Purification by NH silica gel column chromatography afforded <b>31</b> (4.86 g, yield 86%) as solid. Mp 164–165 °C (recrystallized from ethyl acetate). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 4.06 (3H, s), 7.48 (1H, dd, <i>J</i> = 8.8, 1.1 Hz), 7.63 (1H, d, <i>J</i> = 8.8 Hz), 8.26 (1H, d, <i>J</i> = 1.1 Hz), 10.59 (1H, brs).</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Methyl 5-Bromo-2-methyl-2<i>H</i>-indazole-4-carboxylate (<b>32</b>)</h3><div class="NLM_p last">To a stirred solution of <b>31</b> (4.50 g, 17.6 mmol) in ethyl acetate (176 mL) was added trimethyloxonium tetrafluoroborate (3.38 g, 22.9 mmol) at room temperature. After 2.5 h, the reaction solution was diluted with saturated aqueous sodium hydrogen carbonate and extracted with ethyl acetate. The extract was washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>32</b> (3.42 g, yield 73%) as solid. Mp 103–104 °C (recrystallized from ethyl acetate/hexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 4.01 (3H, s), 4.22 (3H, s), 7.49 (1H, d, <i>J</i> = 9.1 Hz), 7.66 (1H, dd, <i>J</i> = 9.1, 0.8 Hz), 8.15 (1H, s). Anal. Calcd for C<sub>10</sub>H<sub>9</sub>N<sub>2</sub>O<sub>2</sub>Br: C, 44.63; H, 3.37; N, 10.41. Found: C, 44.69; H, 3.30; N, 10.50.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl 5-[3-Methoxy-3-oxoprop-1-en-1-yl]-2-methyl-2<i>H</i>-indazole-4-carboxylate (<b>33</b>)</h3><div class="NLM_p last">A suspension of <b>32</b> (1.65 g, 6.18 mmol), palladium acetate (139 mg, 0.62 mmol), triphenylphosphine (325 mg, 1.24 mmol), potassium carbonate (1.28 g, 9.27 mmol), and methyl acrylate (834 μL, 9.27 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (60 mL) was stirred at 100 °C for 50 min. After cooling, the reaction mixture was diluted with water and extracted with ethyl acetate. The extract was washed with water and brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>33</b> (1.33 g, yield 78%) as solid. Mp 232–234 °C (recrystallized from ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 275 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.83 (3H, s), 4.03 (3H, s), 4.25 (3H, s), 6.39 (1H, d, <i>J</i> = 15.9 Hz), 7.54 (1H, d, <i>J</i> = 9.1 Hz), 7.85 (1H, d, <i>J</i> = 9.1 Hz), 8.28 (1H, s), 8.61 (1H, d, <i>J</i> = 15.9 Hz). Anal. Calcd for C<sub>14</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub>: C, 61.31; H, 5.14; N, 10.21. Found: C, 61.02; H, 5.13; N, 10.26.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Methyl 5-(3-Methoxy-3-oxopropyl)-2-methyl-2<i>H</i>-indazole-4-carboxylate (<b>34</b>)</h3><div class="NLM_p last">A mixture of <b>33</b> (1.02 g, 3.72 mmol) and 10% palladium on carbon (100 mg, containing 50% water) in methanol (40 mL) was stirred at room temperature for 12 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. Purification by silica gel column chromatography afforded <b>34</b> (813 mg, yield 79%) as oil. MS (ESI): <i>m</i>/<i>z</i> 277 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.61–2.74 (2H, m), 3.30–3.42 (2H, m), 3.67 (3H, s), 3.99 (3H, s), 4.23 (3H, s), 7.21 (1H, d, <i>J</i> = 8.0 Hz), 7.79 (1H, d, <i>J</i> = 8.0 Hz), 8.20 (1H, s),</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 2-Methyl-6,7-dihydrocyclopenta[<i>e</i>]indazol-8(2<i>H</i>)-one (<b>35</b>)</h3><div class="NLM_p last">To a stirred suspension of 60% sodium hydride (in mineral oil, 145 mg, 3.62 mmol) in tetrahydrofuran (10 mL) was added a solution of <b>34</b> (500 mg, 1.81 mmol) in tetrahydrofuran (10 mL) and methanol (1 drop), and the mixture was refluxed for 3 h. The reaction mixture was concentrated in vacuo, and the resulting solid was added portion wise to 12 M hydrochloric acid (5 mL) heated to 100 °C. After 4 h, the reaction solution was neutralized with 8 M aqueous sodium hydroxide after cooling, and the mixture was extracted with ethyl acetate. The extract was washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>35</b> (285 mg, yield 85%) as solid. Mp 162–164 °C (recrystallized from ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 187 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.65–2.80 (2H, m), 3.14–3.25 (2H, m), 4.25 (3H, s), 7.36 (1H, d, <i>J</i> = 8.9 Hz), 7.95 (1H, d, <i>J</i> = 8.9 Hz), 8.36 (1H, s). Anal. Calcd for C<sub>11</sub>H<sub>10</sub>N<sub>2</sub>O: C, 70.95; H, 5.41; N, 15.04. Found: C, 70.87; H, 5.37; N, 15.16.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>E</i>)-2-(2-Methyl-6,7-dihydrocyclopenta[<i>e</i>]indazol-8(2<i>H</i>)-ylidene)acetonitrile (<b>36</b>)</h3><div class="NLM_p last">To a stirred suspension of 60% sodium hydride (in mineral oil, 116 mg, 2.90 mmol) in tetrahydrofuran (8 mL) was added diethyl cyanomethylphosphonate (516 μL, 3.19 mmol) at room temperature, and the mixture was stirred for 30 min. A solution of <b>35</b> (180 mg, 0.97 mmol) in tetrahydrofuran (2 mL) was added, and the mixture was stirred at 50 °C for 30 min. Water was added, and the mixture was extracted with ethyl acetate. The extract was washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>36</b> (138 mg, 68%) as solid. The Z form was removed by column chromatography. Mp 189–192 °C (recrystallized from hexane/ethyl acetate). MS (ESI): <i>m</i>/<i>z</i> 210 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.16–3.21 (4H, m), 4.27 (3H, s), 5.53 (1H, s), 7.29 (1H, d, <i>J</i> = 8.9 Hz), 7.79 (1H, d, <i>J</i> = 8.9 Hz), 8.00 (1H, s). Anal. Calcd for C<sub>13</sub>H<sub>11</sub>N<sub>3</sub>: C, 74.62; H, 5.30; N, 20.08. Found: C, 74.48; H, 5.27; N, 20.16.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>E</i>)-2-(2-Methyl-6,7-dihydrocyclopenta[<i>e</i>]indazol-8(2<i>H</i>)-ylidene)ethanamine (<b>37</b>)</h3><div class="NLM_p last">A mixture of <b>36</b> (600 mg, 2.87 mmol) and Raney cobalt (6.0 g, washed with water and ethanol before use) in 1.0 M ammonia ethanol solution (28 mL) was stirred at room temperature for 3 h under hydrogen atmosphere. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo to afford <b>37</b> (614 mg, 99%) as solid. MS (ESI): <i>m</i>/<i>z</i> 214 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.77–2.89 (2H, m), 3.01–3.15 (2H, m), 3.55 (2H, d, <i>J</i> = 6.9 Hz), 4.23 (3H, s), 5.89–6.01 (1H, m), 7.20 (1H, d, <i>J</i> = 8.8 Hz), 7.57 (1H, d, <i>J</i> = 8.8 Hz), 8.11 (1H, s).</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (<i>E</i>)-<i>N</i>-[2-(2-Methyl-6,7-dihydrocyclopenta[<i>e</i>]indazol-8(2<i>H</i>)-ylidene)ethyl]acetamide (<b>38a</b>)</h3><div class="NLM_p last">To a stirred solution of <b>37</b> (400 mg, 1.88 mmol) in tetrahydrofuran (19 mL) were added triethylamine (287 μL, 2.06 mmol) and acetic anhydride (195 μL, 2.06 mmol) at 0 °C. After 15 min, saturated aqueous sodium hydrogencarbonate was added, and the mixture was extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtrated, and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>38a</b> (393 mg, 82%) as solid. Mp 200–202 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 256 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.03 (3H, s), 2.81–2.93 (2H, m), 3.05–3.13 (2H, m), 4.06–4.15 (2H, m), 4.23 (3H, s), 5.62 (1H, brs), 5.81–5.91 (1H, m), 7.20 (1H, d, <i>J</i> = 8.8 Hz), 7.60 (1H, d, <i>J</i> = 8.8 Hz), 8.06 (1H, s). Anal. Calcd for C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O: C, 70.56; H, 6.71; N, 16.46. Found: C, 70.20; H, 6.78; N, 16.41.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (<i>E</i>)-<i>N</i>-[2-(2-Methyl-6,7-dihydrocyclopenta[<i>e</i>]indazol-8(2<i>H</i>)-ylidene)ethyl]propionamide (<b>38b</b>)</h3><div class="NLM_p last">To a stirred solution of <b>37</b> (100 mg, 0.469 mmol) in tetrahydrofuran (4.7 mL) were added triethylamine (72.0 μL, 0.516 mmol) and propionic anhydride (66.2 μL, 0.516 mmol) at 0 °C. After 15 min, saturated aqueous sodium hydrogencarbonate was added and concentrated in vacuo. Purification by silica gel column chromatography afforded <b>38b</b> (108 mg, 85%) as solid. Mp 185–187 °C (recrystallized from ethyl acetate/hexane). MS (ESI): <i>m</i>/<i>z</i> 270 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.20 (3H, t, <i>J</i> = 7.4 Hz), 2.25 (2H, q, <i>J</i> = 7.4 Hz), 2.81–2.94 (2H, m), 3.04–3.15 (2H, m), 4.05–4.16 (2H, m), 4.23 (3H, s), 5.56 (1H, brs), 5.81–5.92 (1H, m), 7.20 (1H, d, <i>J</i> = 8.8 Hz), 7.60 (1H, d, <i>J</i> = 8.8 Hz), 8.07 (1H, s). Anal. Calcd for C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O: C, 71.35; H, 7.11; N, 15.60. Found: C, 71.29; H, 7.04; N, 15.69.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Preparation of CHO Membrane for Melatonin Receptor (MT<sub>1</sub> or MT<sub>2</sub>) Binding Assays</h3><div class="NLM_p last">Cell lines stably expressing human MT<sub>1</sub> receptor (hMT<sub>1</sub>-CHO/binding, cell line: TPCCB0117) or human MT<sub>2</sub> receptor (hMT<sub>2</sub>-CHO, cell line: TPCCB0098) were used for the experiments. hMT<sub>1</sub>-CHO/binding cells and hMT<sub>2</sub>-CHO cells were cultured in F-12 Nutrient Mixture (Ham) supplemented with 10% fetal bovine serum (FBS) and 500 μg/mL of Geneticin, 100 U/mL penicillin, and 100 μg/mL streptomycin in a 5% CO<sub>2</sub>/95% air atmosphere. Cells were harvested at confluence in Ca<sup>2+</sup>–Mg<sup>2+</sup>-free phosphate buffered saline (PBS) containing 0.5 mM ethylenediaminetetraacetic acid (EDTA) and collected by centrifugation. Cells were washed with PBS, pelleted, and homogenized in ice-cold 10 mM NaHCO<sub>3</sub> buffer (pH 7.4 at 25 °C) containing 5 mM EDTA and 1× Complete proteinase inhibitor (Roche). Cell homogenates were centrifuged (1000<i>g</i>, 10 min, 4 °C). The supernatant was collected by centrifugation (140,000<i>g</i>, 60 min, 4 °C). Pellets were resuspended in ice-cold Tris–HCl buffer (pH 7.4 at 25 °C) containing 1 mM EDTA and 1× Complete proteinase inhibitor and stored at −80 °C until binding assays.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Affinity for the Human MT<sub>1</sub> and MT<sub>2</sub> Receptors</h3><div class="NLM_p last">The frozen homogenate was thawed, suspended in ice-cold 50 mM Tris–HCl buffer (pH 7.7 at 25 °C), and used for the binding assay. For the assay using CHO cell membrane homogenate, 2 μL of DMSO solution of a test compound was mixed with homogenate and 40 (MT<sub>1</sub>) or 80 pM (MT<sub>2</sub>) 2-[<sup>125</sup>I]iodomelatonin in a total volume of 200 μL and incubated at 25 °C for 150 min. The binding reaction was terminated by rapid filtration using a cell harvester (PerkinElmer) followed by four 300 μL washes with ice-cold incubation buffer. Nonspecific binding was defined in the presence of 1 μM melatonin. GF/C filter plates were dried, and radioactivity was determined after the addition of 25 μL Microscint-0 using a TopCount (PerkinElmer). The 50% inhibitory concentration (IC<sub>50</sub>) was calculated using nonlinear regression analysis (a three-parameter dose–response curve) in the GraphPad Prism software (GraphPad Software). The dissociation constant of the compound for the receptor (<i>K</i><sub>i</sub>) was calculated using the following equation:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_m001.gif" alt="" id="_i73" /></img></span>where <i>L</i> and <i>K</i><sub>d</sub> represent the concentration and the affinity constant of 2-[<sup>125</sup>I]melatonin in the binding assay, respectively. The specific binding of 2-[<sup>125</sup>I]melatonin for human MT<sub>1</sub> receptors in hMT<sub>1</sub>-CHO/binding was saturable. The one-site specific binding plot in the GraphPad Prism software (GraphPad Software) of saturation isotherm using ligand concentrations ranging from 5 to 160 pM revealed affinity binding sites with a <i>K</i><sub>d</sub> value of 33.9 ± 4.2 pM and a <i>B</i><sub>max</sub> of 33.8 ± 1.6 fmol/mg protein (one experiment). Human MT<sub>2</sub> receptors expressed in hMT<sub>2</sub>-CHO showed lower affinities than those of human MT<sub>1</sub> receptors, and its <i>K</i><sub>d</sub> value and <i>B</i><sub>max</sub> were 72.6 ± 9.4 pM and 72.1 ± 4.4 fmol/mg protein (one experiment), respectively, determined with ligand concentrations ranging from 5 to 160 pM. Data for melatonin were obtained from six experiments in more than triplicate. Data for the other compounds were obtained from a single experiment in triplicate.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> In Vitro Clearance in Human and Rat Hepatic Microsomes</h3><div class="NLM_p last">Hepatic microsomes from rats and humans were purchased from Xenotech, LLC (Lenexa, KS). An incubation mixture with a final volume of 0.1 mL consisted of microsomal protein in 50 mmol/L KH<sub>2</sub>PO<sub>4</sub>_K<sub>2</sub>HPO<sub>4</sub> phosphate buffer (pH 7.4) and 1 μmol/L test compound. The concentration of hepatic microsomal protein was 0.2 mg/mL. An NADPH-generating system containing 50 mmol/L MgCl<sub>2</sub>, 50 mmol/L glucose 6-phosphate, 5 mmol/L β-NADP<sup>+</sup>, and 15 U/mL glucose 6-phosphate dehydrogenase was added to the incubation mixture with a 10% volume of the reaction mixture to initiate the enzyme reaction. After the addition of the NADPH-generating system, the reaction mixture was incubated at 37 °C for 20 min. The reaction was terminated by the addition of acetonitrile equivalent to the volume of the reaction mixture. As a control, the mixture without 37 °C incubation was also prepared. The test compound in the reaction mixture was measured by an HPLC system equipped with a UV detector. For the determinations of the metabolic clearance, chromatograms were analyzed for parent compound disappearance from the reaction mixtures. Data were obtained from a single experiment in duplicate.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Oral Bioavailability</h3><div class="NLM_p last">Test compounds were administered to male Sprague–Dawley rats (8 weeks old, nonfasted, <i>n</i> = 3 or 5). After oral and intravenous administration, blood samples were collected and immediately centrifuged to obtain the plasma fraction. The plasma samples were deproteinized with acetonitrile containing an internal standard. After centrifugation, the supernatant was diluted with 0.2% (v/v) formic acid in 10 mmol/L ammonium formate (pH 3) and centrifuged again. The compound concentrations in the supernatant were measured by LC/MS/MS.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Brain-to-Plasma Concentration Ratio in Rats</h3><div class="NLM_p last">Ramelteon and compound (<i>S</i>)-<b>3b</b> were administered to male Sprague–Dawley rats (8 weeks old, nonfasted, <i>n</i> = 3). In 60 min after oral administration at 1.0 mg/kg (ramelteon) and 0.1 mg/kg ((<i>S</i>)-<b>3b</b>), blood and plasma samples were collected. The blood samples were centrifuged to obtain the plasma fraction. The brain samples were homogenized in saline to obtain the brain homogenate. The plasma and brain homogenate samples were deproteinized with acetonitrile containing an internal standard. After centrifugation, the supernatant was diluted with 0.2% (v/v) formic acid in 10 mmol/L ammonium formate (pH 3) and centrifuged again. The compound concentrations in the supernatant were measured by LC/MS/MS.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Inhibition of Forskolin-Induced cAMP Formation in CHO Cells Expressing Human Melatonin Receptor (MT<sub>1</sub> or MT<sub>2</sub>)</h3><div class="NLM_p last">For the assay of human MT<sub>1</sub> receptor, we used Chinese hamster ovary (CHO) cells expressing human MT<sub>1</sub> receptors. A cell line stably expressing human MT<sub>1</sub> receptors (human MT<sub>1</sub>/CHO-K1 CL3) was selected after transfection with human MT<sub>1</sub> genes to parental CHO cells (Health Science Research Resources Bank, Japan) and cultured in Ham’s F-12 supplemented with 10% FBS, 100 U/mL penicillin/100 μg/mL streptomycin solution, and 500 μg/mL G418 at 37 °C in 5% CO<sub>2</sub>/95% air atmosphere in humid conditions. For the assay of human MT<sub>2</sub> receptor, we used CHO cells expressing human MT<sub>2</sub> receptors. A cell line stably expressing human MT<sub>2</sub> receptor [human MT<sub>2</sub>/CHO-K1 (PerkinElmer)] was purchased from PerkinElmer and cultured in Ham’s F-12 supplemented with 10% FBS, 100 U/mL penicillin/100 μg/mL streptomycin solution, and 500 μg/mL G418 at 37 °C in 5% CO<sub>2</sub>/95% air atmosphere in humid conditions. The following buffers (A and B) were used for cAMP production assay: buffer A: modified Hanks’ balanced salt solution [mHBSS: HBSS without NaHCO<sub>3</sub> containing 5 mmol/L HEPES] containing 0.1% BSA, 100 μmol/L IBMX, 100 μmol/L Ro 20-1724, and 6 μmol/L forskolin and buffer B: mHBSS containing 0.1% BSA, 100 μmol/L IBMX, and 100 μmol/L Ro 20-1724. Plates (384-well) were added with 10 μL of buffer B. Melatonin and (<i>S</i>)-<b>3b</b> were dissolved in DMSO to make 0.03, 0.3, 3, 30, 300, 3000, and 30,000 nmol/L solutions and diluted with buffer A to make 100 times the final desired concentration. Each compound solution was added with 10 μL/well. All cell lines were cultured in HAM’s F-12 containing 10% FBS and harvested at confluence by Accutase treatment. The cell line of human MT<sub>1</sub> was seeded at 2 × 10<sup>4</sup> cells/well in the plates with 10 μL of buffer B. The cell line of human MT<sub>2</sub> was seeded at 4 × 10<sup>4</sup> cells/well, same as another cell line. After short shaking, cells were incubated at room temperature for 30 min. Melatonin and (<i>S</i>)-<b>3b</b> were dissolved in the final reaction solution to make 0.0001, 0.001, 0.01, 0.1, 1, 10, and 100 nmol/L solutions. We used AlphaScreen cAMP assay kit to measure concentrations of cAMP in cells. After the incubation, 10 μL of buffer B containing 100 U/mL anti cAMP-acceptor beads was added to each well. The reaction was terminated by the addition of 10 μL of buffer B containing 1.5% Tween-20, 106 U/mL biotinylated cAMP, and 50 μg/mL donor-SA beads. After shaking for 5 min, the plates were incubated in the dark at room temperature for more than 6 to 18 h. The AlphaScreen’s chemiluminescence of each well was detected by using an EnVision plate reader (PerkinElmer). The procedure of cAMP production assay was based on the method of PerkinElmer’s AlphaScreen cAMP assay kit protocol with minor modifications. The counts of the AlphaScreen’s chemiluminescence were converted to concentrations of cAMP accumulations in the cells by using standard curves estimated by a four-parameter nonlinear logistic regression analysis. The 100% value was the mean cAMP production with 2 μmol/L forskolin. The 0% value was that with 1 μmol/L melatonin and 2 μmol/L forskolin. The EC<sub>50</sub> values were estimated by a two-parameter nonlinear logistic regression analysis. Data were expressed as percentage forskolin response at each receptor (mean ± S.D.). Data were obtained from a single experiment in quadruplicate.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Sleep-Promoting Effect of (<i>S</i>)-<b>3b</b> in Cats</h3><div class="NLM_p">Healthy male and female European Shorthair cats were purchased from Nisseiken Company, Ltd. (Tokyo, Japan) and housed individually in a room maintained at 22–24 °C with a 12 h light–dark cycle (light on at 7:00 a.m.). They were fed once daily (7:00 a.m.), and water was available ad libitum.</div><div class="NLM_p">Surgery for EEG/EMG recordings was performed as previously described.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Cats were placed on a stereotaxic apparatus under general anesthesia. Electrodes for electroencephalogram (EEG) recording were implanted bilaterally in the frontal and parietal cortices and hippocampus according to the cat brain atlas of Snider and Niemer (1961). Stainless-steel screws were used as cortical electrodes. The depth bipolar recording electrode consisted of insulated stainless-steel wires (0.3 mm in diameter) except at the tips (0.5 mm). A pair of stainless-steel wires was implanted into the back cervical muscles to record electromyogram (EMG) data.</div><div class="NLM_p last">The cats were allowed to recover from surgery for at least 7 days before habituation to the test chamber (an acrylic cage 75 × 65 × 40 cm located in a soundproof, electrically shielded room that was maintained under conditions similar to those of the home cage). The animals were connected to the recording equipment via a light flexible cable with a slip-ring connector that permitted them free movement. After we confirmed that animals sleep sufficiently in the experimental room, polysomnographic recordings were conducted. The behavioral and postural changes of the animals were observed using a video camera continuously throughout the experiment. The EEG–EMG signals were acquired using an electroencephalograph (GE Yokogawa Medical System, Osaka, Japan). These recordings were performed for 8 h after drug administration. Compound (<i>S</i>)-<b>3b</b> (10 mg/kg) or vehicle was orally administered between 9:30 and 10:00 a.m. The signals were digitally filtered (EEG, 0.5–30 Hz; EMG, 20–200 Hz) and semiautomatically scored in 20 s epochs as wakefulness, slow wave sleep (SWS), or rapid eye movement sleep (REM) by a sleep scoring system (Sleep Sign ver. 2; Kissei Comtec, Matsumoto, Japan). This preliminary scoring was visually inspected and corrected if necessary. Compound (<i>S</i>)-<b>3b</b> was suspended in 0.5% (w/v) methylcellulose solution. The solution was administered orally to each cat in a gelatin capsule. In the control trial, each cat was given a capsule-containing vehicle. We used a crossover design with seven cats per group and at least 7 days of washout periods. Data were expressed as the total time spent in sleep stages (SWS and REM) during 8 h following the oral administration. The statistical differences between the vehicle-treated group and compound (<i>S</i>)-<b>3b</b>-treated group were analyzed using a crossover analysis of variance (ANOVA) followed by a contrast test with significance set at <i>p</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01836" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01836?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01836</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR charts of (<i>S</i>)-<b>3b</b>, determination of the absolute configuration of (<i>S</i>)-<b>3b</b>, HPLC analysis of <b>3f</b>, functional analysis of the other tricyclic series than indeno[5,4-<i>d</i>][1,3]oxazole, and brain and plasma concentrations of (<i>S</i>)-<b>3b</b> in individual rats (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all reported final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_001.pdf">jm0c01836_si_001.pdf (458.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_002.csv">jm0c01836_si_002.csv (1.12 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01836" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasutaka Hoashi</span> - <span class="hlFld-Affiliation affiliation">Takeda Pharmaceutical Company,
Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0863-1304" title="Orcid link">http://orcid.org/0000-0002-0863-1304</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2c554d5f59584d474d0244434d5f44456c584d4749484d024f4341"><span class="__cf_email__" data-cfemail="b5ccd4c6c0c1d4ded49bdddad4c6dddcf5c1d4ded0d1d49bd6dad8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takafumi Takai</span> - <span class="hlFld-Affiliation affiliation">Takeda Pharmaceutical Company,
Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yohei Kosugi</span> - <span class="hlFld-Affiliation affiliation">Takeda Pharmaceutical Company,
Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9318-4723" title="Orcid link">http://orcid.org/0000-0001-9318-4723</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masato Nakashima</span> - <span class="hlFld-Affiliation affiliation">Takeda Pharmaceutical Company,
Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masaharu Nakayama</span> - <span class="hlFld-Affiliation affiliation">Takeda Pharmaceutical Company,
Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keisuke Hirai</span> - <span class="hlFld-Affiliation affiliation">Takeda Pharmaceutical Company,
Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Osamu Uchikawa</span> - <span class="hlFld-Affiliation affiliation">Takeda Pharmaceutical Company,
Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatsuki Koike</span> - <span class="hlFld-Affiliation affiliation">Takeda Pharmaceutical Company,
Ltd.., 26-1, Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3264-1406" title="Orcid link">http://orcid.org/0000-0002-3264-1406</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Masayuki Yamashita and Keiko Higashikawa for determination of absolute configuration.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">Ac2O</td><td class="NLM_def"><p class="first last">acetic anhydride</p></td></tr><tr><td class="NLM_term">AcOEt</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">EEG</td><td class="NLM_def"><p class="first last">electroencephalogram</p></td></tr><tr><td class="NLM_term">EMG</td><td class="NLM_def"><p class="first last">electromyogram</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeI</td><td class="NLM_def"><p class="first last">iodomethane</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">Pd/C</td><td class="NLM_def"><p class="first last">palladium on carbon</p></td></tr><tr><td class="NLM_term">Pd(OAc)<sub>2</sub></td><td class="NLM_def"><p class="first last">palladium(II) acetate</p></td></tr><tr><td class="NLM_term">REM</td><td class="NLM_def"><p class="first last">rapid eye movement</p></td></tr><tr><td class="NLM_term">SWS</td><td class="NLM_def"><p class="first last">slow wave sleep</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrenetxe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delagrange, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, J. A.</span></span> <span> </span><span class="NLM_article-title">Physiological and metabolic functions of melatonin</span>. <i>J. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1007/BF03168221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1007%2FBF03168221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15352385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFOru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=61-72&author=J.+Barrenetxeauthor=P.+Delagrangeauthor=J.+A.+Mart%C3%ADnez&title=Physiological+and+metabolic+functions+of+melatonin&doi=10.1007%2FBF03168221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological and metabolic functions of melatonin</span></div><div class="casAuthors">Barrenetxe, J.; Delagrange, P.; Martinez, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-72</span>CODEN:
                <span class="NLM_cas:coden">JPBIF2</span>;
        ISSN:<span class="NLM_cas:issn">1138-7548</span>.
    
            (<span class="NLM_cas:orgname">Servicio de Publicaciones de la Universidad de Navarra</span>)
        </div><div class="casAbstract">A review.  Melatonin is a lipophilic hormone, mainly produced and secreted at night by the pineal gland.  Melatonin synthesis is under the control of postganglionic sympathetic fibers that innervates the pineal gland.  Melatonin acts via high affinity G protein-coupled membrane receptors.  To date, three different receptor subtypes have been identified in mammals: MT1 (Mel 1a) and MT2 (Mel 1b) and a putative binding site called MT3.  The chronobiotic properties of the hormone for resynchronization of sleep and circadian rhythms disturbances has been demonstrated both in animal models or in clin. trials.  Several other physiol. effects of melatonin in different peripheral tissues have been described in the past years.  In this way, it has been demonstrated that the hormone is involved in the regulation of seasonal reprodn., body wt. and energy balance.  This contribution has been focused to review some of the physiol. functions of melatonin as well as the role of the hormone in the regulation of energy balance and its possible involvement in the development of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoVCpdxMAe7Vg90H21EOLACvtfcHk0lhyXxbjB2lYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFOru78%253D&md5=53adbe499600cacf18591531ed74dee0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2FBF03168221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03168221%26sid%3Dliteratum%253Aachs%26aulast%3DBarrenetxe%26aufirst%3DJ.%26aulast%3DDelagrange%26aufirst%3DP.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DJ.%2BA.%26atitle%3DPhysiological%2520and%2520metabolic%2520functions%2520of%2520melatonin%26jtitle%3DJ.%2520Physiol.%2520Biochem.%26date%3D2004%26volume%3D60%26spage%3D61%26epage%3D72%26doi%3D10.1007%2FBF03168221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inouye, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, H.</span></span> <span> </span><span class="NLM_article-title">Persistence of circadian rhythmicity in a mammalian hypothalamic ″island″ containing the suprachiasmatic nucleus</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">5962</span>– <span class="NLM_lpage">5966</span>, <span class="refDoi"> DOI: 10.1073/pnas.76.11.5962</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1073%2Fpnas.76.11.5962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=293695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A280%3ADyaL3c7gtFGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1979&pages=5962-5966&author=S.+T.+Inouyeauthor=H.+Kawamura&title=Persistence+of+circadian+rhythmicity+in+a+mammalian+hypothalamic+%E2%80%B3island%E2%80%B3+containing+the+suprachiasmatic+nucleus&doi=10.1073%2Fpnas.76.11.5962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus</span></div><div class="casAuthors">Inouye S T; Kawamura H</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5962-6</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The experimental work described tested the prosposition that the suprachiasmatic nucleus of the hypothalamus is an autonomous circadian pacemaker.  Simultaneous recording from two extracellular electrodes indicated neural (multiple unit) activity at two sites in the brain, one of which is in or near the suprachiasmatic nucleus and the other in one of many other brain locations.  Both sites in intact rats displayed clear circadian rhythmicity of spontaneous neural activity.  In experimental animals, a Halasz knife was used to create an island of hypothalamic tissue that contained the suprachiasmatic nuclei.  In such animals that were also blinded by bilateral ocular enucleation, circadian rhythmicity was lost at all brain locations recorded outside the island, but it persisted within the island that contained the suprachiasmatic nuclei.  The rhythmicity of the island is thus not dependent on afferent inputs from elsewhere in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwKnk0Z1ZFeDC850By6mxpfW6udTcc2eYQ58UaaJXS9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c7gtFGnsw%253D%253D&md5=27d001f2f922db94a31a1be497c6f922</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.76.11.5962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.76.11.5962%26sid%3Dliteratum%253Aachs%26aulast%3DInouye%26aufirst%3DS.%2BT.%26aulast%3DKawamura%26aufirst%3DH.%26atitle%3DPersistence%2520of%2520circadian%2520rhythmicity%2520in%2520a%2520mammalian%2520hypothalamic%2520%25E2%2580%25B3island%25E2%2580%25B3%2520containing%2520the%2520suprachiasmatic%2520nucleus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D1979%26volume%3D76%26spage%3D5962%26epage%3D5966%26doi%3D10.1073%2Fpnas.76.11.5962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reppart, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godson, C.</span></span> <span> </span><span class="NLM_article-title">Melatonin receptors step into the light: cloning and classification of subtypes</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(96)10005-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2F0165-6147%2896%2910005-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=8936344" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=100-102&author=S.+M.+Reppartauthor=D.+R.+Weaverauthor=C.+Godson&title=Melatonin+receptors+step+into+the+light%3A+cloning+and+classification+of+subtypes&doi=10.1016%2F0165-6147%2896%2910005-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2896%2910005-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252896%252910005-5%26sid%3Dliteratum%253Aachs%26aulast%3DReppart%26aufirst%3DS.%2BM.%26aulast%3DWeaver%26aufirst%3DD.%2BR.%26aulast%3DGodson%26aufirst%3DC.%26atitle%3DMelatonin%2520receptors%2520step%2520into%2520the%2520light%253A%2520cloning%2520and%2520classification%2520of%2520subtypes%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1996%26volume%3D17%26spage%3D100%26epage%3D102%26doi%3D10.1016%2F0165-6147%2896%2910005-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubocovich, M. L.</span>; <span class="NLM_string-name">Cardinali, D. P.</span>; <span class="NLM_string-name">Delagrange, P.</span>; <span class="NLM_string-name">Krause, D. N.</span>; <span class="NLM_string-name">Strosberg, A. D.</span>; <span class="NLM_string-name">Sugden, D.</span>; <span class="NLM_string-name">Yocca, F. D.</span></span> <i>The IUPHAR Compendium of Receptor Characterization and Classification</i>; <span class="NLM_publisher-name">IUPHAR Media</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2000</span>; pp.  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">277</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=271-277&author=M.+L.+Dubocovich&author=D.+P.+Cardinali&author=P.+Delagrange&author=D.+N.+Krause&author=A.+D.+Strosberg&author=D.+Sugden&author=F.+D.+Yocca&title=The+IUPHAR+Compendium+of+Receptor+Characterization+and+Classification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26btitle%3DThe%2520IUPHAR%2520Compendium%2520of%2520Receptor%2520Characterization%2520and%2520Classification%26pub%3DIUPHAR%2520Media%26date%3D2000%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helliwell, R.</span></span> <span> </span><span class="NLM_article-title">Melatonin receptors: localization, molecular pharmacology and physiological significance</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/0197-0186(94)90100-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2F0197-0186%2894%2990100-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=8161940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=101-146&author=P.+J.+Morganauthor=P.+Barrettauthor=H.+E.+Howellauthor=R.+Helliwell&title=Melatonin+receptors%3A+localization%2C+molecular+pharmacology+and+physiological+significance&doi=10.1016%2F0197-0186%2894%2990100-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin receptors: localization, molecular pharmacology and physiological significance</span></div><div class="casAuthors">Morgan, Peter J.; Barrett, Perry; Howell, H. Edward; Helliwell, Rachel</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-46</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    </div><div class="casAbstract">A review with ∼ 300 refs. The radioligand 2-[125I]iodomelatonin has been used extensively to localize melatonin binding sites in both the brain and peripheral tissues.  In general these binding sites have been found to be high affinity, with Kd in the low picomolar range, and selective for structural analogs of melatonin.  The affinity of these sites can generally be modulated by guanine nucleotides, consistent with the notion that they are putative G-protein coupled receptors.  Only a few studies have demonstrated that these putative receptors mediate biochem. and cellular responses.  In the pars tuberalis (PT) and pars distalis (PD) of the pituitary, the amphibian melanophore and vertebrate retina, evidence indicates that melatonin acts to inhibit intracellular cAMP through a G-protein coupled mechanism, demonstrating that this is a common signal transduction pathway for many melatonin receptors.  However in the PD the inhibition of Ca influx and membrane potential are also important mediators of melatonin effects.  Melatonin receptor(s) structure and their localization in the brain and melatonin analogs are also discussed.  A model of how melatonin might mediate the timing of the circannual events through the PT is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ8QwPWjM4frVg90H21EOLACvtfcHk0liczuPYgpVRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKhu7k%253D&md5=0785780ded2d0aed62f8971d4e9f953a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0197-0186%2894%2990100-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0197-0186%252894%252990100-7%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DP.%2BJ.%26aulast%3DBarrett%26aufirst%3DP.%26aulast%3DHowell%26aufirst%3DH.%2BE.%26aulast%3DHelliwell%26aufirst%3DR.%26atitle%3DMelatonin%2520receptors%253A%2520localization%252C%2520molecular%2520pharmacology%2520and%2520physiological%2520significance%26jtitle%3DNeurochem.%2520Int.%26date%3D1994%26volume%3D24%26spage%3D101%26epage%3D146%26doi%3D10.1016%2F0197-0186%2894%2990100-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribkoff, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reppert, S. M.</span></span> <span> </span><span class="NLM_article-title">Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(00)80350-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2FS0896-6273%2800%2980350-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=9247266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK2sXltFCjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=91-102&author=C.+Liuauthor=D.+R.+Weaverauthor=X.+Jinauthor=L.+P.+Shearmanauthor=R.+L.+Pieschlauthor=V.+K.+Gribkoffauthor=S.+M.+Reppert&title=Molecular+dissection+of+two+distinct+actions+of+melatonin+on+the+suprachiasmatic+circadian+clock&doi=10.1016%2FS0896-6273%2800%2980350-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock</span></div><div class="casAuthors">Liu, Chen; Weaver, David R.; Jin, Xiaowei; Shearman, Lauren P.; Pieschl, Rick L.; Gribkoff, Valentin K.; Reppert, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-102</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Melatonin elicits 2 effects on the suprachiasmatic nuclei (SCN): acute neuronal inhibition and phase-shifting.  Melatonin evokes its biol. effects through G protein-coupled receptors.  Since the Mel1a melatonin receptor may transduce the major neurobiol. actions of melatonin in mammals, we examd. whether it mediates both melatonin effects on SCN function by using mice with targeted disruption of the Mel1a receptor.  The Mel1a receptor accounts for all detectable, high-affinity melatonin binding in mouse brain.  Functionally, this receptor is necessary for the acute inhibitory action of melatonin on the SCN.  Melatonin-induced phase shifts, however, are only modestly altered in the receptor-deficient mice; pertussis toxin still blocks melatonin-induced phase shifts in Mel1a receptor-deficient mice.  The other melatonin receptor subtype, the Mel1b receptor, is expressed in mouse SCN, implicating it in the phase-shifting response.  The results provide a mol. basis for 2 distinct, mechanistically separable effects of melatonin on SCN physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmqdWvDwZBa7Vg90H21EOLACvtfcHk0liczuPYgpVRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltFCjsrk%253D&md5=e3d39a2b58e1d0fb52d1a94ac5b382a9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980350-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980350-5%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWeaver%26aufirst%3DD.%2BR.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DShearman%26aufirst%3DL.%2BP.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DGribkoff%26aufirst%3DV.%2BK.%26aulast%3DReppert%26aufirst%3DS.%2BM.%26atitle%3DMolecular%2520dissection%2520of%2520two%2520distinct%2520actions%2520of%2520melatonin%2520on%2520the%2520suprachiasmatic%2520circadian%2520clock%26jtitle%3DNeuron%26date%3D1997%26volume%3D19%26spage%3D91%26epage%3D102%26doi%3D10.1016%2FS0896-6273%2800%2980350-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubocovich, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ghoul, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benloucif, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masana, M. I.</span></span> <span> </span><span class="NLM_article-title">Selective MT<sub>2</sub> melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1220</span>, <span class="refDoi"> DOI: 10.1096/fasebj.12.12.1211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1096%2Ffasebj.12.12.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=9737724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK1cXlvFWktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=1211-1220&author=M.+L.+Dubocovichauthor=K.+Yunauthor=W.+M.+Al-Ghoulauthor=S.+Benloucifauthor=M.+I.+Masana&title=Selective+MT2+melatonin+receptor+antagonists+block+melatonin-mediated+phase+advances+of+circadian+rhythms&doi=10.1096%2Ffasebj.12.12.1211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms</span></div><div class="casAuthors">Dubocovich, Margarita L.; Yun, Kenneth; Al-Ghou, Walid M.; Benloucif, Susan; Masana, Monica I.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1211-1220</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">This study demonstrates the involvement of the MT2 (Mel1b) melatonin receptor in mediating phase advances of circadian activity rhythms by melatonin.  In situ hybridization histochem. with digoxigenin-labeled oligonucleotide probes revealed for the first time the expression of mt1 and MT2 melatonin receptor mRNA within the suprachiasmatic nucleus of the C3H/HeN mouse.  Melatonin (0.9-30 μg/mouse, s.c.) administration during 3 days at the end of the subjective day (CT 10) to C3H/HeN mice kept in const. dark phase advanced circadian rhythms of wheel running activity in a dose-dependent manner [EC50 = 0.72 μg/mouse; 0.98 h maximal advance at 9 μg/mouse].  Neither the selective MT2 melatonin receptor antagonists 4P-ADOT and 4P-PDOT (90 μg/mouse, s.c.) nor luzindole (300 μg/mouse, s.c.), which shows 25-fold higher affinity for the MT2 than the mt1 sub-type, affected the phase of circadian activity rhythms when given alone at CT 10.  All three antagonists, however, shifted to the right the dose-response curve to melatonin, as they significantly reduced the phase shifting effects of 0.9 and 3 μg melatonin.  This is the first study to demonstrate that melatonin phase advances circadian rhythms by activation of a membrane-bound melatonin receptor and strongly suggests that this effect is mediated through the MT2 melatonin receptor subtype within the circadian timing system.  The authors conclude that the MT2 melatonin receptor subtype is a novel therapeutic target for the development of subtype-selective analogs for the treatment of circadian sleep and mood-related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ojeVXHYuUbVg90H21EOLACvtfcHk0liczuPYgpVRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvFWktL8%253D&md5=9a9e7679df1e98fc362b45b88d61dd12</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.12.12.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.12.12.1211%26sid%3Dliteratum%253Aachs%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26aulast%3DYun%26aufirst%3DK.%26aulast%3DAl-Ghoul%26aufirst%3DW.%2BM.%26aulast%3DBenloucif%26aufirst%3DS.%26aulast%3DMasana%26aufirst%3DM.%2BI.%26atitle%3DSelective%2520MT2%2520melatonin%2520receptor%2520antagonists%2520block%2520melatonin-mediated%2520phase%2520advances%2520of%2520circadian%2520rhythms%26jtitle%3DFASEB%2520J.%26date%3D1998%26volume%3D12%26spage%3D1211%26epage%3D1220%26doi%3D10.1096%2Ffasebj.12.12.1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubocovich, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markowska, M.</span></span> <span> </span><span class="NLM_article-title">Functional MT<sub>1</sub> and MT<sub>2</sub> melatonin receptors in mammals</span>. <i>Endocrine</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1385/ENDO:27:2:101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1385%2FENDO%3A27%3A2%3A101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=16217123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFansLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=101-110&author=M.+L.+Dubocovichauthor=M.+Markowska&title=Functional+MT1+and+MT2+melatonin+receptors+in+mammals&doi=10.1385%2FENDO%3A27%3A2%3A101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Functional MT1 and MT2 melatonin receptors in mammals</span></div><div class="casAuthors">Dubocovich, Margarita L.; Markowska, Magdalena</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">EOCRE5</span>;
        ISSN:<span class="NLM_cas:issn">1355-008X</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Melatonin, dubbed the hormone of darkness, is known to regulate a wide variety of physiol. processes in mammals.  This review describes well-defined functional responses mediated through activation of high-affinity MT1 and MT2 G protein-coupled receptors viewed as potential targets for drug discovery.  MT1 melatonin receptors modulate neuronal firing, arterial vasoconstriction, cell proliferation in cancer cells, and reproductive and metabolic functions.  Activation of MT2 melatonin receptors phase shift circadian rhythms of neuronal firing in the suprachiasmatic nucleus, inhibit dopamine release in retina, induce vasodilation and inhibition of leukocyte rolling in arterial beds, and enhance immune responses.  The melatonin-mediated responses elicited by activation of MT1 and MT2 native melatonin receptors are dependent on circadian time, duration and mode of exposure to endogenous or exogenous melatonin, and functional receptor sensitivity.  Together, these studies underscore the importance of carefully linking each melatonin receptor type to specific functional responses in target tissues to facilitate the design and development of novel therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoKKZffUZ0BbVg90H21EOLACvtfcHk0liczuPYgpVRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFansLjE&md5=e02b44bdfda9e9bad81db7843d6e08f1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1385%2FENDO%3A27%3A2%3A101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FENDO%253A27%253A2%253A101%26sid%3Dliteratum%253Aachs%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26aulast%3DMarkowska%26aufirst%3DM.%26atitle%3DFunctional%2520MT1%2520and%2520MT2%2520melatonin%2520receptors%2520in%2520mammals%26jtitle%3DEndocrine%26date%3D2005%26volume%3D27%26spage%3D101%26epage%3D110%26doi%3D10.1385%2FENDO%3A27%3A2%3A101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhdanova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollins, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morabito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schomer, D. L.</span></span> <span> </span><span class="NLM_article-title">Sleep-inducing effects of low doses of melatonin ingested in the evening</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">552</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1016/0009-9236(95)90040-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2F0009-9236%2895%2990040-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=7768078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK2MXmsVGqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=552-558&author=I.+V.+Zhdanovaauthor=R.+J.+Wurtmanauthor=H.+J.+Lynchauthor=J.+R.+Ivesauthor=A.+B.+Dollinsauthor=C.+Morabitoauthor=J.+K.+Mathesonauthor=D.+L.+Schomer&title=Sleep-inducing+effects+of+low+doses+of+melatonin+ingested+in+the+evening&doi=10.1016%2F0009-9236%2895%2990040-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sleep-inducing effects of low doses of melatonin ingested in the evening</span></div><div class="casAuthors">Zhdanova, Irina V.; Wurtman, Richard J.; Lynch, Harry J.; Ives, John R.; Dollins, Andrew B.; Morabito, Claudia; Matheson, Jean K.; Schomer, Donald L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">552-8</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">We previously obsd. that low oral doses of melatonin given at noon increase blood melatonin concns. to those normally occurring nocturnally and facilitate sleep onset, as assessed using an involuntary muscle relaxation test.  In this study we examd. the induction of polysomnog. recorded sleep by similar doses given later in the evening, close to the times of endogenous melatonin release and habitual sleep onset.  Volunteers received the hormone (oral doses of 0.3 or 1.0 mg) or placebo at 6, 8, or 9 PM.  Latencies to sleep onset, to stage 2 sleep, and to rapid eye movement (REM) sleep were measured polysomnog.  Either dose given at any of the three time points decreased sleep onset latency and latency to stage 2 sleep.  Melatonin did not suppress REM sleep or delay its onset.  Most volunteers could clearly distinguish between the effects of melatonin and those of placebo when the hormone was tested at 6 or 8 PM.  Neither melatonin dose induced "hangover" effects, as assessed with mood and performance tests administered on the morning after treatment.  These data provide new evidence that nocturnal melatonin secretion may be involved in physiol. sleep onset and that exogenous melatonin may be useful in treating insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocVA9-wfyZR7Vg90H21EOLACvtfcHk0lh6GY3BQI4YUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsVGqs7o%253D&md5=8f820b1027a2beef17db7d36500ed55e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0009-9236%2895%2990040-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-9236%252895%252990040-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhdanova%26aufirst%3DI.%2BV.%26aulast%3DWurtman%26aufirst%3DR.%2BJ.%26aulast%3DLynch%26aufirst%3DH.%2BJ.%26aulast%3DIves%26aufirst%3DJ.%2BR.%26aulast%3DDollins%26aufirst%3DA.%2BB.%26aulast%3DMorabito%26aufirst%3DC.%26aulast%3DMatheson%26aufirst%3DJ.%2BK.%26aulast%3DSchomer%26aufirst%3DD.%2BL.%26atitle%3DSleep-inducing%2520effects%2520of%2520low%2520doses%2520of%2520melatonin%2520ingested%2520in%2520the%2520evening%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1995%26volume%3D57%26spage%3D552%26epage%3D558%26doi%3D10.1016%2F0009-9236%2895%2990040-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Attenburrow, M. E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpley, A. L.</span></span> <span> </span><span class="NLM_article-title">Low dose melatonin improves sleep in healthy middle-aged subjects</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1007/BF02246354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1007%2FBF02246354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=8856838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK28XlsFKrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1996&pages=179-181&author=M.+E.+J.+Attenburrowauthor=P.+J.+Cowenauthor=A.+L.+Sharpley&title=Low+dose+melatonin+improves+sleep+in+healthy+middle-aged+subjects&doi=10.1007%2FBF02246354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Low dose melatonin improves sleep in healthy middle-aged subjects</span></div><div class="casAuthors">Attenburrow, M. E. J.; Cowen, P. J.; Sharpley, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-181</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We studied the effects of single evening doses of melatonin (0.3 mg and 1.0 mg orally) on polysomnog. measured sleep in 15 healthy middle-aged volunteers, using a placebo-controlled, double-blind, cross-over design.  Compared to placebo, the 1.0 mg dose of melatonin significantly increased Actual Sleep Time, Sleep Efficiency, non-REM Sleep and REM Sleep Latency.  These data are consistent with the hypothesis that low dose melatonin has hypnotic effects in humans.  It is possible that administered melatonin may have a role to play in the treatment of sleep disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYYkwy5O8X3rVg90H21EOLACvtfcHk0lh6GY3BQI4YUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFKrtrw%253D&md5=5932c7a254cf59ba14815e164f804c8f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2FBF02246354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02246354%26sid%3Dliteratum%253Aachs%26aulast%3DAttenburrow%26aufirst%3DM.%2BE.%2BJ.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26aulast%3DSharpley%26aufirst%3DA.%2BL.%26atitle%3DLow%2520dose%2520melatonin%2520improves%2520sleep%2520in%2520healthy%2520middle-aged%2520subjects%26jtitle%3DPsychopharmacology%26date%3D1996%26volume%3D126%26spage%3D179%26epage%3D181%26doi%3D10.1007%2FBF02246354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, J.</span></span> <span> </span><span class="NLM_article-title">Melatonin in humans: Jet Lag and After</span>. <i>Adv. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK3MXmt1emt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=299-302&author=J.+Arendt&title=Melatonin+in+humans%3A+Jet+Lag+and+After"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin in humans:  jet-lag and after</span></div><div class="casAuthors">Arendt, Josephine</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pineal Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">299-302</span>CODEN:
                <span class="NLM_cas:coden">APIREW</span>;
        ISSN:<span class="NLM_cas:issn">0269-0071</span>.
    </div><div class="casAbstract">A review, with 23 refs., on the use of melatonin in humans to modify circadian rhythm, including studies on subjects with jetlag, shift workers, and blind people.  The general properties and problems of melatonin as a therapeutic agent are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5VZ5M4qrpSLVg90H21EOLACvtfcHk0lh6GY3BQI4YUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmt1emt7w%253D&md5=d37950da04e4cb1f3589e7806e193525</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArendt%26aufirst%3DJ.%26atitle%3DMelatonin%2520in%2520humans%253A%2520Jet%2520Lag%2520and%2520After%26jtitle%3DAdv.%2520Pineal%2520Res.%26date%3D1991%26volume%3D5%26spage%3D299%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sack, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blood, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewy, A. J.</span></span> <span> </span><span class="NLM_article-title">Melatonin rhythms in night shift workers</span>. <i>Sleep</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1093/sleep/15.5.434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1093%2Fsleep%2F15.5.434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1455127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A280%3ADyaK3s%252Fosl2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1992&pages=434-441&author=R.+L.+Sackauthor=M.+L.+Bloodauthor=A.+J.+Lewy&title=Melatonin+rhythms+in+night+shift+workers&doi=10.1093%2Fsleep%2F15.5.434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin rhythms in night shift workers</span></div><div class="casAuthors">Sack R L; Blood M L; Lewy A J</div><div class="citationInfo"><span class="NLM_cas:title">Sleep</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">434-41</span>
        ISSN:<span class="NLM_cas:issn">0161-8105</span>.
    </div><div class="casAbstract">For some time, it has remained uncertain whether the circadian rhythms of permanent night shift workers are adapted to their night-active schedule.  Previous studies of this question have often been limited by "masking" (evoked) effects of sleep and activity on body temperature and cortisol, used as marker rhythms.  In this study, the problem of masking was minimized by measuring the timing of melatonin production under dim light conditions.  Nine permanent night shift workers were admitted to the Clinical Research Center (CRC) directly from their last work shift of the week and remained in dim light while blood samples were obtained hourly for 24 hours.  Melatonin concentrations were measured in these samples using a gas-chromatographic mass-spectrometric method.  Sleep diaries were completed for two weeks prior to the admission to the CRC.  Overall, the onset of the melatonin rhythm was about 7.2 hours earlier (or 16.8 hours later) in the night workers compared to day-active controls.  It was not possible to know whether the phase of the melatonin rhythm was the result of advances or delays.  In night shift workers, sleep was initiated (on average) about three hours prior to the onset of melatonin production.  In contrast, day-active subjects initiated sleep (on average) about three hours after their melatonin onset.  Thus, the sleep times selected by night shift workers may not be well-synchronized to their melatonin rhythm, assumed to mark the phase of their underlying circadian pacemaker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRabrJDwAfSOhdUSIfHIn4FfW6udTcc2eZ-JvAput21v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252Fosl2htg%253D%253D&md5=c59afd2a2c91c597900950e387bc9634</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fsleep%2F15.5.434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fsleep%252F15.5.434%26sid%3Dliteratum%253Aachs%26aulast%3DSack%26aufirst%3DR.%2BL.%26aulast%3DBlood%26aufirst%3DM.%2BL.%26aulast%3DLewy%26aufirst%3DA.%2BJ.%26atitle%3DMelatonin%2520rhythms%2520in%2520night%2520shift%2520workers%26jtitle%3DSleep%26date%3D1992%26volume%3D15%26spage%3D434%26epage%3D441%26doi%3D10.1093%2Fsleep%2F15.5.434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lewy, A. J.</span></span> <span> </span><span class="NLM_article-title">Circadian misalignment in mood disturbances</span>. <i>Curr. Psychiatry Rep.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1007/s11920-009-0070-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1007%2Fs11920-009-0070-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=19909668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A280%3ADC%252BD1MjlvFCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=459-465&author=A.+J.+Lewy&title=Circadian+misalignment+in+mood+disturbances&doi=10.1007%2Fs11920-009-0070-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Circadian misalignment in mood disturbances</span></div><div class="casAuthors">Lewy Alfred J</div><div class="citationInfo"><span class="NLM_cas:title">Current psychiatry reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">459-65</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent refinements in methodology allow chronobiological researchers to answer the following questions: is there circadian misalignment in sleep and mood disturbances, and, if so, is it of the phase-advance or phase-delay type? Measurement of the dim light melatonin onset-to-midsleep interval, or phase-angle difference, in sleep and mood disorders should answer these questions.  Although the phase-advance hypothesis of affective disorders was formulated three decades ago, recent studies suggest that many, if not all, mood disturbances have a circadian misalignment component of the phase-delay type, operationally defined as a delay in the dim light melatonin onset relative to the sleep/wake cycle.  Phase-delayed disorders can be treated with bright light in the morning and/or low-dose melatonin in the afternoon/evening.  Phase-advanced disorders can be treated with bright light in the evening and/or low-dose melatonin in the morning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJoD1dTwP38xgd2Wuil24tfW6udTcc2eZ-JvAput21v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjlvFCltw%253D%253D&md5=83ed7e8915f2a16826b0e228217ac1d3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs11920-009-0070-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11920-009-0070-5%26sid%3Dliteratum%253Aachs%26aulast%3DLewy%26aufirst%3DA.%2BJ.%26atitle%3DCircadian%2520misalignment%2520in%2520mood%2520disturbances%26jtitle%3DCurr.%2520Psychiatry%2520Rep.%26date%3D2009%26volume%3D11%26spage%3D459%26epage%3D465%26doi%3D10.1007%2Fs11920-009-0070-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch-Rodriguez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manev, H.</span></span> <span> </span><span class="NLM_article-title">The pattern of melatonin receptor expression in the brain may influence antidepressant treatment</span>. <i>Med. Hypotheses</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/j.mehy.2006.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.mehy.2006.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=17197111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Sjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2007&pages=120-124&author=E.+Hirsch-Rodriguezauthor=M.+Imbesiauthor=R.+Manevauthor=T.+Uzauthor=H.+Manev&title=The+pattern+of+melatonin+receptor+expression+in+the+brain+may+influence+antidepressant+treatment&doi=10.1016%2Fj.mehy.2006.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The pattern of melatonin receptor expression in the brain may influence antidepressant treatment</span></div><div class="casAuthors">Hirsch-Rodriguez, Eric; Imbesi, Marta; Manev, Radmila; Uz, Tolga; Manev, Hari</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-124</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The pineal hormone melatonin produces most of its biol. effects via G protein-coupled receptors MT1 and MT2.  In mammals, these receptors are expressed in various tissues and organs including in the brain.  Recent research points to a putative role of MT1/MT2 dimerization as a mechanism that could det. the receptor-mediated biol. effects of melatonin.  Brain content and the ratios between MT1 and MT2 receptors are affected by illness, e.g., Alzheimer's disease, and by prolonged drug treatment, e.g., antidepressants.  New drugs with antidepressant properties that bind and activate melatonin receptors have been discovered.  We hypothesize that endogenous, i.e., low, levels of melatonin could contribute to antidepressant effects depending on the expression pattern of melatonin receptors in the brain.  Hence, we propose that a prolonged treatment with classical antidepressant drugs alters the brain ratio of MT1/MT2 receptors to enable the endogenous melatonin, which is secreted during the night, to further improve the antidepressant effects.  A corollary of this hypothesis is that antidepressants would be less effective in conditions of pathol. altered brain melatonin receptors, e.g., in Alzheimer's patients or due to genetic polymorphisms.  If our hypothesis is confirmed, supplementing classical antidepressant treatment with an appropriate dose of a melatonin receptor agonist might be used to improve antidepressant effects in subjects with a susceptible pattern of brain melatonin receptor expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqli43a40rghrVg90H21EOLACvtfcHk0ljDkKg5xrFdTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Sjtbw%253D&md5=c3fdcd2f20baf69a7af8debc6dc3cea0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2006.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2006.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch-Rodriguez%26aufirst%3DE.%26aulast%3DImbesi%26aufirst%3DM.%26aulast%3DManev%26aufirst%3DR.%26aulast%3DUz%26aufirst%3DT.%26aulast%3DManev%26aufirst%3DH.%26atitle%3DThe%2520pattern%2520of%2520melatonin%2520receptor%2520expression%2520in%2520the%2520brain%2520may%2520influence%2520antidepressant%2520treatment%26jtitle%3DMed.%2520Hypotheses%26date%3D2007%26volume%3D69%26spage%3D120%26epage%3D124%26doi%3D10.1016%2Fj.mehy.2006.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golombek, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardinali, D. P.</span></span> <span> </span><span class="NLM_article-title">Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(93)90273-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2F0014-2999%2893%2990273-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=8103462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2nu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1993&pages=231-236&author=D.+A.+Golombekauthor=M.+Martiniauthor=D.+P.+Cardinali&title=Melatonin+as+an+anxiolytic+in+rats%3A+time+dependence+and+interaction+with+the+central+GABAergic+system&doi=10.1016%2F0014-2999%2893%2990273-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin as an anxiolytic in rats: Time dependence and interaction with the central GABAergic system</span></div><div class="casAuthors">Golombek, Diego A.; Martini, Mariana; Cardinali, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">231-6</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Anxiolytic and pro-exploratory melatonin properties were assessed in rats using a plus-maze procedure.  Both melatonin (1 mg/kg) and diazepam (0.5 mg/kg) showed a diurnal variation to decrease anxiety and to promote exploratory behavior.  Melatonin displayed anxiolytic activity at night, with absence of effects at noon and a weak activity at the beginning of the light phase.  Melatonin pro-exploratory activity was found only at night.  Diazepam exerted anxiolysis during the night, with less activity during the day.  Diazepam pro-exploratory activity was found during the night only.  A dose-response study carried out by injecting 1-20 mg/kg melatonin at 12:00 or 18:00 h indicated that melatonin activity was greatest at 18:00 h.  Diazepam was anxiolytic at both times, and pro-exploratory at 18:00 h only.  Melatonin activity was blunted by administration of the benzodiazepine antagonist, flumazenil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM9HTTn76BdrVg90H21EOLACvtfcHk0lhqHmI8C-N8Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2nu7Y%253D&md5=c317a786322add9a3261d8e1e88102b6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990273-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990273-K%26sid%3Dliteratum%253Aachs%26aulast%3DGolombek%26aufirst%3DD.%2BA.%26aulast%3DMartini%26aufirst%3DM.%26aulast%3DCardinali%26aufirst%3DD.%2BP.%26atitle%3DMelatonin%2520as%2520an%2520anxiolytic%2520in%2520rats%253A%2520time%2520dependence%2520and%2520interaction%2520with%2520the%2520central%2520GABAergic%2520system%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D237%26spage%3D231%26epage%3D236%26doi%3D10.1016%2F0014-2999%2893%2990273-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blask, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauchy, R. T.</span></span> <span> </span><span class="NLM_article-title">Melatonin as a chronobiotic/anticancer agent: Cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.2174/1568026023394407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.2174%2F1568026023394407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=11899096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVaqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=113-132&author=D.+E.+Blaskauthor=L.+A.+Sauerauthor=R.+T.+Dauchy&title=Melatonin+as+a+chronobiotic%2Fanticancer+agent%3A+Cellular%2C+biochemical%2C+and+molecular+mechanisms+of+action+and+their+implications+for+circadian-based+cancer+therapy&doi=10.2174%2F1568026023394407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy</span></div><div class="casAuthors">Blask, David E.; Sauer, Leonard A.; Dauchy, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-132</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Melatonin, as a new member of an expanding group of regulatory factors that control cell proliferation and loss, is the only known chronobiotic, hormonal regulator of neoplastic cell growth.  At physiol. circulating concns., this indoleamine is cytostatic and inhibits cancer cell proliferation in vitro via specific cell cycle effects.  At pharmacol. concns., melatonin exhibits cytotoxic activity in cancer cells.  At both physiol. and pharmacol. concns., melatonin acts as a differentiating agent in some cancer cells and lowers their invasive and metastatic status through alterations in adhesion mols. and maintenance of gap junctional intercellular communication.  In other cancer cell types, melatonin, either alone or in combination with other agents, induces apoptotic cell death.  Biochem. and mol. mechanisms of melatonin's oncostatic action may include regulation of estrogen receptor expression and transactivation, calcium/calmodulin activity, protein kinase C activity, cytoskeletal architecture and function, intracellular redox status, melatonin receptor-mediated signal transduction cascades, and fatty acid transport and metab.  A major mechanism mediating melatonin's circadian stage-dependent tumor growth inhibitory action is the suppression of epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activity.  This occurs via melatonin receptor-mediated blockade of tumor linoleic acid uptake and its conversion to 13-hydroxyoctadecadienoic acid (13-HODE) which normally activates EGFR/MAPK mitogenic signaling.  This represents a potentially unifying model for the chronobiol. inhibitory regulation of cancer growth by melatonin in the maintenance of the host/cancer balance.  It also provides the 1st biol. explanation of melatonin-induced enhancement of the efficacy and reduced toxicity of chemo- and radiotherapy in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOhZSyiotpHrVg90H21EOLACvtfcHk0lhqHmI8C-N8Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVaqu7o%253D&md5=cf6a9fb4f057847ab7ccf044c0e9a898</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1568026023394407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023394407%26sid%3Dliteratum%253Aachs%26aulast%3DBlask%26aufirst%3DD.%2BE.%26aulast%3DSauer%26aufirst%3DL.%2BA.%26aulast%3DDauchy%26aufirst%3DR.%2BT.%26atitle%3DMelatonin%2520as%2520a%2520chronobiotic%252Fanticancer%2520agent%253A%2520Cellular%252C%2520biochemical%252C%2520and%2520molecular%2520mechanisms%2520of%2520action%2520and%2520their%2520implications%2520for%2520circadian-based%2520cancer%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D113%26epage%3D132%26doi%3D10.2174%2F1568026023394407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seely, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyatt, G.</span></span> <span> </span><span class="NLM_article-title">Melatonin in the treatment of cancer: A systematic review of randomized controlled trials and meta-analysis</span>. <i>J. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1111/j.1600-079X.2005.00258.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1111%2Fj.1600-079X.2005.00258.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=16207291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGqurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=360-366&author=E.+Millsauthor=P.+Wuauthor=D.+Seelyauthor=G.+Guyatt&title=Melatonin+in+the+treatment+of+cancer%3A+A+systematic+review+of+randomized+controlled+trials+and+meta-analysis&doi=10.1111%2Fj.1600-079X.2005.00258.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin in the treatment of cancer: A systematic review of randomized controlled trials and meta-analysis</span></div><div class="casAuthors">Mills, Edward; Wu, Ping; Seely, Dugald; Guyatt, Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">360-366</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Most observational studies show an assocn. between melatonin and cancer in humans.  We conducted a systematic review of randomized controlled trials (RCTs) of melatonin in solid tumor cancer patients and its effect on survival at 1 yr.  With the aid of an information specialist, we searched 10 electronic databases from inception to Oct. 2004.  We included trials using melatonin as either sole treatment or as adjunct treatment.  Prespecified criteria guided our assessment of trial quality.  We conducted a meta-anal. using a random effects model.  We included 10 RCTs published between 1992 and 2003 and included 643 patients.  All trials included solid tumor cancers.  All trials were conducted at the same hospital network, and were unblinded.  Melatonin reduced the risk of death at 1 yr (relative risk: 0.66, 95% confidence interval: 0.59 - 0.73, I2 = 0%, heterogeneity P ≤ 0.56).  Effects were consistent across melatonin dose, and type of cancer.  No severe adverse events were reported.  The substantial redn. in risk of death, low adverse events reported and low costs related to this intervention suggest great potential for melatonin in treating cancer.  Confirming the efficacy and safety of melatonin in cancer treatment will require completion of blinded, independently conducted RCTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIJjwBw40vULVg90H21EOLACvtfcHk0lhqHmI8C-N8Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGqurvJ&md5=bb67876885e97add7c9618f7e6de5c99</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-079X.2005.00258.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-079X.2005.00258.x%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DSeely%26aufirst%3DD.%26aulast%3DGuyatt%26aufirst%3DG.%26atitle%3DMelatonin%2520in%2520the%2520treatment%2520of%2520cancer%253A%2520A%2520systematic%2520review%2520of%2520randomized%2520controlled%2520trials%2520and%2520meta-analysis%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2005%26volume%3D39%26spage%3D360%26epage%3D366%26doi%3D10.1111%2Fj.1600-079X.2005.00258.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, C. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, P. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhães, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lourdes Seabra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, V. M. S.</span></span> <span> </span><span class="NLM_article-title">Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease</span>. <i>J. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1007/s00415-006-0390-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1007%2Fs00415-006-0390-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=17404779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvF2isrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=459-464&author=C.+A.+M.+Medeirosauthor=P.+F.+C.+de+Bruinauthor=L.+A.+Lopesauthor=M.+C.+Magalh%C3%A3esauthor=M.+de+Lourdes+Seabraauthor=V.+M.+S.+de+Bruin&title=Effect+of+exogenous+melatonin+on+sleep+and+motor+dysfunction+in+Parkinson%E2%80%99s+disease&doi=10.1007%2Fs00415-006-0390-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study</span></div><div class="casAuthors">Medeiros, Camila Andrade Mendes; Carvalhedo de Bruin, Pedro Felipe; Lopes, Livia Ariane; Magalhaes, Maria Cecilia; Seabra, Maria de Lourdes; Sales de Bruin, Veralice Meireles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">459-464</span>CODEN:
                <span class="NLM_cas:coden">JNRYA9</span>;
        ISSN:<span class="NLM_cas:issn">0340-5354</span>.
    
            (<span class="NLM_cas:orgname">Steinkopff Verlag</span>)
        </div><div class="casAbstract">Insomnia, sleep fragmentation and excessive daytime sleepiness are common in Parkinson's disease (PD) and may contribute to the redn. of cognition and alertness in those patients.  Melatonin has been shown to improve sleep in several conditions.  In exptl. models of PD, melatonin can ameliorate motor symptoms.  To evaluate the effect of melatonin on sleep and motor dysfunction in PD, we studied 18 patients (Hoehn & Yahr I to III) from a PD clinic.  Prior to treatment, motor dysfunction was assessed by UP-DRS II, III and IV.  Subjective sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI) and daytime somnolence by the Epworth Sleepiness Scale (ESS).  Full polysomnog. (PSG) was performed in all subjects.  Patients were then randomized to receive melatonin (3mg) or placebo one hour before bedtime for four weeks.  All measures were repeated at the end of treatment.  On initial assessment, 14 patients (70%) showed poor quality sleep (PSQI > 6) and eight (40%) excessive daytime sleepiness (ESS > 10).  Increased sleep latency (50%), REM sleep without atonia (66%), and reduced sleep efficiency (72%) were found on PSG.  Eight patients had an apnea/hypopnea index greater than 15 but no severe oxygen desatn. was obsd.  Sleep fragmentation tended to be more severe in patients on lower doses of levodopa (p = 0.07).  Although melatonin significantly improved subjective quality of sleep (p = 0.03) as evaluated by the PSQI index, PSG abnormalities were not changed.  Motor dysfunction was not improved by the use of melatonin.  Undetected differences in motor scores and PSG findings may have been due to a small sample size and a type II error.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-GCJCXVMF-rVg90H21EOLACvtfcHk0lj0S0OwDbCGGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvF2isrw%253D&md5=570de6357c99a70299fb13bd9f8eed51</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00415-006-0390-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00415-006-0390-x%26sid%3Dliteratum%253Aachs%26aulast%3DMedeiros%26aufirst%3DC.%2BA.%2BM.%26aulast%3Dde%2BBruin%26aufirst%3DP.%2BF.%2BC.%26aulast%3DLopes%26aufirst%3DL.%2BA.%26aulast%3DMagalh%25C3%25A3es%26aufirst%3DM.%2BC.%26aulast%3Dde%2BLourdes%2BSeabra%26aufirst%3DM.%26aulast%3Dde%2BBruin%26aufirst%3DV.%2BM.%2BS.%26atitle%3DEffect%2520of%2520exogenous%2520melatonin%2520on%2520sleep%2520and%2520motor%2520dysfunction%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2007%26volume%3D254%26spage%3D459%26epage%3D464%26doi%3D10.1007%2Fs00415-006-0390-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waldhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldhauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtman, R. J.</span></span> <span> </span><span class="NLM_article-title">Bioavailability of oral melatonin in humans</span>. <i>Neuroendocrinology</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1159/000123997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1159%2F000123997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=6493445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaL2MXht1aktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1984&pages=307-313&author=F.+Waldhauserauthor=M.+Waldhauserauthor=H.+R.+Liebermanauthor=M.-H.+Dengauthor=H.+J.+Lynchauthor=R.+J.+Wurtman&title=Bioavailability+of+oral+melatonin+in+humans&doi=10.1159%2F000123997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bioavailability of oral melatonin in humans</span></div><div class="casAuthors">Waldhauser, Franz; Waldhauser, Maria; Lieberman, Harris R.; Deng, Mei Hua; Lynch, Harry J.; Wurtman, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroendocrinology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-13</span>CODEN:
                <span class="NLM_cas:coden">NUNDAJ</span>;
        ISSN:<span class="NLM_cas:issn">0028-3835</span>.
    </div><div class="casAbstract">Cryst. melatonin (I)  [73-31-4] (80 mg) in gelatin capsules was administered to 5 young male volunteers and serum and urinary I levels was measured at intervals.  Changes in serum I levels were best described by a biexponential equation with an absorption const. (ka) of 1.72 h-1 (half-life = 0.40 h) and an elimination const. (kel) of 0.87 h-1 (half-life = 0.80 h).  Peak serum I levels, ranging from 350 to 10,000 times those occurring physiol. at nighttime, were obsd. 60-150 min after its administration, remaining stable for approx. 1.5 h.  The fraction of ingested I that was absorbed, estd. from the area under the curve describing serum I concns. as a function of time after I administration (the concn.-time curve), varied by 25-fold among subjects.  3 Addnl. volunteers received 3 I-contg. capsules (80 mg each) at 60-min intervals.  This regimen extended the duration of elevated serum I levels to 4-6 h.  I excretion closely paralleled serum I levels until 9 h after the hormone's administration, after which urinary levels tended to be higher than those predicted from serum levels.  However, the area under the concn.-time curve for serum I correlated well with the cumulative I excretion during the initial 15 h after I administration, indicating that either approach can be used to est. the absorption of orally administered I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPRh-h4FOJM7Vg90H21EOLACvtfcHk0lj0S0OwDbCGGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXht1aktA%253D%253D&md5=2c24563e18c01d6b418d60041f31327e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1159%2F000123997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000123997%26sid%3Dliteratum%253Aachs%26aulast%3DWaldhauser%26aufirst%3DF.%26aulast%3DWaldhauser%26aufirst%3DM.%26aulast%3DLieberman%26aufirst%3DH.%2BR.%26aulast%3DDeng%26aufirst%3DM.-H.%26aulast%3DLynch%26aufirst%3DH.%2BJ.%26aulast%3DWurtman%26aufirst%3DR.%2BJ.%26atitle%3DBioavailability%2520of%2520oral%2520melatonin%2520in%2520humans%26jtitle%3DNeuroendocrinology%26date%3D1984%26volume%3D39%26spage%3D307%26epage%3D313%26doi%3D10.1159%2F000123997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeMuro, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nafziger, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blask, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menhinick, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertino, J. S.,  Jr.</span></span> <span> </span><span class="NLM_article-title">The absolute bioavailability of oral melatonin</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1177/00912700022009422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1177%2F00912700022009422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10883420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksFWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2000&pages=781-784&author=R.+L.+DeMuroauthor=A.+N.+Nafzigerauthor=D.+E.+Blaskauthor=A.+M.+Menhinickauthor=J.+S.+Bertino&title=The+absolute+bioavailability+of+oral+melatonin&doi=10.1177%2F00912700022009422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The absolute bioavailability of oral melatonin</span></div><div class="casAuthors">DeMuro, Rob L.; Nafziger, Anne N.; Blask, David E.; Menhinick, Anne M.; Bertino, Joseph S., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">781-784</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The abs. bioavailability of oral melatonin tablets was studied in 12 normal healthy volunteers.  Subjects were administered, in a randomized crossover fashion, melatonin 2 mg i.v. and 2 and 4 mg orally.  Both the 2 and the 4 mg oral dosages showed an abs. bioavailability of approx. 15%.  No difference in serum half-life was seen in any of the study phases.  Oral melatonin tablets in dosages of 2 and 4 mg had poor abs. bioavailability, either due to poor oral absorption, large first-pass metab., or a combination of both.  Further studies examg. larger doses, in an attempt to sat. first-pass metab. if it occurs, may be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-4IvXfCxd5bVg90H21EOLACvtfcHk0lj0S0OwDbCGGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksFWrtbc%253D&md5=f38ac768cc72222a521a04d11dc0d3ee</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F00912700022009422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F00912700022009422%26sid%3Dliteratum%253Aachs%26aulast%3DDeMuro%26aufirst%3DR.%2BL.%26aulast%3DNafziger%26aufirst%3DA.%2BN.%26aulast%3DBlask%26aufirst%3DD.%2BE.%26aulast%3DMenhinick%26aufirst%3DA.%2BM.%26aulast%3DBertino%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520absolute%2520bioavailability%2520of%2520oral%2520melatonin%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D40%26spage%3D781%26epage%3D784%26doi%3D10.1177%2F00912700022009422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jockers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delagrange, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubocovich, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markus, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renault, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotos, D. P.</span></span> <span> </span><span class="NLM_article-title">Update on melatonin receptors: IUPHAR Review 20</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">2702</span>– <span class="NLM_lpage">2725</span>, <span class="refDoi"> DOI: 10.1111/bph.13536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1111%2Fbph.13536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=27314810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12ksbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=2702-2725&author=R.+Jockersauthor=P.+Delagrangeauthor=M.+L.+Dubocovichauthor=R.+P.+Markusauthor=N.+Renaultauthor=G.+Tosiniauthor=E.+Ceconauthor=D.+P.+Zlotos&title=Update+on+melatonin+receptors%3A+IUPHAR+Review+20&doi=10.1111%2Fbph.13536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Update on melatonin receptors: IUPHAR Review 20</span></div><div class="casAuthors">Jockers, Ralf; Delagrange, Philippe; Dubocovich, Margarita L.; Markus, Regina P.; Renault, Nicolas; Tosini, Gianluca; Cecon, Erika; Zlotos, Darius P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2702-2725</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Melatonin receptors are seven transmembrane-spanning proteins belonging to the GPCR superfamily.  In mammals, two melatonin receptor subtypes exist - MT1 and MT2 - encoded by the MTNR1A and MTNR1B genes resp.  The current review provides an update on melatonin receptors by the corresponding subcommittee of the International Union of Basic and Clin. Pharmacol.  We will highlight recent developments of melatonin receptor ligands, including radioligands, and give an update on the latest phenotyping results of melatonin receptor knockout mice.  The current status and perspectives of the structure of melatonin receptor will be summarized.  The physiol. importance of melatonin receptor dimers and biol. important and type 2 diabetes-assocd. genetic variants of melatonin receptors will be discussed.  The role of melatonin receptors in physiol. and disease will be further exemplified by their functions in the immune system and the CNS.  Finally, antioxidant and free radical scavenger properties of melatonin and its relation to melatonin receptors will be critically addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKhV4YSnAj7Vg90H21EOLACvtfcHk0liHpO6PreLiwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12ksbrM&md5=91a1f7bc33cdd02656ffc6a2363dffb3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fbph.13536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13536%26sid%3Dliteratum%253Aachs%26aulast%3DJockers%26aufirst%3DR.%26aulast%3DDelagrange%26aufirst%3DP.%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26aulast%3DMarkus%26aufirst%3DR.%2BP.%26aulast%3DRenault%26aufirst%3DN.%26aulast%3DTosini%26aufirst%3DG.%26aulast%3DCecon%26aufirst%3DE.%26aulast%3DZlotos%26aufirst%3DD.%2BP.%26atitle%3DUpdate%2520on%2520melatonin%2520receptors%253A%2520IUPHAR%2520Review%252020%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D2702%26epage%3D2725%26doi%3D10.1111%2Fbph.13536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunoh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkawa, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4222</span>– <span class="NLM_lpage">4239</span>, <span class="refDoi"> DOI: 10.1021/jm0201159</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0201159" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVymsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4222-4239&author=O.+Uchikawaauthor=K.+Fukatsuauthor=R.+Tokunohauthor=M.+Kawadaauthor=K.+Matsumotoauthor=Y.+Imaiauthor=S.+Hinumaauthor=K.+Katoauthor=H.+Nishikawaauthor=K.+Hiraiauthor=M.+Miyamotoauthor=S.+Ohkawa&title=Synthesis+of+a+novel+series+of+tricyclic+indan+derivatives+as+melatonin+receptor+agonists&doi=10.1021%2Fjm0201159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists</span></div><div class="casAuthors">Uchikawa, Osamu; Fukatsu, Kohji; Tokunoh, Ryosuke; Kawada, Mitsuru; Matsumoto, Kiyoharu; Imai, Yumi; Hinuma, Shuji; Kato, Koki; Nishikawa, Hisao; Hirai, Keisuke; Miyamoto, Masaomi; Ohkawa, Shigenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4222-4239</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of tricyclic indan derivs. were prepd. as potential therapeutic agents for sleep disorders and evaluated for their binding affinity to melatonin receptors.  Previously, a conformation of the methoxy group of melatonin (I) resulting in optimal binding of the MT1 receptor had been proposed.  To fix the methoxy group in an active conformation, we decided to synthesize conformationally restricted tricyclic indan analogs with the oxygen atom in the 6-position incorporated into a furan, 1,3-dioxane, oxazole, pyran, morpholine, or 1,4-dioxane ring system.  Among these compds., indeno[5,4-b]furan analogs II (R = Me, Et, n-Pr) were found to be the most potent and selective MT1 receptor ligands and to have superior metabolic stability.  The optimization of substituents led to (S)-II [R = Et (III)], which showed very strong affinity for human MT1 (Ki = 0.014 nM), but no significant affinity for hamster MT3 (Ki = 2600 nM) or other neurotransmitter receptors.  The pharmacol. effects of III were studied in exptl. animals, and it was found that a dose of 0.1 mg/kg, po promoted a sleep in freely moving cats, as demonstrated by a decrease in wakefulness and increases in slow wave sleep and rapid eye movement sleep, which lasted for 6 h after administration.  I (1 mg/kg, po) also had a sleep-promoting effect, though it lasted only 2 h.  A new chiral method for the synthesis of III starting from IV, which was prepd. from V employing asym. hydrogenation with the (S)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl-Ru complex, was developed.  III (TAK-375) is currently in clin. trials for the treatment of insomnia and circadian rhythm disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-sBC1iSUoY7Vg90H21EOLACvtfcHk0liHpO6PreLiwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVymsrk%253D&md5=3ad626e9e7e94fa016758a8886ab3724</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0201159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0201159%26sid%3Dliteratum%253Aachs%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DFukatsu%26aufirst%3DK.%26aulast%3DTokunoh%26aufirst%3DR.%26aulast%3DKawada%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DOhkawa%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520series%2520of%2520tricyclic%2520indan%2520derivatives%2520as%2520melatonin%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4222%26epage%3D4239%26doi%3D10.1021%2Fjm0201159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span> <span> </span><span class="NLM_article-title">Neurochemical propertie of ramelteon (TAK-375), a selective MT<sub>1</sub>/MT<sub>2</sub> receptor agonist</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.neuropharm.2004.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15695169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=301-310&author=K.+Katoauthor=K.+Hiraiauthor=K.+Nishiyamaauthor=O.+Uchikawaauthor=K.+Fukatsuauthor=S.+Ohkawaauthor=Y.+Kawamataauthor=S.+Hinumaauthor=M.+Miyamoto&title=Neurochemical+propertie+of+ramelteon+%28TAK-375%29%2C+a+selective+MT1%2FMT2+receptor+agonist&doi=10.1016%2Fj.neuropharm.2004.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist</span></div><div class="casAuthors">Kato, Koki; Hirai, Keisuke; Nishiyama, Keiji; Uchikawa, Osamu; Fukatsu, Kohji; Ohkawa, Shigenori; Kawamata, Yuji; Hinuma, Shuji; Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-310</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ramelteon (TAK-375) is a novel melatonin receptor agonist currently under investigation for the treatment of insomnia.  This study describes the neurochem. and receptor binding characteristics of ramelteon in vitro.  Ramelteon showed very high affinity for human MT1 (Mel1a) and MT2 (Mel1b) receptors (expressed in Chinese hamster ovary [CHO] cells), and chick forebrain melatonin receptors (consisting of Mel1a and Mel1c receptors) with K i values of 14.0, 112, and 23.1 pM, resp., making the affinities of ramelteon for these receptors 3 - 16 times higher than those of melatonin.  The affinity of ramelteon for hamster brain MT3 binding sites was extremely weak (K i: 2.65 μM) compared to melatonin's affinity for the MT3 binding site (K i: 24.1 nM).  In addn., ramelteon showed no measurable affinity for a large no. of ligand binding sites (including benzodiazepine receptors, dopamine receptors, opiate receptors, ion channels, and transporters) and no effect on the activity of various enzymes.  Ramelteon inhibited forskolin-stimulated cAMP prodn. in the CHO cells that express the human MT1 or MT2 receptors.  Taken together, these results indicate that ramelteon is a potent and highly selective agonist of MT1/MT2 melatonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom8AZjargfI7Vg90H21EOLACvtfcHk0liHpO6PreLiwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOksLk%253D&md5=3b21530d660512328ab64d5cbab3d734</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DNishiyama%26aufirst%3DK.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DFukatsu%26aufirst%3DK.%26aulast%3DOhkawa%26aufirst%3DS.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DNeurochemical%2520propertie%2520of%2520ramelteon%2520%2528TAK-375%2529%252C%2520a%2520selective%2520MT1%252FMT2%2520receptor%2520agonist%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D48%26spage%3D301%26epage%3D310%26doi%3D10.1016%2Fj.neuropharm.2004.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of ramelteon, a selective MT<sub>1</sub>/MT<sub>2</sub> receptor agonist: a novel therapeutic drug for sleep disorders</span>. <i>CNS Neurosci. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1111/j.1755-5949.2008.00066.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1111%2Fj.1755-5949.2008.00066.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=19228178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=32-51&author=M.+Miyamoto&title=Pharmacology+of+ramelteon%2C+a+selective+MT1%2FMT2+receptor+agonist%3A+a+novel+therapeutic+drug+for+sleep+disorders&doi=10.1111%2Fj.1755-5949.2008.00066.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders</span></div><div class="casAuthors">Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-51</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  An estd. one-third of the general population is affected by insomnia, and this no. is increasing due to more stressful working conditions and the progressive aging of society.  However, current treatment of insomnia with hypnotics, gamma-aminobutyric acid A (GABAA) receptor modulators, induces various side effects, including cognitive impairment, motor disturbance, dependence, tolerance, hangover, and rebound insomnia.  Ramelteon (Rozerem; Takeda Pharmaceutical Company Limited, Osaka, Japan) is an orally active, highly selective melatonin MT1/MT2 receptor agonist.  Unlike the sedative hypnotics that target GABAA receptor complexes, ramelteon is a chronohypnotic that acts on the melatonin MT1 and MT2 receptors, which are primarily located in the suprachiasmatic nucleus, the body's "master clock.".  As such, ramelteon possesses the first new therapeutic mechanism of action for a prescription insomnia medication in over three decades.  Ramelteon has demonstrated sleep-promoting effects in clin. trials, and coupled with its favorable safety profile and lack of abuse potential or dependence, this chronohypnotic provides an important treatment option for insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaq1w47EuISbVg90H21EOLACvtfcHk0lhfFBEw2CQktg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnsbw%253D&md5=323034d6dc75770fbe7d8f3f3d925ab5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2008.00066.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2008.00066.x%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DPharmacology%2520of%2520ramelteon%252C%2520a%2520selective%2520MT1%252FMT2%2520receptor%2520agonist%253A%2520a%2520novel%2520therapeutic%2520drug%2520for%2520sleep%2520disorders%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2009%26volume%3D15%26spage%3D32%26epage%3D51%26doi%3D10.1111%2Fj.1755-5949.2008.00066.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolbert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span> <span> </span><span class="NLM_article-title">Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT<sub>1</sub> and MT<sub>2</sub> melatonin receptor agonist indicated for treatment of insomnia</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1177/0091270005283461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1177%2F0091270005283461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=16432265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFejs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=140-148&author=A.+Karimauthor=D.+Tolbertauthor=C.+Cao&title=Disposition+kinetics+and+tolerance+of+escalating+single+doses+of+ramelteon%2C+a+high-affinity+MT1+and+MT2+melatonin+receptor+agonist+indicated+for+treatment+of+insomnia&doi=10.1177%2F0091270005283461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia</span></div><div class="casAuthors">Karim, Aziz; Tolbert, Dwain; Cao, Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Ramelteon is a selective MT1/MT2 receptor agonist, indicated for insomnia treatment.  Safety, tolerance, pharmacokinetics, and cognitive performance were evaluated following increasing ramelteon doses.  Healthy adults (35-65 years) were randomly assigned to receive 1 of 5 oral ramelteon doses (4, 8, 16, 32, or 64 mg; n = 8 per group) or placebo (n = 20).  Cmax and AUC∞ (mean [%CV]) increased with each dose: Cmax = 1.15 (109), 5.73 (97), 6.92 (77), 17.4 (76), and 25.9 (77) ng/mL, resp., and AUC∞ = 1.71 (114), 6.95 (108), 9.88 (78), 22.5 (80), and 36.1 (71 ng•h/mL), resp.  Mean Tmax values of 0.75 to 0.94 h and mean elimination half-life of 0.83 to 1.90 h remained relatively const.  Ramelteon was extensively metabolized.  Besides ramelteon, 4 metabolites, M-I, M-II, M-III, and M-IV, were measured in serum.  Metabolite M-II, which has shown weak ramelteon-like activity in vitro, was the major metabolite in serum.  Digit Symbol Substitution Test and visual analog scale alertness scores were similar across all dose groups and did not differ from placebo.  All adverse events were mild or moderate and resolved before study completion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQKT7xinirK7Vg90H21EOLACvtfcHk0lhfFBEw2CQktg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFejs7c%253D&md5=2d241de7296dcff0d4d1fa6cfa847bd7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1177%2F0091270005283461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270005283461%26sid%3Dliteratum%253Aachs%26aulast%3DKarim%26aufirst%3DA.%26aulast%3DTolbert%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DC.%26atitle%3DDisposition%2520kinetics%2520and%2520tolerance%2520of%2520escalating%2520single%2520doses%2520of%2520ramelteon%252C%2520a%2520high-affinity%2520MT1%2520and%2520MT2%2520melatonin%2520receptor%2520agonist%2520indicated%2520for%2520treatment%2520of%2520insomnia%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D140%26epage%3D148%26doi%3D10.1177%2F0091270005283461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, A.-E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarimont, C.</span></span> <span> </span><span class="NLM_article-title">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2FS1359-6446%2804%2903280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15574318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1020-1028&author=A.-E.+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+decision-making+process+in+the+structural+modification+of+drug+candidates%3A+enhancing+metabolic+stability&doi=10.1016%2FS1359-6446%2804%2903280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Kamel, Amin M.; Clarimont, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1020-1028</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.  The activity-exposure-toxicity relationship, which can be described as the rule of three', presents the single most difficult challenge in the design of drug candidates and their subsequent advancement to the development stage.  ADME studies are widely used in drug discovery to optimize the balance of properties necessary to convert lead candidates into drugs that are safe and effective for humans.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokn5ucRSES-rVg90H21EOLACvtfcHk0lhfFBEw2CQktg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL&md5=67a85a167b62f0ea4e9f43d25f3e0866</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903280-5%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.-E.%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520decision-making%2520process%2520in%2520the%2520structural%2520modification%2520of%2520drug%2520candidates%253A%2520enhancing%2520metabolic%2520stability%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1020%26epage%3D1028%26doi%3D10.1016%2FS1359-6446%2804%2903280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4-aza analog of ramelteon: a novel tricyclic 1,6,7,8-tetrahydro-2<i>H</i>-cyclopenta[<i>d</i>]furo[2,3-<i>b</i>]pyridine derivative as melatonin receptor ligand</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3009</span>– <span class="NLM_lpage">3011</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.03.147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.tetlet.2011.03.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=3009-3011&author=T.+Koikeauthor=Y.+Hoashiauthor=T.+Takaiauthor=O.+Uchikawa&title=Synthesis+of+4-aza+analog+of+ramelteon%3A+a+novel+tricyclic+1%2C6%2C7%2C8-tetrahydro-2H-cyclopenta%5Bd%5Dfuro%5B2%2C3-b%5Dpyridine+derivative+as+melatonin+receptor+ligand&doi=10.1016%2Fj.tetlet.2011.03.147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4-aza analog of ramelteon: a novel tricyclic 1,6,7,8-tetrahydro-2H-cyclopenta[d]furo[2,3-b]pyridine derivative as melatonin receptor ligand</span></div><div class="casAuthors">Koike, Tatsuki; Hoashi, Yasutaka; Takai, Takafumi; Uchikawa, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3009-3011</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The 4-aza analog of ramelteon (-)-I, a novel tricyclic 1,6,7,8-tetrahydro-2H-cyclopenta[d]furo[2,3-b]pyridine deriv., was synthesized via the intramol. inverse electron demand Diels-Alder reaction followed by fluoride-induced desilylation-cyclization.  (-)-I was shown to exhibit potent binding affinities for melatonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4ahHll0X4kLVg90H21EOLACvtfcHk0li-A7ethugu3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWntbo%253D&md5=e8e4acb32517063506f3095001ddb75b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.03.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.03.147%26sid%3Dliteratum%253Aachs%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DUchikawa%26aufirst%3DO.%26atitle%3DSynthesis%2520of%25204-aza%2520analog%2520of%2520ramelteon%253A%2520a%2520novel%2520tricyclic%25201%252C6%252C7%252C8-tetrahydro-2H-cyclopenta%255Bd%255Dfuro%255B2%252C3-b%255Dpyridine%2520derivative%2520as%2520melatonin%2520receptor%2520ligand%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D3009%26epage%3D3011%26doi%3D10.1016%2Fj.tetlet.2011.03.147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a novel tricyclic 1,6,7,8-tetrahydro-2<i>H</i>-cyclopenta[<i>b</i>]furo[3,2-<i>d</i>]pyridine derivative, the 5-aza analog of ramelteon</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4014</span>– <span class="NLM_lpage">4016</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.05.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.tetlet.2014.05.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsl2js7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=4014-4016&author=Y.+Hoashiauthor=T.+Takaiauthor=T.+Koikeauthor=O.+Uchikawa&title=Synthesis+of+a+novel+tricyclic+1%2C6%2C7%2C8-tetrahydro-2H-cyclopenta%5Bb%5Dfuro%5B3%2C2-d%5Dpyridine+derivative%2C+the+5-aza+analog+of+ramelteon&doi=10.1016%2Fj.tetlet.2014.05.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a novel tricyclic 1,6,7,8-tetrahydro-2H-cyclopenta[b]furo[3,2-d]pyridine derivative, the 5-aza analog of ramelteon</span></div><div class="casAuthors">Hoashi, Yasutaka; Takai, Takafumi; Koike, Tatsuki; Uchikawa, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">4014-4016</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The 5-aza analog of ramelteon I, a novel tricyclic 1,6,7,8-tetrahydro-2H-cyclopenta[b]furo[3,2-d]pyridine deriv., was synthesized by hetero-Diels-Alder reaction and chemoselective Dieckmann condensation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0pNY2EeE4fbVg90H21EOLACvtfcHk0li-A7ethugu3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsl2js7g%253D&md5=ac41b03904574c5e88b66c46e99367a8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DUchikawa%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520tricyclic%25201%252C6%252C7%252C8-tetrahydro-2H-cyclopenta%255Bb%255Dfuro%255B3%252C2-d%255Dpyridine%2520derivative%252C%2520the%25205-aza%2520analog%2520of%2520ramelteon%26jtitle%3DTetrahedron%2520Lett.%26date%3D2014%26volume%3D55%26spage%3D4014%26epage%3D4016%26doi%3D10.1016%2Fj.tetlet.2014.05.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridines as melatonin receptor (MT<sub>1</sub>/MT<sub>2</sub>) ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4207</span>– <span class="NLM_lpage">4218</span>, <span class="refDoi"> DOI: 10.1021/jm200385u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200385u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFymtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4207-4218&author=T.+Koikeauthor=T.+Takaiauthor=Y.+Hoashiauthor=M.+Nakayamaauthor=Y.+Kosugiauthor=M.+Nakashimaauthor=S.+Yoshikuboauthor=K.+Hiraiauthor=O.+Uchikawa&title=Synthesis+of+a+novel+series+of+tricyclic+dihydrofuran+derivatives%3A+discovery+of+8%2C9-dihydrofuro%5B3%2C2-c%5Dpyrazolo%5B1%2C5-a%5Dpyridines+as+melatonin+receptor+%28MT1%2FMT2%29+ligands&doi=10.1021%2Fjm200385u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Novel Series of Tricyclic Dihydrofuran Derivatives: Discovery of 8,9-Dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as Melatonin Receptor (MT1/MT2) Ligands</span></div><div class="casAuthors">Koike, Tatsuki; Takai, Takafumi; Hoashi, Yasutaka; Nakayama, Masaharu; Kosugi, Yohei; Nakashima, Masato; Yoshikubo, Shin-ichi; Hirai, Keisuke; Uchikawa, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4207-4218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel tricyclic dihydrofuran derivs. were designed, synthesized, and evaluated as melatonin receptor (MT1/MT2) ligands based on the previously reported 1,6-dihydro-2H-indeno[5,4-b]furan I.  By screening the central tricyclic cores, 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridine was identified as a potent scaffold with a high ligand-lipophilicity efficiency (LLE) value.  Subsequent optimization of the side chains led to identification of the potent MT1/MT2 agonist II (MT1, Ki = 0.062 nM; MT2, Ki = 0.420 nM) with good oral absorption and blood-brain barrier (BBB) penetration in rats.  The oral administration of compd. II exhibited a sleep-promoting action in freely moving cats at 0.1 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjmbUJVsQKUrVg90H21EOLACvtfcHk0li-A7ethugu3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFymtLw%253D&md5=6e698973df776694731852f6c5215aa7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm200385u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200385u%26sid%3Dliteratum%253Aachs%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DKosugi%26aufirst%3DY.%26aulast%3DNakashima%26aufirst%3DM.%26aulast%3DYoshikubo%26aufirst%3DS.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DUchikawa%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520series%2520of%2520tricyclic%2520dihydrofuran%2520derivatives%253A%2520discovery%2520of%25208%252C9-dihydrofuro%255B3%252C2-c%255Dpyrazolo%255B1%252C5-a%255Dpyridines%2520as%2520melatonin%2520receptor%2520%2528MT1%252FMT2%2529%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4207%26epage%3D4218%26doi%3D10.1021%2Fjm200385u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stauch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slocum, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brehm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiriaeva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, R. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tribo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weierstall, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span> <span> </span><span class="NLM_article-title">Structural basis of ligand recognition at the human MT<sub>1</sub> melatonin receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>569</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1141-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1038%2Fs41586-019-1141-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=31019306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosVSkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=569&publication_year=2019&pages=284-288&author=B.+Stauchauthor=L.+C.+Johanssonauthor=J.+D.+McCorvyauthor=N.+Patelauthor=G.+W.+Hanauthor=X.+P.+Huangauthor=C.+Gatiauthor=A.+Batyukauthor=S.+T.+Slocumauthor=A.+Ishchenkoauthor=W.+Brehmauthor=T.+A.+Whiteauthor=N.+Michaelianauthor=C.+Madsenauthor=L.+Zhuauthor=T.+D.+Grantauthor=J.+M.+Grandnerauthor=A.+Shiriaevaauthor=R.+H.+J.+Olsenauthor=A.+R.+Triboauthor=S.+Yousauthor=R.+C.+Stevensauthor=U.+Weierstallauthor=V.+Katritchauthor=B.+L.+Rothauthor=W.+Liuauthor=V.+Cherezov&title=Structural+basis+of+ligand+recognition+at+the+human+MT1+melatonin+receptor&doi=10.1038%2Fs41586-019-1141-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of ligand recognition at the human MT1 melatonin receptor</span></div><div class="casAuthors">Stauch, Benjamin; Johansson, Linda C.; McCorvy, John D.; Patel, Nilkanth; Han, Gye Won; Huang, Xi-Ping; Gati, Cornelius; Batyuk, Alexander; Slocum, Samuel T.; Ishchenko, Andrii; Brehm, Wolfgang; White, Thomas A.; Michaelian, Nairie; Madsen, Caleb; Zhu, Lan; Grant, Thomas D.; Grandner, Jessica M.; Shiriaeva, Anna; Olsen, Reid H. J.; Tribo, Alexandra R.; Yous, Said; Stevens, Raymond C.; Weierstall, Uwe; Katritch, Vsevolod; Roth, Bryan L.; Liu, Wei; Cherezov, Vadim</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">569</span>
        (<span class="NLM_cas:issue">7755</span>),
    <span class="NLM_cas:pages">284-288</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone that maintains circadian rhythms by synchronization to environmental cues and is involved in diverse physiol. processes such as the regulation of blood pressure and core body temp., oncogenesis, and immune function.  Melatonin is formed in the pineal gland in a light-regulated manner by enzymic conversion from 5-hydroxytryptamine (5-HT or serotonin), and modulates sleep and wakefulness by activating two high-affinity G-protein-coupled receptors, type 1A (MT1) and type 1B (MT2).  Shift work, travel, and ubiquitous artificial lighting can disrupt natural circadian rhythms; as a result, sleep disorders affect a substantial population in modern society and pose a considerable economic burden.  Over-the-counter melatonin is widely used to alleviate jet lag and as a safer alternative to benzodiazepines and other sleeping aids, and is one of the most popular supplements in the United States.  Here, we present high-resoln. room-temp. X-ray free electron laser (XFEL) structures of MT1 in complex with four agonists: the insomnia drug ramelteon, two melatonin analogs, and the mixed melatonin-serotonin antidepressant agomelatine.  The structure of MT2 is described in an accompanying paper.  Although the MT1 and 5-HT receptors have similar endogenous ligands, and agomelatine acts on both receptors, the receptors differ markedly in the structure and compn. of their ligand pockets; in MT1, access to the ligand pocket is tightly sealed from solvent by extracellular loop 2, leaving only a narrow channel between transmembrane helixes IV and V that connects it to the lipid bilayer.  The binding site is extremely compact, and ligands interact with MT1 mainly by strong arom. stacking with Phe179 and auxiliary hydrogen bonds with Asn162 and Gln181.  Our structures provide an unexpected example of atypical ligand entry for a non-lipid receptor, lay the mol. foundation of ligand recognition by melatonin receptors, and will facilitate the design of future tool compds. and therapeutic agents, while their comparison to 5-HT receptors yields insights into the evolution and polypharmacol. of G-protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplFhqB4FkpoLVg90H21EOLACvtfcHk0ljERrigOu_Ilg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosVSkur0%253D&md5=61cecfc7a75118449d015c5b695d2f8f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1141-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1141-3%26sid%3Dliteratum%253Aachs%26aulast%3DStauch%26aufirst%3DB.%26aulast%3DJohansson%26aufirst%3DL.%2BC.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DSlocum%26aufirst%3DS.%2BT.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DBrehm%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DMichaelian%26aufirst%3DN.%26aulast%3DMadsen%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DGrant%26aufirst%3DT.%2BD.%26aulast%3DGrandner%26aufirst%3DJ.%2BM.%26aulast%3DShiriaeva%26aufirst%3DA.%26aulast%3DOlsen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DTribo%26aufirst%3DA.%2BR.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DStructural%2520basis%2520of%2520ligand%2520recognition%2520at%2520the%2520human%2520MT1%2520melatonin%2520receptor%26jtitle%3DNature%26date%3D2019%26volume%3D569%26spage%3D284%26epage%3D288%26doi%3D10.1038%2Fs41586-019-1141-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slocum, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, R. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tribo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatsepin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weierstall, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span> <span> </span><span class="NLM_article-title">XFEL structures of the human MT<sub>2</sub> melatonin receptor reveal the basis of subtype selectivity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>569</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1144-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1038%2Fs41586-019-1144-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=31019305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosVSkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=569&publication_year=2019&pages=289-292&author=L.+C.+Johanssonauthor=B.+Stauchauthor=J.+D.+McCorvyauthor=G.+W.+Hanauthor=N.+Patelauthor=X.-P.+Huangauthor=A.+Batyukauthor=C.+Gatiauthor=S.+T.+Slocumauthor=C.+Liauthor=J.+M.+Grandnerauthor=S.+Haoauthor=R.+H.+J.+Olsenauthor=A.+R.+Triboauthor=S.+Zaareauthor=L.+Zhuauthor=N.+A.+Zatsepinauthor=U.+Weierstallauthor=S.+Yousauthor=R.+C.+Stevensauthor=W.+Liuauthor=B.+L.+Rothauthor=V.+Katritchauthor=V.+Cherezov&title=XFEL+structures+of+the+human+MT2+melatonin+receptor+reveal+the+basis+of+subtype+selectivity&doi=10.1038%2Fs41586-019-1144-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity</span></div><div class="casAuthors">Johansson, Linda C.; Stauch, Benjamin; McCorvy, John D.; Han, Gye Won; Patel, Nilkanth; Huang, Xi-Ping; Batyuk, Alexander; Gati, Cornelius; Slocum, Samuel T.; Li, Chufeng; Grandner, Jessica M.; Hao, Shuming; Olsen, Reid H. J.; Tribo, Alexandra R.; Zaare, Sahba; Zhu, Lan; Zatsepin, Nadia A.; Weierstall, Uwe; Yous, Said; Stevens, Raymond C.; Liu, Wei; Roth, Bryan L.; Katritch, Vsevolod; Cherezov, Vadim</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">569</span>
        (<span class="NLM_cas:issue">7755</span>),
    <span class="NLM_cas:pages">289-292</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The human MT1 and MT2 melatonin receptors1,2 are G-protein-coupled receptors (GPCRs) that help to regulate circadian rhythm and sleep patterns3.  Drug development efforts have targeted both receptors for the treatment of insomnia, circadian rhythm and mood disorders, and cancer3, and MT2 has also been implicated in type 2 diabetes4,5.  Here we report X-ray free electron laser (XFEL) structures of the human MT2 receptor in complex with the agonists 2-phenylmelatonin (2-PMT) and ramelteon6 at resolns. of 2.8 Å and 3.3 Å, resp., along with two structures of function-related mutants: H2085.46A (superscripts represent the Ballesteros-Weinstein residue numbering nomenclature7) and N862.50D, obtained in complex with 2-PMT.  Comparison of the structures of MT2 with a published structure8 of MT1 reveals that, despite conservation of the orthosteric ligand-binding site residues, there are notable conformational variations as well as differences in [3H]melatonin dissocn. kinetics that provide insights into the selectivity between melatonin receptor subtypes.  A membrane-buried lateral ligand entry channel is obsd. in both MT1 and MT2, but in addn. the MT2 structures reveal a narrow opening towards the solvent in the extracellular part of the receptor.  We provide functional and kinetic data that support a prominent role for intramembrane ligand entry in both receptors, and suggest that there might also be an extracellular entry path in MT2.  Our findings contribute to a mol. understanding of melatonin receptor subtype selectivity and ligand access modes, which are essential for the design of highly selective melatonin tool compds. and therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrePfxnJ1rXDbVg90H21EOLACvtfcHk0ljERrigOu_Ilg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosVSkuro%253D&md5=6627fc1e26c873f6a14a7a4d4bf3a346</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1144-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1144-0%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DL.%2BC.%26aulast%3DStauch%26aufirst%3DB.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DSlocum%26aufirst%3DS.%2BT.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DGrandner%26aufirst%3DJ.%2BM.%26aulast%3DHao%26aufirst%3DS.%26aulast%3DOlsen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DTribo%26aufirst%3DA.%2BR.%26aulast%3DZaare%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZatsepin%26aufirst%3DN.%2BA.%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DXFEL%2520structures%2520of%2520the%2520human%2520MT2%2520melatonin%2520receptor%2520reveal%2520the%2520basis%2520of%2520subtype%2520selectivity%26jtitle%3DNature%26date%3D2019%26volume%3D569%26spage%3D289%26epage%3D292%26doi%3D10.1038%2Fs41586-019-1144-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iben, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1197</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.bmcl.2003.12.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=14980664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1197-1200&author=L.-Q.+Sunauthor=J.+Chenauthor=K.+Takakiauthor=G.+Johnsonauthor=L.+Ibenauthor=C.+D.+Mahleauthor=E.+Ryanauthor=C.+Xu&title=Design+and+synthesis+of+benzoxazole+derivatives+as+novel+melatoninergic+ligands&doi=10.1016%2Fj.bmcl.2003.12.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands</span></div><div class="casAuthors">Sun, Li-Qiang; Chen, Jie; Takaki, Katherine; Johnson, Graham; Iben, Lawrence; Mahle, Cathy D.; Ryan, Elaine; Xu, Cen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1197-1200</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A novel series of benzoxazole derivs. was synthesized and evaluated as melatoninergic ligands.  The binding affinity of these compds. for human MT1 and MT2 receptors was detd. using 2-[125I]-iodomelatonin as the radioligand.  The benzoxazole I exhibited better MT1 and MT2 receptor affinities than melatonin itself.  This work also established the benzoxazole nucleus as a melatoninergic pharmacophore, which served as an isosteric replacement to the previously established alkoxyaryl core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocaz6w4FAKT7Vg90H21EOLACvtfcHk0lgnUPynmuPx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFemur4%253D&md5=68b709c6e89526b54d3296ffe8577611</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTakaki%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DG.%26aulast%3DIben%26aufirst%3DL.%26aulast%3DMahle%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520benzoxazole%2520derivatives%2520as%2520novel%2520melatoninergic%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1197%26epage%3D1200%26doi%3D10.1016%2Fj.bmcl.2003.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deskus, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epperson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iben, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship of novel benzoxazole derivatives as melatonin receptor agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3799</span>– <span class="NLM_lpage">3802</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.bmcl.2004.04.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15203165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFymurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3799-3802&author=L.-Q.+Sunauthor=J.+Chenauthor=M.+Bruceauthor=J.+A.+Deskusauthor=J.+R.+Eppersonauthor=K.+Takakiauthor=G.+Johnsonauthor=L.+Ibenauthor=C.+D.+Mahleauthor=E.+Ryanauthor=C.+Xu&title=Synthesis+and+structure%E2%80%93activity+relationship+of+novel+benzoxazole+derivatives+as+melatonin+receptor+agonists&doi=10.1016%2Fj.bmcl.2004.04.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists</span></div><div class="casAuthors">Sun, Li-Qiang; Chen, Jie; Bruce, Marc; Deskus, Jeffrey A.; Epperson, James R.; Takaki, Katherine; Johnson, Graham; Iben, Lawrence; Mahle, Cathy D.; Ryan, Elaine; Xu, Cen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3799-3802</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A series of benzoxazoles I [R1 = H, Me, Et, n-Pr, Me2CH, Ph, Ph(CH2)4; R2 = Me, Et, n-Pr, Me2CH, cyclopropyl, EtNH] was synthesized and evaluated as melatoninergic ligands.  The binding affinity of these compds. for human MT1 and MT2 receptors was detd. using 2-[125I]-iodomelatonin as the radioligand.  From this series of benzoxazole derivs., I (R1 = Me; R2 = Et, cyclopropyl) were identified as melatonin receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8oFAqTptsrrVg90H21EOLACvtfcHk0lgnUPynmuPx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFymurk%253D&md5=c93a2a49b441778615f5c1fb20fd9ee1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.082%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBruce%26aufirst%3DM.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DEpperson%26aufirst%3DJ.%2BR.%26aulast%3DTakaki%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DG.%26aulast%3DIben%26aufirst%3DL.%26aulast%3DMahle%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520novel%2520benzoxazole%2520derivatives%2520as%2520melatonin%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3799%26epage%3D3802%26doi%3D10.1016%2Fj.bmcl.2004.04.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">Values for cLogP were calculated by the software of Daylight Chemical Information Systems, Inc.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muckensturm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diyani, F.</span></span> <span> </span><span class="NLM_article-title">An improved preparation of 7-hydroxyindan-1-ones</span>. <i>J. Chem. Res. Miniprint</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2544</span>– <span class="NLM_lpage">2556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1995&pages=2544-2556&author=B.+Muckensturmauthor=F.+Diyani&title=An+improved+preparation+of+7-hydroxyindan-1-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuckensturm%26aufirst%3DB.%26aulast%3DDiyani%26aufirst%3DF.%26atitle%3DAn%2520improved%2520preparation%2520of%25207-hydroxyindan-1-ones%26jtitle%3DJ.%2520Chem.%2520Res.%2520Miniprint%26date%3D1995%26volume%3D11%26spage%3D2544%26epage%3D2556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musso, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selph, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigdon, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styles, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, W. R.</span></span> <span> </span><span class="NLM_article-title">Indanylidenes. 1. Design and synthesis of (<i>E</i>)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1021/jm020067s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020067s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD38XpvVantL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=399-408&author=D.+L.+Mussoauthor=F.+R.+Cochranauthor=J.+L.+Kelleyauthor=E.+W.+McLeanauthor=J.+L.+Selphauthor=G.+C.+Rigdonauthor=G.+F.+Orrauthor=R.+G.+Davisauthor=B.+R.+Cooperauthor=V.+L.+Stylesauthor=J.+B.+Thompsonauthor=W.+R.+Hall&title=Indanylidenes.+1.+Design+and+synthesis+of+%28E%29-2-%284%2C6-difluoro-1-indanylidene%29acetamide%2C+a+potent%2C+centrally+acting+muscle+relaxant+with+antiinflammatory+and+analgesic+activity&doi=10.1021%2Fjm020067s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Indanylidenes. 1. Design and Synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a Potent, Centrally Acting Muscle Relaxant with Antiinflammatory and Analgesic Activity</span></div><div class="casAuthors">Musso, David L.; Cochran, Felicia R.; Kelley, James L.; McLean, Ed W.; Selph, Jeffrey L.; Rigdon, Greg C.; Orr, G. Faye; Davis, Ronda G.; Cooper, Barrett R.; Styles, Virgil L.; Thompson, James B.; Hall, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-408</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design of rigid cyclic analogs derived from (E)-N-cyclopropyl-3-(3-fluorophenyl)prop-2-enamide and (E)-N-cyclopropyl-3-(3-fluorophenyl)but-2-enamide has led to the discovery of the potent, centrally acting muscle relaxant (E)-2-(4,6-difluoro-1-indanylidene)acetamide (I).  I also possesses potent antiinflammatory and analgesic activity.  The synthesis and the muscle relaxant, antiinflammatory, and analgesic structure-activity relationships of I and 67 of its analogs is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoY3cTrqnfTLVg90H21EOLACvtfcHk0lgnUPynmuPx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpvVantL4%253D&md5=6b62635649508e1700ac4adea68efdb3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm020067s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020067s%26sid%3Dliteratum%253Aachs%26aulast%3DMusso%26aufirst%3DD.%2BL.%26aulast%3DCochran%26aufirst%3DF.%2BR.%26aulast%3DKelley%26aufirst%3DJ.%2BL.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DSelph%26aufirst%3DJ.%2BL.%26aulast%3DRigdon%26aufirst%3DG.%2BC.%26aulast%3DOrr%26aufirst%3DG.%2BF.%26aulast%3DDavis%26aufirst%3DR.%2BG.%26aulast%3DCooper%26aufirst%3DB.%2BR.%26aulast%3DStyles%26aufirst%3DV.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DHall%26aufirst%3DW.%2BR.%26atitle%3DIndanylidenes.%25201.%2520Design%2520and%2520synthesis%2520of%2520%2528E%2529-2-%25284%252C6-difluoro-1-indanylidene%2529acetamide%252C%2520a%2520potent%252C%2520centrally%2520acting%2520muscle%2520relaxant%2520with%2520antiinflammatory%2520and%2520analgesic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D399%26epage%3D408%26doi%3D10.1021%2Fjm020067s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwachido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayama, N.</span></span> <span> </span><span class="NLM_article-title">Palladium(0)-catalyzed synthesis of 2-alkylbenzothiazoles by a novel thiation of 1-amino-2-iodoarenes with thioamides</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1246/cl.1987.839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1246%2Fcl.1987.839" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1987&pages=839-840&author=K.+Takagiauthor=T.+Iwachidoauthor=N.+Hayama&title=Palladium%280%29-catalyzed+synthesis+of+2-alkylbenzothiazoles+by+a+novel+thiation+of+1-amino-2-iodoarenes+with+thioamides&doi=10.1246%2Fcl.1987.839"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1246%2Fcl.1987.839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.1987.839%26sid%3Dliteratum%253Aachs%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DIwachido%26aufirst%3DT.%26aulast%3DHayama%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520synthesis%2520of%25202-alkylbenzothiazoles%2520by%2520a%2520novel%2520thiation%2520of%25201-amino-2-iodoarenes%2520with%2520thioamides%26jtitle%3DChem.%2520Lett.%26date%3D1987%26volume%3D16%26spage%3D839%26epage%3D840%26doi%3D10.1246%2Fcl.1987.839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiao, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-C.</span></span> <span> </span><span class="NLM_article-title">Facile synthesis of two pyridine alkaloids via functionalized 3,4-dialkylpyridines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3162</span>– <span class="NLM_lpage">3164</span>, <span class="refDoi"> DOI: 10.1021/jo00063a043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00063a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1ynsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=3162-3164&author=M.-J.+Shiaoauthor=W.-L.+Chiaauthor=C.-J.+Pengauthor=C.-C.+Shen&title=Facile+synthesis+of+two+pyridine+alkaloids+via+functionalized+3%2C4-dialkylpyridines&doi=10.1021%2Fjo00063a043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Facile synthesis of two pyridine alkaloids via functionalized 3,4-dialkylpyridines</span></div><div class="casAuthors">Shiao, Min Jen; Chia, Win Long; Peng, Chin Jen; Shen, Chien Chang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3162-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">3-Substituted 4-alkylpyridines, e.g. I (R = H, R1 = Me; R = Me, R1 = H), were obtained in good yields (27-88%) by reaction of mixed copper zinc alkyl organometallics with 3-substituted 1-(ethoxycarbonyl)pyridinium chlorides followed by sulfur oxidn. in boiling xylene.  Compds. I (R = H, R1 = Me; R = Me, R1 = H) were further cyclized and then decarboxylated to give 3,4-annulated pyridines II.  II are important precursors which can be used for the synthesis of two pyridine alkaloids 3,6,6-trimethyl-5,6-dihydro-2-pyrindin-7-one (III) and (±)-actinidine (IV) in 1 and 2 steps, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa7tR9PhcQXLVg90H21EOLACvtfcHk0liPUjIhepnriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1ynsr4%253D&md5=ad474a95ef1e2cfd41a3d5956deff1e2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo00063a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00063a043%26sid%3Dliteratum%253Aachs%26aulast%3DShiao%26aufirst%3DM.-J.%26aulast%3DChia%26aufirst%3DW.-L.%26aulast%3DPeng%26aufirst%3DC.-J.%26aulast%3DShen%26aufirst%3DC.-C.%26atitle%3DFacile%2520synthesis%2520of%2520two%2520pyridine%2520alkaloids%2520via%2520functionalized%25203%252C4-dialkylpyridines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D3162%26epage%3D3164%26doi%3D10.1021%2Fjo00063a043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boekelheide, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedoruk, N. A.</span></span> <span> </span><span class="NLM_article-title">Syntheses of fused aromatic heterocycles by 1,3-dipolar addition reactions. 3-Azapyrrocolines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2062</span>– <span class="NLM_lpage">2064</span>, <span class="refDoi"> DOI: 10.1021/jo01269a075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01269a075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaF1cXktVaqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1968&pages=2062-2064&author=V.+Boekelheideauthor=N.+A.+Fedoruk&title=Syntheses+of+fused+aromatic+heterocycles+by+1%2C3-dipolar+addition+reactions.+3-Azapyrrocolines&doi=10.1021%2Fjo01269a075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of fused aromatic heterocycles by 1,3-dipolar addition reactions.  3-Azapyrrocolines</span></div><div class="casAuthors">Boekelheide, Virgil; Fedoruk, N. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2062-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The reaction of pyridine-N-imines with Et propiolate is a convenient method for prepg. 3-azapyrrocolines.  However, attempts to convert 3,5-trimethylene-3-azapyrrocolinium iodide (I) into 10-azacycl[3.3.2]azine (II) were unsuccessful.  20 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpowSVSuQ1qX7Vg90H21EOLACvtfcHk0liPUjIhepnriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXktVaqsLk%253D&md5=ca79bd74abd9bed30639eeef0b40b169</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo01269a075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01269a075%26sid%3Dliteratum%253Aachs%26aulast%3DBoekelheide%26aufirst%3DV.%26aulast%3DFedoruk%26aufirst%3DN.%2BA.%26atitle%3DSyntheses%2520of%2520fused%2520aromatic%2520heterocycles%2520by%25201%252C3-dipolar%2520addition%2520reactions.%25203-Azapyrrocolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1968%26volume%3D33%26spage%3D2062%26epage%3D2064%26doi%3D10.1021%2Fjo01269a075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Legault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charette, A. B.</span></span> <span> </span><span class="NLM_article-title">Highly efficient synthesis of O-(2,4-dinitrophenyl)hydroxylamine. Application to the synthesis of substituted N-benzoyliminopyridinium ylides</span>. <i>J. Org. Chem..</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">7119</span>– <span class="NLM_lpage">7122</span>, <span class="refDoi"> DOI: 10.1021/jo034456l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo034456l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFOlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=7119-7122&author=C.+Legaultauthor=A.+B.+Charette&title=Highly+efficient+synthesis+of+O-%282%2C4-dinitrophenyl%29hydroxylamine.+Application+to+the+synthesis+of+substituted+N-benzoyliminopyridinium+ylides&doi=10.1021%2Fjo034456l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Efficient Synthesis of O-(2,4-Dinitrophenyl)hydroxylamine. Application to the Synthesis of Substituted N-Benzoyliminopyridinium Ylides</span></div><div class="casAuthors">Legault, Claude; Charette, Andre B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7119-7122</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient two-step synthesis of O-(2,4-dinitrophenyl)hydroxylamine is described along with a comparison of its aminating efficiency with O-mesitylenesulfonylhydroxylamine (MSH).  It was used in an expedient N-amination/benzoylation procedure involving various substituted pyridines, leading to polysubstituted N-benzoyliminopyridinium ylides, and the scope of its amination power was studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro9rq3O_nxx7Vg90H21EOLACvtfcHk0liPUjIhepnriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFOlsLk%253D&md5=78ca7ceaa59fe3a687604f891c9e5685</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo034456l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034456l%26sid%3Dliteratum%253Aachs%26aulast%3DLegault%26aufirst%3DC.%26aulast%3DCharette%26aufirst%3DA.%2BB.%26atitle%3DHighly%2520efficient%2520synthesis%2520of%2520O-%25282%252C4-dinitrophenyl%2529hydroxylamine.%2520Application%2520to%2520the%2520synthesis%2520of%2520substituted%2520N-benzoyliminopyridinium%2520ylides%26jtitle%3DJ.%2520Org.%2520Chem..%26date%3D2003%26volume%3D68%26spage%3D7119%26epage%3D7122%26doi%3D10.1021%2Fjo034456l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boloor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span> <span> </span><span class="NLM_article-title">Efficient and regioselective synthesis of 2-alkyl-2<i>H</i>-indazoles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">4093</span>– <span class="NLM_lpage">4095</span>, <span class="refDoi"> DOI: 10.1021/jo0265434</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0265434" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=4093-4095&author=M.+Cheungauthor=A.+Boloorauthor=J.+A.+Stafford&title=Efficient+and+regioselective+synthesis+of+2-alkyl-2H-indazoles&doi=10.1021%2Fjo0265434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Regioselective Synthesis of 2-Alkyl-2H-indazoles</span></div><div class="casAuthors">Cheung, Mui; Boloor, Amogh; Stafford, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4093-4095</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-Methyl-2H-indazoles and 2-ethyl-2H-indazoles are prepd. regioselectively in 82-96% yields by treatment of 1H-indazoles with either trimethyloxonium tetrafluoroborate or triethyloxonium hexafluorophosphate in Et acetate.  Methoxy, chloro, and nitro-substituted indazoles are regioselectively alkylated under the reaction conditions.  Et acetate is the most effective solvent for the methylation or ethylation reactions; ethylation of 6-nitro-1H-indazole in methylene chloride gives the desired 2-Me indazole in only 50% yield, while in Et acetate ethylation under similar conditions gives the 2-Me indazole in 90% yield.  The regioselectivity and chemoselectivity of methylation of 6-nitro-1H-indazole is strongly dependent upon the methylating agent used; the use of diazomethane in the presence of boron trifluoride etherate gives 1-Me-6-nitro-1H-indazole in 75% yield, Me tosylate gives 2-Me-6-nitro-2H-indazole in 50% yield, and Me iodide gives mixts. contg. both 1-Me and 2-Me indazoles in addn. to 1,2-dimethyl-6-nitro-1H-indazolium iodide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgDXjoXLAPJbVg90H21EOLACvtfcHk0lju28Bz1rKgEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFansb8%253D&md5=6a94eacdbb4247e83c7df66e963ae1f7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo0265434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0265434%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26atitle%3DEfficient%2520and%2520regioselective%2520synthesis%2520of%25202-alkyl-2H-indazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D4093%26epage%3D4095%26doi%3D10.1021%2Fjo0265434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doken, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkawa, S.</span></span> <span> </span><span class="NLM_article-title">The sleep-promoting action of ramelteon (TAK-375) in freely moving cats</span>. <i>Sleep</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1319</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1093/sleep/27.7.1319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1093%2Fsleep%2F27.7.1319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15586784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A280%3ADC%252BD2cnhsVSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1319-1325&author=M.+Miyamotoauthor=H.+Nishikawaauthor=Y.+Dokenauthor=K.+Hiraiauthor=O.+Uchikawaauthor=S.+Ohkawa&title=The+sleep-promoting+action+of+ramelteon+%28TAK-375%29+in+freely+moving+cats&doi=10.1093%2Fsleep%2F27.7.1319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The sleep-promoting action of ramelteon (TAK-375) in freely moving cats</span></div><div class="casAuthors">Miyamoto Masaomi; Nishikawa Hisao; Doken Yayoi; Hirai Keisuke; Uchikawa Osamu; Ohkawa Shigenori</div><div class="citationInfo"><span class="NLM_cas:title">Sleep</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1319-25</span>
        ISSN:<span class="NLM_cas:issn">0161-8105</span>.
    </div><div class="casAbstract">INTRODUCTION:  Ramelteon (TAK-375) is an MT1/MT2 receptor agonist being studied for the treatment of insomnia and circadian rhythm sleep disorders.  We compared the behavioral effects of ramelteon and exogenous melatonin in freely moving cats.  METHODS:  Ramelteon and melatonin were each suspended in a 0.5% (weight per volume) methylcellulose solution and administered orally to freely moving cats.  In the control trial, each cat was given vehicle.  Each dose of ramelteon or melatonin was compared with the vehicle control in a crossover design.  Electroencephalogram, electromyogram, and electrooculogram recordings were assessed.  RESULTS:  Ramelteon significantly decreased wakefulness at doses of 0.001,0.01, and 0.1 mg/kg, increased slow-wave sleep at doses of 0.001, 0.01, and 0.1 mg/kg, and increased rapid eye movement sleep at a dose of 0.1 mg/kg, compared with the vehicle controls, as assessed by analysis of variance.  The effects of ramelteon lasted for up to 6 hours when evaluated by reduction of wakefulness.  Exogenous melatonin (0.01-1 mg/kg) significantly increased slow-wave sleep, but the effect was weaker than that of ramelteon and lasted for only 2 hours.  The lowest doses of ramelteon (0.0001 mg/kg) and melatonin (0.001 mg/kg) had no significant effect on sleep-wakefulness stage.  CONCLUSIONS:  Ramelteon was more effective than exogenous melatonin in promoting and maintaining sleep in freely moving cats.  Based on its unique mechanism of action, ramelteon should be studied further to evaluate its potential for the treatment of sleep disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpxhu-p8KJDzAEfvC7EH1LfW6udTcc2eZ3X2kpIiruMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnhsVSltA%253D%253D&md5=9ae5a4c001b4aad4ff0b66a114d95fde</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fsleep%2F27.7.1319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fsleep%252F27.7.1319%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DDoken%26aufirst%3DY.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DOhkawa%26aufirst%3DS.%26atitle%3DThe%2520sleep-promoting%2520action%2520of%2520ramelteon%2520%2528TAK-375%2529%2520in%2520freely%2520moving%2520cats%26jtitle%3DSleep%26date%3D2004%26volume%3D27%26spage%3D1319%26epage%3D1325%26doi%3D10.1093%2Fsleep%2F27.7.1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':[],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of melatonin, ramelteon, and dihydrofuran-fused tricyclic derivatives (<b>1a</b>, <b>1b</b>, <b>2a</b>, <b>2b</b>, and <b>2c</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of novel tricyclic derivatives and cLogP values of representative compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indeno[5,4-<i>d</i>][1,3]oxazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) fuming HNO<sub>3</sub>, Ac<sub>2</sub>O, AcOH, room temp; (b) Pd/C, H<sub>2</sub>, MeOH, room temp; (c) triethyl orthoformate, THF, reflux; (d) (1) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, room temp, (2) pyridinium <i>p</i>-toluenesulfonate, xylene, reflux; (e) NaH, diethyl cyanomethylphosphonate, THF, 0 °C; (f) (1) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, EtOH, room temp, (2) (R<sup>3</sup>CO)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C, (3) Pd/C, H<sub>2</sub>, MeOH, room temp; and (g) HPLC resolution (CHIRALPAK AD).</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Diversity-Oriented Synthesis of Indeno[5,4-<i>d</i>][1,3]oxazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeI, 1,8-diazabicyclo[5.4.0]undec-7-ene, DMF, room temp; (b) NaH, diethyl cyanomethylphosphonate, THF, 0 °C; (c) Pd/C, H<sub>2</sub>, Et<sub>3</sub>N, AcOEt, room temp; (d) (1) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, EtOH, room temp, (2) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; (e) Pd/C, H<sub>2</sub>, MeOH, room temp; (f) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (g) (1) (R<sup>1</sup>CO)<sub>2</sub>O or R<sup>1</sup>COCl, pyridine, 0 °C; (2) pyridinium p-toluenesulfonate, xylene, reflux; (h) tetramethyl orthocarbonate, THF, reflux; and (i) Pd/C, H<sub>2</sub>, MeOH, room temp.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Indeno[5,4-<i>d</i>][1,3]thiazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodine(I) chloride, CaCO<sub>3</sub>, MeOH, H2O, room temp; (b) thioacetamide, tris(dibenzylideneacetone)dipalladium(0), 1,1′-bis(diphenylphosphino)ferrocene, CaO, DMF, 60 °C; (c) NaH, diethyl cyanomethylphosphonate, THF, 0 °C; (d) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, MeOH, room temp; (e) Pd/C, H<sub>2</sub>, MeOH, room temp; and (f) (R<sup>3</sup>CO)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Cyclopenta[<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, MeOH, THF, reflux, then hydrochloric acid, reflux; (b) (1) diethyl cyanomethylphosphonate, NaH, THF, 0 °C, (2) Pd/C, H<sub>2</sub>, MeOH, room temp; (c) 1-(aminooxy)-2,4-dinitrobenzene, MeCN, 40 °C; (d) ethyl 2-butynoate, K<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (e) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, EtOH, room temp; (f) (1) hydrochloric acid, 100 °C, (2) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; (g) (1) diisobutylaluminum hydride in toluene, THF, (2) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; (h) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; and (i) (1) 40% sulfuric acid, 100 °C, (2) (EtCO)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Cyclopenta[<i>e</i>]indazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-bromosuccimide, MeOH, 0 °C; (b) NaNO<sub>2</sub>, H<sub>2</sub>O, acetic acid, room temp; (c) trimethyloxonium tetrafluoroborate, AcOEt, room temp; (d) Pd(OAc)<sub>2</sub>, triphenylphosphine, K<sub>2</sub>CO<sub>3</sub>, methyl acrylate, DMF, 100 °C; (e) Pd/C, H<sub>2</sub>, MeOH, room temp; (f) NaH, MeOH, THF, then hydrochloric acid, reflux; (g) NaH, diethyl cyanomethylphosphonate, THF, 50 °C; (h) H<sub>2</sub>, Raney cobalt, NH<sub>3</sub>, EtOH , room temp; (i) Ac<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; (j) (EtCO)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 °C; and (k) Pd/C, H<sub>2</sub>, MeOH, room temp.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of clearance in human (a) or rat (b) hepatic microsomes against cLogP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of rat oral bioavailability against clearance in rat hepatic microsomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Functional analysis of melatonin and (<i>S</i>)-<b>3b</b> on forskolin-stimulated cAMP formation in CHO cells expressing either human MT<sub>1</sub> or human MT<sub>2</sub> receptor. The 100% value was the mean cAMP production with 2 μmol/L forskolin. The 0% value was that with 1 μmol/L melatonin and 2 μmol/L forskolin. Data were expressed as mean of percentage forskolin response at each receptor. The EC<sub>50</sub> values were estimated by a two-parameter nonlinear logistic regression analysis. The EC<sub>50</sub> values for melatonin are 0.022 nM (MT<sub>1</sub>, 95% confidence interval = 0.019–0.025 nM) and 0.85 nM (MT<sub>2</sub>, 95% confidence interval = 0.65–1.1 nM). Those for (<i>S</i>)-<b>3b</b> are 0.015 nM (MT<sub>1</sub>, 95% confidence interval = 0.012–0.023) and 0.51 nM (MT<sub>2</sub>, 95% confidence interval = 0.33–0.77).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/medium/jm0c01836_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of (<i>S</i>)-<b>3b</b> on total sleep time in freely moving cats. Seven cats were treated with (<i>S</i>)-<b>3b</b> (10 mg/kg, po) or vehicle. Data were expressed as the mean of total time sleep during 8 h following the oral administration with standard error of mean.*<i>p</i> < 0.05 (versus the vehicle-treated control by ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01836/20210319/images/large/jm0c01836_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01836&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrenetxe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delagrange, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, J. A.</span></span> <span> </span><span class="NLM_article-title">Physiological and metabolic functions of melatonin</span>. <i>J. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1007/BF03168221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1007%2FBF03168221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15352385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFOru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=61-72&author=J.+Barrenetxeauthor=P.+Delagrangeauthor=J.+A.+Mart%C3%ADnez&title=Physiological+and+metabolic+functions+of+melatonin&doi=10.1007%2FBF03168221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological and metabolic functions of melatonin</span></div><div class="casAuthors">Barrenetxe, J.; Delagrange, P.; Martinez, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-72</span>CODEN:
                <span class="NLM_cas:coden">JPBIF2</span>;
        ISSN:<span class="NLM_cas:issn">1138-7548</span>.
    
            (<span class="NLM_cas:orgname">Servicio de Publicaciones de la Universidad de Navarra</span>)
        </div><div class="casAbstract">A review.  Melatonin is a lipophilic hormone, mainly produced and secreted at night by the pineal gland.  Melatonin synthesis is under the control of postganglionic sympathetic fibers that innervates the pineal gland.  Melatonin acts via high affinity G protein-coupled membrane receptors.  To date, three different receptor subtypes have been identified in mammals: MT1 (Mel 1a) and MT2 (Mel 1b) and a putative binding site called MT3.  The chronobiotic properties of the hormone for resynchronization of sleep and circadian rhythms disturbances has been demonstrated both in animal models or in clin. trials.  Several other physiol. effects of melatonin in different peripheral tissues have been described in the past years.  In this way, it has been demonstrated that the hormone is involved in the regulation of seasonal reprodn., body wt. and energy balance.  This contribution has been focused to review some of the physiol. functions of melatonin as well as the role of the hormone in the regulation of energy balance and its possible involvement in the development of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoVCpdxMAe7Vg90H21EOLACvtfcHk0lgRGyYDnJo9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFOru78%253D&md5=53adbe499600cacf18591531ed74dee0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2FBF03168221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03168221%26sid%3Dliteratum%253Aachs%26aulast%3DBarrenetxe%26aufirst%3DJ.%26aulast%3DDelagrange%26aufirst%3DP.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DJ.%2BA.%26atitle%3DPhysiological%2520and%2520metabolic%2520functions%2520of%2520melatonin%26jtitle%3DJ.%2520Physiol.%2520Biochem.%26date%3D2004%26volume%3D60%26spage%3D61%26epage%3D72%26doi%3D10.1007%2FBF03168221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inouye, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, H.</span></span> <span> </span><span class="NLM_article-title">Persistence of circadian rhythmicity in a mammalian hypothalamic ″island″ containing the suprachiasmatic nucleus</span>. <i>Proc. Natl. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">5962</span>– <span class="NLM_lpage">5966</span>, <span class="refDoi"> DOI: 10.1073/pnas.76.11.5962</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1073%2Fpnas.76.11.5962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=293695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A280%3ADyaL3c7gtFGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1979&pages=5962-5966&author=S.+T.+Inouyeauthor=H.+Kawamura&title=Persistence+of+circadian+rhythmicity+in+a+mammalian+hypothalamic+%E2%80%B3island%E2%80%B3+containing+the+suprachiasmatic+nucleus&doi=10.1073%2Fpnas.76.11.5962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus</span></div><div class="casAuthors">Inouye S T; Kawamura H</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5962-6</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The experimental work described tested the prosposition that the suprachiasmatic nucleus of the hypothalamus is an autonomous circadian pacemaker.  Simultaneous recording from two extracellular electrodes indicated neural (multiple unit) activity at two sites in the brain, one of which is in or near the suprachiasmatic nucleus and the other in one of many other brain locations.  Both sites in intact rats displayed clear circadian rhythmicity of spontaneous neural activity.  In experimental animals, a Halasz knife was used to create an island of hypothalamic tissue that contained the suprachiasmatic nuclei.  In such animals that were also blinded by bilateral ocular enucleation, circadian rhythmicity was lost at all brain locations recorded outside the island, but it persisted within the island that contained the suprachiasmatic nuclei.  The rhythmicity of the island is thus not dependent on afferent inputs from elsewhere in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwKnk0Z1ZFeDC850By6mxpfW6udTcc2eY8Vl1oyP5dcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c7gtFGnsw%253D%253D&md5=27d001f2f922db94a31a1be497c6f922</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.76.11.5962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.76.11.5962%26sid%3Dliteratum%253Aachs%26aulast%3DInouye%26aufirst%3DS.%2BT.%26aulast%3DKawamura%26aufirst%3DH.%26atitle%3DPersistence%2520of%2520circadian%2520rhythmicity%2520in%2520a%2520mammalian%2520hypothalamic%2520%25E2%2580%25B3island%25E2%2580%25B3%2520containing%2520the%2520suprachiasmatic%2520nucleus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D1979%26volume%3D76%26spage%3D5962%26epage%3D5966%26doi%3D10.1073%2Fpnas.76.11.5962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reppart, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godson, C.</span></span> <span> </span><span class="NLM_article-title">Melatonin receptors step into the light: cloning and classification of subtypes</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(96)10005-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2F0165-6147%2896%2910005-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=8936344" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=100-102&author=S.+M.+Reppartauthor=D.+R.+Weaverauthor=C.+Godson&title=Melatonin+receptors+step+into+the+light%3A+cloning+and+classification+of+subtypes&doi=10.1016%2F0165-6147%2896%2910005-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2896%2910005-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252896%252910005-5%26sid%3Dliteratum%253Aachs%26aulast%3DReppart%26aufirst%3DS.%2BM.%26aulast%3DWeaver%26aufirst%3DD.%2BR.%26aulast%3DGodson%26aufirst%3DC.%26atitle%3DMelatonin%2520receptors%2520step%2520into%2520the%2520light%253A%2520cloning%2520and%2520classification%2520of%2520subtypes%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1996%26volume%3D17%26spage%3D100%26epage%3D102%26doi%3D10.1016%2F0165-6147%2896%2910005-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubocovich, M. L.</span>; <span class="NLM_string-name">Cardinali, D. P.</span>; <span class="NLM_string-name">Delagrange, P.</span>; <span class="NLM_string-name">Krause, D. N.</span>; <span class="NLM_string-name">Strosberg, A. D.</span>; <span class="NLM_string-name">Sugden, D.</span>; <span class="NLM_string-name">Yocca, F. D.</span></span> <i>The IUPHAR Compendium of Receptor Characterization and Classification</i>; <span class="NLM_publisher-name">IUPHAR Media</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2000</span>; pp.  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">277</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=271-277&author=M.+L.+Dubocovich&author=D.+P.+Cardinali&author=P.+Delagrange&author=D.+N.+Krause&author=A.+D.+Strosberg&author=D.+Sugden&author=F.+D.+Yocca&title=The+IUPHAR+Compendium+of+Receptor+Characterization+and+Classification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26btitle%3DThe%2520IUPHAR%2520Compendium%2520of%2520Receptor%2520Characterization%2520and%2520Classification%26pub%3DIUPHAR%2520Media%26date%3D2000%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helliwell, R.</span></span> <span> </span><span class="NLM_article-title">Melatonin receptors: localization, molecular pharmacology and physiological significance</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/0197-0186(94)90100-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2F0197-0186%2894%2990100-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=8161940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=101-146&author=P.+J.+Morganauthor=P.+Barrettauthor=H.+E.+Howellauthor=R.+Helliwell&title=Melatonin+receptors%3A+localization%2C+molecular+pharmacology+and+physiological+significance&doi=10.1016%2F0197-0186%2894%2990100-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin receptors: localization, molecular pharmacology and physiological significance</span></div><div class="casAuthors">Morgan, Peter J.; Barrett, Perry; Howell, H. Edward; Helliwell, Rachel</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-46</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    </div><div class="casAbstract">A review with ∼ 300 refs. The radioligand 2-[125I]iodomelatonin has been used extensively to localize melatonin binding sites in both the brain and peripheral tissues.  In general these binding sites have been found to be high affinity, with Kd in the low picomolar range, and selective for structural analogs of melatonin.  The affinity of these sites can generally be modulated by guanine nucleotides, consistent with the notion that they are putative G-protein coupled receptors.  Only a few studies have demonstrated that these putative receptors mediate biochem. and cellular responses.  In the pars tuberalis (PT) and pars distalis (PD) of the pituitary, the amphibian melanophore and vertebrate retina, evidence indicates that melatonin acts to inhibit intracellular cAMP through a G-protein coupled mechanism, demonstrating that this is a common signal transduction pathway for many melatonin receptors.  However in the PD the inhibition of Ca influx and membrane potential are also important mediators of melatonin effects.  Melatonin receptor(s) structure and their localization in the brain and melatonin analogs are also discussed.  A model of how melatonin might mediate the timing of the circannual events through the PT is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ8QwPWjM4frVg90H21EOLACvtfcHk0lgYeZ4c7EMI8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKhu7k%253D&md5=0785780ded2d0aed62f8971d4e9f953a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0197-0186%2894%2990100-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0197-0186%252894%252990100-7%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DP.%2BJ.%26aulast%3DBarrett%26aufirst%3DP.%26aulast%3DHowell%26aufirst%3DH.%2BE.%26aulast%3DHelliwell%26aufirst%3DR.%26atitle%3DMelatonin%2520receptors%253A%2520localization%252C%2520molecular%2520pharmacology%2520and%2520physiological%2520significance%26jtitle%3DNeurochem.%2520Int.%26date%3D1994%26volume%3D24%26spage%3D101%26epage%3D146%26doi%3D10.1016%2F0197-0186%2894%2990100-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribkoff, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reppert, S. M.</span></span> <span> </span><span class="NLM_article-title">Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(00)80350-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2FS0896-6273%2800%2980350-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=9247266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK2sXltFCjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=91-102&author=C.+Liuauthor=D.+R.+Weaverauthor=X.+Jinauthor=L.+P.+Shearmanauthor=R.+L.+Pieschlauthor=V.+K.+Gribkoffauthor=S.+M.+Reppert&title=Molecular+dissection+of+two+distinct+actions+of+melatonin+on+the+suprachiasmatic+circadian+clock&doi=10.1016%2FS0896-6273%2800%2980350-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock</span></div><div class="casAuthors">Liu, Chen; Weaver, David R.; Jin, Xiaowei; Shearman, Lauren P.; Pieschl, Rick L.; Gribkoff, Valentin K.; Reppert, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-102</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Melatonin elicits 2 effects on the suprachiasmatic nuclei (SCN): acute neuronal inhibition and phase-shifting.  Melatonin evokes its biol. effects through G protein-coupled receptors.  Since the Mel1a melatonin receptor may transduce the major neurobiol. actions of melatonin in mammals, we examd. whether it mediates both melatonin effects on SCN function by using mice with targeted disruption of the Mel1a receptor.  The Mel1a receptor accounts for all detectable, high-affinity melatonin binding in mouse brain.  Functionally, this receptor is necessary for the acute inhibitory action of melatonin on the SCN.  Melatonin-induced phase shifts, however, are only modestly altered in the receptor-deficient mice; pertussis toxin still blocks melatonin-induced phase shifts in Mel1a receptor-deficient mice.  The other melatonin receptor subtype, the Mel1b receptor, is expressed in mouse SCN, implicating it in the phase-shifting response.  The results provide a mol. basis for 2 distinct, mechanistically separable effects of melatonin on SCN physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmqdWvDwZBa7Vg90H21EOLACvtfcHk0lhJFiSAsY70Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltFCjsrk%253D&md5=e3d39a2b58e1d0fb52d1a94ac5b382a9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980350-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980350-5%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWeaver%26aufirst%3DD.%2BR.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DShearman%26aufirst%3DL.%2BP.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DGribkoff%26aufirst%3DV.%2BK.%26aulast%3DReppert%26aufirst%3DS.%2BM.%26atitle%3DMolecular%2520dissection%2520of%2520two%2520distinct%2520actions%2520of%2520melatonin%2520on%2520the%2520suprachiasmatic%2520circadian%2520clock%26jtitle%3DNeuron%26date%3D1997%26volume%3D19%26spage%3D91%26epage%3D102%26doi%3D10.1016%2FS0896-6273%2800%2980350-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubocovich, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ghoul, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benloucif, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masana, M. I.</span></span> <span> </span><span class="NLM_article-title">Selective MT<sub>2</sub> melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1220</span>, <span class="refDoi"> DOI: 10.1096/fasebj.12.12.1211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1096%2Ffasebj.12.12.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=9737724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK1cXlvFWktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=1211-1220&author=M.+L.+Dubocovichauthor=K.+Yunauthor=W.+M.+Al-Ghoulauthor=S.+Benloucifauthor=M.+I.+Masana&title=Selective+MT2+melatonin+receptor+antagonists+block+melatonin-mediated+phase+advances+of+circadian+rhythms&doi=10.1096%2Ffasebj.12.12.1211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms</span></div><div class="casAuthors">Dubocovich, Margarita L.; Yun, Kenneth; Al-Ghou, Walid M.; Benloucif, Susan; Masana, Monica I.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1211-1220</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">This study demonstrates the involvement of the MT2 (Mel1b) melatonin receptor in mediating phase advances of circadian activity rhythms by melatonin.  In situ hybridization histochem. with digoxigenin-labeled oligonucleotide probes revealed for the first time the expression of mt1 and MT2 melatonin receptor mRNA within the suprachiasmatic nucleus of the C3H/HeN mouse.  Melatonin (0.9-30 μg/mouse, s.c.) administration during 3 days at the end of the subjective day (CT 10) to C3H/HeN mice kept in const. dark phase advanced circadian rhythms of wheel running activity in a dose-dependent manner [EC50 = 0.72 μg/mouse; 0.98 h maximal advance at 9 μg/mouse].  Neither the selective MT2 melatonin receptor antagonists 4P-ADOT and 4P-PDOT (90 μg/mouse, s.c.) nor luzindole (300 μg/mouse, s.c.), which shows 25-fold higher affinity for the MT2 than the mt1 sub-type, affected the phase of circadian activity rhythms when given alone at CT 10.  All three antagonists, however, shifted to the right the dose-response curve to melatonin, as they significantly reduced the phase shifting effects of 0.9 and 3 μg melatonin.  This is the first study to demonstrate that melatonin phase advances circadian rhythms by activation of a membrane-bound melatonin receptor and strongly suggests that this effect is mediated through the MT2 melatonin receptor subtype within the circadian timing system.  The authors conclude that the MT2 melatonin receptor subtype is a novel therapeutic target for the development of subtype-selective analogs for the treatment of circadian sleep and mood-related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ojeVXHYuUbVg90H21EOLACvtfcHk0lhJFiSAsY70Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvFWktL8%253D&md5=9a9e7679df1e98fc362b45b88d61dd12</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.12.12.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.12.12.1211%26sid%3Dliteratum%253Aachs%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26aulast%3DYun%26aufirst%3DK.%26aulast%3DAl-Ghoul%26aufirst%3DW.%2BM.%26aulast%3DBenloucif%26aufirst%3DS.%26aulast%3DMasana%26aufirst%3DM.%2BI.%26atitle%3DSelective%2520MT2%2520melatonin%2520receptor%2520antagonists%2520block%2520melatonin-mediated%2520phase%2520advances%2520of%2520circadian%2520rhythms%26jtitle%3DFASEB%2520J.%26date%3D1998%26volume%3D12%26spage%3D1211%26epage%3D1220%26doi%3D10.1096%2Ffasebj.12.12.1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubocovich, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markowska, M.</span></span> <span> </span><span class="NLM_article-title">Functional MT<sub>1</sub> and MT<sub>2</sub> melatonin receptors in mammals</span>. <i>Endocrine</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1385/ENDO:27:2:101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1385%2FENDO%3A27%3A2%3A101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=16217123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFansLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=101-110&author=M.+L.+Dubocovichauthor=M.+Markowska&title=Functional+MT1+and+MT2+melatonin+receptors+in+mammals&doi=10.1385%2FENDO%3A27%3A2%3A101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Functional MT1 and MT2 melatonin receptors in mammals</span></div><div class="casAuthors">Dubocovich, Margarita L.; Markowska, Magdalena</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">EOCRE5</span>;
        ISSN:<span class="NLM_cas:issn">1355-008X</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Melatonin, dubbed the hormone of darkness, is known to regulate a wide variety of physiol. processes in mammals.  This review describes well-defined functional responses mediated through activation of high-affinity MT1 and MT2 G protein-coupled receptors viewed as potential targets for drug discovery.  MT1 melatonin receptors modulate neuronal firing, arterial vasoconstriction, cell proliferation in cancer cells, and reproductive and metabolic functions.  Activation of MT2 melatonin receptors phase shift circadian rhythms of neuronal firing in the suprachiasmatic nucleus, inhibit dopamine release in retina, induce vasodilation and inhibition of leukocyte rolling in arterial beds, and enhance immune responses.  The melatonin-mediated responses elicited by activation of MT1 and MT2 native melatonin receptors are dependent on circadian time, duration and mode of exposure to endogenous or exogenous melatonin, and functional receptor sensitivity.  Together, these studies underscore the importance of carefully linking each melatonin receptor type to specific functional responses in target tissues to facilitate the design and development of novel therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoKKZffUZ0BbVg90H21EOLACvtfcHk0lhJFiSAsY70Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFansLjE&md5=e02b44bdfda9e9bad81db7843d6e08f1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1385%2FENDO%3A27%3A2%3A101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FENDO%253A27%253A2%253A101%26sid%3Dliteratum%253Aachs%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26aulast%3DMarkowska%26aufirst%3DM.%26atitle%3DFunctional%2520MT1%2520and%2520MT2%2520melatonin%2520receptors%2520in%2520mammals%26jtitle%3DEndocrine%26date%3D2005%26volume%3D27%26spage%3D101%26epage%3D110%26doi%3D10.1385%2FENDO%3A27%3A2%3A101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhdanova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollins, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morabito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schomer, D. L.</span></span> <span> </span><span class="NLM_article-title">Sleep-inducing effects of low doses of melatonin ingested in the evening</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">552</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1016/0009-9236(95)90040-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2F0009-9236%2895%2990040-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=7768078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK2MXmsVGqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=552-558&author=I.+V.+Zhdanovaauthor=R.+J.+Wurtmanauthor=H.+J.+Lynchauthor=J.+R.+Ivesauthor=A.+B.+Dollinsauthor=C.+Morabitoauthor=J.+K.+Mathesonauthor=D.+L.+Schomer&title=Sleep-inducing+effects+of+low+doses+of+melatonin+ingested+in+the+evening&doi=10.1016%2F0009-9236%2895%2990040-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sleep-inducing effects of low doses of melatonin ingested in the evening</span></div><div class="casAuthors">Zhdanova, Irina V.; Wurtman, Richard J.; Lynch, Harry J.; Ives, John R.; Dollins, Andrew B.; Morabito, Claudia; Matheson, Jean K.; Schomer, Donald L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">552-8</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">We previously obsd. that low oral doses of melatonin given at noon increase blood melatonin concns. to those normally occurring nocturnally and facilitate sleep onset, as assessed using an involuntary muscle relaxation test.  In this study we examd. the induction of polysomnog. recorded sleep by similar doses given later in the evening, close to the times of endogenous melatonin release and habitual sleep onset.  Volunteers received the hormone (oral doses of 0.3 or 1.0 mg) or placebo at 6, 8, or 9 PM.  Latencies to sleep onset, to stage 2 sleep, and to rapid eye movement (REM) sleep were measured polysomnog.  Either dose given at any of the three time points decreased sleep onset latency and latency to stage 2 sleep.  Melatonin did not suppress REM sleep or delay its onset.  Most volunteers could clearly distinguish between the effects of melatonin and those of placebo when the hormone was tested at 6 or 8 PM.  Neither melatonin dose induced "hangover" effects, as assessed with mood and performance tests administered on the morning after treatment.  These data provide new evidence that nocturnal melatonin secretion may be involved in physiol. sleep onset and that exogenous melatonin may be useful in treating insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocVA9-wfyZR7Vg90H21EOLACvtfcHk0lhJO7z9PWLbKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsVGqs7o%253D&md5=8f820b1027a2beef17db7d36500ed55e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0009-9236%2895%2990040-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-9236%252895%252990040-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhdanova%26aufirst%3DI.%2BV.%26aulast%3DWurtman%26aufirst%3DR.%2BJ.%26aulast%3DLynch%26aufirst%3DH.%2BJ.%26aulast%3DIves%26aufirst%3DJ.%2BR.%26aulast%3DDollins%26aufirst%3DA.%2BB.%26aulast%3DMorabito%26aufirst%3DC.%26aulast%3DMatheson%26aufirst%3DJ.%2BK.%26aulast%3DSchomer%26aufirst%3DD.%2BL.%26atitle%3DSleep-inducing%2520effects%2520of%2520low%2520doses%2520of%2520melatonin%2520ingested%2520in%2520the%2520evening%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1995%26volume%3D57%26spage%3D552%26epage%3D558%26doi%3D10.1016%2F0009-9236%2895%2990040-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Attenburrow, M. E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpley, A. L.</span></span> <span> </span><span class="NLM_article-title">Low dose melatonin improves sleep in healthy middle-aged subjects</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1007/BF02246354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1007%2FBF02246354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=8856838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK28XlsFKrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1996&pages=179-181&author=M.+E.+J.+Attenburrowauthor=P.+J.+Cowenauthor=A.+L.+Sharpley&title=Low+dose+melatonin+improves+sleep+in+healthy+middle-aged+subjects&doi=10.1007%2FBF02246354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Low dose melatonin improves sleep in healthy middle-aged subjects</span></div><div class="casAuthors">Attenburrow, M. E. J.; Cowen, P. J.; Sharpley, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-181</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We studied the effects of single evening doses of melatonin (0.3 mg and 1.0 mg orally) on polysomnog. measured sleep in 15 healthy middle-aged volunteers, using a placebo-controlled, double-blind, cross-over design.  Compared to placebo, the 1.0 mg dose of melatonin significantly increased Actual Sleep Time, Sleep Efficiency, non-REM Sleep and REM Sleep Latency.  These data are consistent with the hypothesis that low dose melatonin has hypnotic effects in humans.  It is possible that administered melatonin may have a role to play in the treatment of sleep disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYYkwy5O8X3rVg90H21EOLACvtfcHk0lhJO7z9PWLbKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFKrtrw%253D&md5=5932c7a254cf59ba14815e164f804c8f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2FBF02246354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02246354%26sid%3Dliteratum%253Aachs%26aulast%3DAttenburrow%26aufirst%3DM.%2BE.%2BJ.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26aulast%3DSharpley%26aufirst%3DA.%2BL.%26atitle%3DLow%2520dose%2520melatonin%2520improves%2520sleep%2520in%2520healthy%2520middle-aged%2520subjects%26jtitle%3DPsychopharmacology%26date%3D1996%26volume%3D126%26spage%3D179%26epage%3D181%26doi%3D10.1007%2FBF02246354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, J.</span></span> <span> </span><span class="NLM_article-title">Melatonin in humans: Jet Lag and After</span>. <i>Adv. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK3MXmt1emt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=299-302&author=J.+Arendt&title=Melatonin+in+humans%3A+Jet+Lag+and+After"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin in humans:  jet-lag and after</span></div><div class="casAuthors">Arendt, Josephine</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pineal Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">299-302</span>CODEN:
                <span class="NLM_cas:coden">APIREW</span>;
        ISSN:<span class="NLM_cas:issn">0269-0071</span>.
    </div><div class="casAbstract">A review, with 23 refs., on the use of melatonin in humans to modify circadian rhythm, including studies on subjects with jetlag, shift workers, and blind people.  The general properties and problems of melatonin as a therapeutic agent are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5VZ5M4qrpSLVg90H21EOLACvtfcHk0liBC_zgQQJ_FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmt1emt7w%253D&md5=d37950da04e4cb1f3589e7806e193525</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArendt%26aufirst%3DJ.%26atitle%3DMelatonin%2520in%2520humans%253A%2520Jet%2520Lag%2520and%2520After%26jtitle%3DAdv.%2520Pineal%2520Res.%26date%3D1991%26volume%3D5%26spage%3D299%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sack, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blood, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewy, A. J.</span></span> <span> </span><span class="NLM_article-title">Melatonin rhythms in night shift workers</span>. <i>Sleep</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1093/sleep/15.5.434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1093%2Fsleep%2F15.5.434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1455127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A280%3ADyaK3s%252Fosl2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1992&pages=434-441&author=R.+L.+Sackauthor=M.+L.+Bloodauthor=A.+J.+Lewy&title=Melatonin+rhythms+in+night+shift+workers&doi=10.1093%2Fsleep%2F15.5.434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin rhythms in night shift workers</span></div><div class="casAuthors">Sack R L; Blood M L; Lewy A J</div><div class="citationInfo"><span class="NLM_cas:title">Sleep</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">434-41</span>
        ISSN:<span class="NLM_cas:issn">0161-8105</span>.
    </div><div class="casAbstract">For some time, it has remained uncertain whether the circadian rhythms of permanent night shift workers are adapted to their night-active schedule.  Previous studies of this question have often been limited by "masking" (evoked) effects of sleep and activity on body temperature and cortisol, used as marker rhythms.  In this study, the problem of masking was minimized by measuring the timing of melatonin production under dim light conditions.  Nine permanent night shift workers were admitted to the Clinical Research Center (CRC) directly from their last work shift of the week and remained in dim light while blood samples were obtained hourly for 24 hours.  Melatonin concentrations were measured in these samples using a gas-chromatographic mass-spectrometric method.  Sleep diaries were completed for two weeks prior to the admission to the CRC.  Overall, the onset of the melatonin rhythm was about 7.2 hours earlier (or 16.8 hours later) in the night workers compared to day-active controls.  It was not possible to know whether the phase of the melatonin rhythm was the result of advances or delays.  In night shift workers, sleep was initiated (on average) about three hours prior to the onset of melatonin production.  In contrast, day-active subjects initiated sleep (on average) about three hours after their melatonin onset.  Thus, the sleep times selected by night shift workers may not be well-synchronized to their melatonin rhythm, assumed to mark the phase of their underlying circadian pacemaker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRabrJDwAfSOhdUSIfHIn4FfW6udTcc2eZEVyb2TPuXX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252Fosl2htg%253D%253D&md5=c59afd2a2c91c597900950e387bc9634</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fsleep%2F15.5.434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fsleep%252F15.5.434%26sid%3Dliteratum%253Aachs%26aulast%3DSack%26aufirst%3DR.%2BL.%26aulast%3DBlood%26aufirst%3DM.%2BL.%26aulast%3DLewy%26aufirst%3DA.%2BJ.%26atitle%3DMelatonin%2520rhythms%2520in%2520night%2520shift%2520workers%26jtitle%3DSleep%26date%3D1992%26volume%3D15%26spage%3D434%26epage%3D441%26doi%3D10.1093%2Fsleep%2F15.5.434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lewy, A. J.</span></span> <span> </span><span class="NLM_article-title">Circadian misalignment in mood disturbances</span>. <i>Curr. Psychiatry Rep.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1007/s11920-009-0070-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1007%2Fs11920-009-0070-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=19909668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A280%3ADC%252BD1MjlvFCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=459-465&author=A.+J.+Lewy&title=Circadian+misalignment+in+mood+disturbances&doi=10.1007%2Fs11920-009-0070-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Circadian misalignment in mood disturbances</span></div><div class="casAuthors">Lewy Alfred J</div><div class="citationInfo"><span class="NLM_cas:title">Current psychiatry reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">459-65</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent refinements in methodology allow chronobiological researchers to answer the following questions: is there circadian misalignment in sleep and mood disturbances, and, if so, is it of the phase-advance or phase-delay type? Measurement of the dim light melatonin onset-to-midsleep interval, or phase-angle difference, in sleep and mood disorders should answer these questions.  Although the phase-advance hypothesis of affective disorders was formulated three decades ago, recent studies suggest that many, if not all, mood disturbances have a circadian misalignment component of the phase-delay type, operationally defined as a delay in the dim light melatonin onset relative to the sleep/wake cycle.  Phase-delayed disorders can be treated with bright light in the morning and/or low-dose melatonin in the afternoon/evening.  Phase-advanced disorders can be treated with bright light in the evening and/or low-dose melatonin in the morning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJoD1dTwP38xgd2Wuil24tfW6udTcc2eZEVyb2TPuXX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjlvFCltw%253D%253D&md5=83ed7e8915f2a16826b0e228217ac1d3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs11920-009-0070-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11920-009-0070-5%26sid%3Dliteratum%253Aachs%26aulast%3DLewy%26aufirst%3DA.%2BJ.%26atitle%3DCircadian%2520misalignment%2520in%2520mood%2520disturbances%26jtitle%3DCurr.%2520Psychiatry%2520Rep.%26date%3D2009%26volume%3D11%26spage%3D459%26epage%3D465%26doi%3D10.1007%2Fs11920-009-0070-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch-Rodriguez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manev, H.</span></span> <span> </span><span class="NLM_article-title">The pattern of melatonin receptor expression in the brain may influence antidepressant treatment</span>. <i>Med. Hypotheses</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/j.mehy.2006.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.mehy.2006.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=17197111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Sjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2007&pages=120-124&author=E.+Hirsch-Rodriguezauthor=M.+Imbesiauthor=R.+Manevauthor=T.+Uzauthor=H.+Manev&title=The+pattern+of+melatonin+receptor+expression+in+the+brain+may+influence+antidepressant+treatment&doi=10.1016%2Fj.mehy.2006.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The pattern of melatonin receptor expression in the brain may influence antidepressant treatment</span></div><div class="casAuthors">Hirsch-Rodriguez, Eric; Imbesi, Marta; Manev, Radmila; Uz, Tolga; Manev, Hari</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-124</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The pineal hormone melatonin produces most of its biol. effects via G protein-coupled receptors MT1 and MT2.  In mammals, these receptors are expressed in various tissues and organs including in the brain.  Recent research points to a putative role of MT1/MT2 dimerization as a mechanism that could det. the receptor-mediated biol. effects of melatonin.  Brain content and the ratios between MT1 and MT2 receptors are affected by illness, e.g., Alzheimer's disease, and by prolonged drug treatment, e.g., antidepressants.  New drugs with antidepressant properties that bind and activate melatonin receptors have been discovered.  We hypothesize that endogenous, i.e., low, levels of melatonin could contribute to antidepressant effects depending on the expression pattern of melatonin receptors in the brain.  Hence, we propose that a prolonged treatment with classical antidepressant drugs alters the brain ratio of MT1/MT2 receptors to enable the endogenous melatonin, which is secreted during the night, to further improve the antidepressant effects.  A corollary of this hypothesis is that antidepressants would be less effective in conditions of pathol. altered brain melatonin receptors, e.g., in Alzheimer's patients or due to genetic polymorphisms.  If our hypothesis is confirmed, supplementing classical antidepressant treatment with an appropriate dose of a melatonin receptor agonist might be used to improve antidepressant effects in subjects with a susceptible pattern of brain melatonin receptor expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqli43a40rghrVg90H21EOLACvtfcHk0li0zFqkw6ujyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Sjtbw%253D&md5=c3fdcd2f20baf69a7af8debc6dc3cea0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2006.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2006.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch-Rodriguez%26aufirst%3DE.%26aulast%3DImbesi%26aufirst%3DM.%26aulast%3DManev%26aufirst%3DR.%26aulast%3DUz%26aufirst%3DT.%26aulast%3DManev%26aufirst%3DH.%26atitle%3DThe%2520pattern%2520of%2520melatonin%2520receptor%2520expression%2520in%2520the%2520brain%2520may%2520influence%2520antidepressant%2520treatment%26jtitle%3DMed.%2520Hypotheses%26date%3D2007%26volume%3D69%26spage%3D120%26epage%3D124%26doi%3D10.1016%2Fj.mehy.2006.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golombek, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardinali, D. P.</span></span> <span> </span><span class="NLM_article-title">Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(93)90273-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2F0014-2999%2893%2990273-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=8103462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2nu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1993&pages=231-236&author=D.+A.+Golombekauthor=M.+Martiniauthor=D.+P.+Cardinali&title=Melatonin+as+an+anxiolytic+in+rats%3A+time+dependence+and+interaction+with+the+central+GABAergic+system&doi=10.1016%2F0014-2999%2893%2990273-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin as an anxiolytic in rats: Time dependence and interaction with the central GABAergic system</span></div><div class="casAuthors">Golombek, Diego A.; Martini, Mariana; Cardinali, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">231-6</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Anxiolytic and pro-exploratory melatonin properties were assessed in rats using a plus-maze procedure.  Both melatonin (1 mg/kg) and diazepam (0.5 mg/kg) showed a diurnal variation to decrease anxiety and to promote exploratory behavior.  Melatonin displayed anxiolytic activity at night, with absence of effects at noon and a weak activity at the beginning of the light phase.  Melatonin pro-exploratory activity was found only at night.  Diazepam exerted anxiolysis during the night, with less activity during the day.  Diazepam pro-exploratory activity was found during the night only.  A dose-response study carried out by injecting 1-20 mg/kg melatonin at 12:00 or 18:00 h indicated that melatonin activity was greatest at 18:00 h.  Diazepam was anxiolytic at both times, and pro-exploratory at 18:00 h only.  Melatonin activity was blunted by administration of the benzodiazepine antagonist, flumazenil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM9HTTn76BdrVg90H21EOLACvtfcHk0li0zFqkw6ujyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2nu7Y%253D&md5=c317a786322add9a3261d8e1e88102b6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990273-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990273-K%26sid%3Dliteratum%253Aachs%26aulast%3DGolombek%26aufirst%3DD.%2BA.%26aulast%3DMartini%26aufirst%3DM.%26aulast%3DCardinali%26aufirst%3DD.%2BP.%26atitle%3DMelatonin%2520as%2520an%2520anxiolytic%2520in%2520rats%253A%2520time%2520dependence%2520and%2520interaction%2520with%2520the%2520central%2520GABAergic%2520system%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D237%26spage%3D231%26epage%3D236%26doi%3D10.1016%2F0014-2999%2893%2990273-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blask, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauchy, R. T.</span></span> <span> </span><span class="NLM_article-title">Melatonin as a chronobiotic/anticancer agent: Cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.2174/1568026023394407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.2174%2F1568026023394407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=11899096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVaqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=113-132&author=D.+E.+Blaskauthor=L.+A.+Sauerauthor=R.+T.+Dauchy&title=Melatonin+as+a+chronobiotic%2Fanticancer+agent%3A+Cellular%2C+biochemical%2C+and+molecular+mechanisms+of+action+and+their+implications+for+circadian-based+cancer+therapy&doi=10.2174%2F1568026023394407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy</span></div><div class="casAuthors">Blask, David E.; Sauer, Leonard A.; Dauchy, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-132</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Melatonin, as a new member of an expanding group of regulatory factors that control cell proliferation and loss, is the only known chronobiotic, hormonal regulator of neoplastic cell growth.  At physiol. circulating concns., this indoleamine is cytostatic and inhibits cancer cell proliferation in vitro via specific cell cycle effects.  At pharmacol. concns., melatonin exhibits cytotoxic activity in cancer cells.  At both physiol. and pharmacol. concns., melatonin acts as a differentiating agent in some cancer cells and lowers their invasive and metastatic status through alterations in adhesion mols. and maintenance of gap junctional intercellular communication.  In other cancer cell types, melatonin, either alone or in combination with other agents, induces apoptotic cell death.  Biochem. and mol. mechanisms of melatonin's oncostatic action may include regulation of estrogen receptor expression and transactivation, calcium/calmodulin activity, protein kinase C activity, cytoskeletal architecture and function, intracellular redox status, melatonin receptor-mediated signal transduction cascades, and fatty acid transport and metab.  A major mechanism mediating melatonin's circadian stage-dependent tumor growth inhibitory action is the suppression of epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activity.  This occurs via melatonin receptor-mediated blockade of tumor linoleic acid uptake and its conversion to 13-hydroxyoctadecadienoic acid (13-HODE) which normally activates EGFR/MAPK mitogenic signaling.  This represents a potentially unifying model for the chronobiol. inhibitory regulation of cancer growth by melatonin in the maintenance of the host/cancer balance.  It also provides the 1st biol. explanation of melatonin-induced enhancement of the efficacy and reduced toxicity of chemo- and radiotherapy in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOhZSyiotpHrVg90H21EOLACvtfcHk0lh8piLgGDW-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVaqu7o%253D&md5=cf6a9fb4f057847ab7ccf044c0e9a898</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1568026023394407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023394407%26sid%3Dliteratum%253Aachs%26aulast%3DBlask%26aufirst%3DD.%2BE.%26aulast%3DSauer%26aufirst%3DL.%2BA.%26aulast%3DDauchy%26aufirst%3DR.%2BT.%26atitle%3DMelatonin%2520as%2520a%2520chronobiotic%252Fanticancer%2520agent%253A%2520Cellular%252C%2520biochemical%252C%2520and%2520molecular%2520mechanisms%2520of%2520action%2520and%2520their%2520implications%2520for%2520circadian-based%2520cancer%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D113%26epage%3D132%26doi%3D10.2174%2F1568026023394407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seely, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyatt, G.</span></span> <span> </span><span class="NLM_article-title">Melatonin in the treatment of cancer: A systematic review of randomized controlled trials and meta-analysis</span>. <i>J. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1111/j.1600-079X.2005.00258.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1111%2Fj.1600-079X.2005.00258.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=16207291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGqurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=360-366&author=E.+Millsauthor=P.+Wuauthor=D.+Seelyauthor=G.+Guyatt&title=Melatonin+in+the+treatment+of+cancer%3A+A+systematic+review+of+randomized+controlled+trials+and+meta-analysis&doi=10.1111%2Fj.1600-079X.2005.00258.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin in the treatment of cancer: A systematic review of randomized controlled trials and meta-analysis</span></div><div class="casAuthors">Mills, Edward; Wu, Ping; Seely, Dugald; Guyatt, Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">360-366</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Most observational studies show an assocn. between melatonin and cancer in humans.  We conducted a systematic review of randomized controlled trials (RCTs) of melatonin in solid tumor cancer patients and its effect on survival at 1 yr.  With the aid of an information specialist, we searched 10 electronic databases from inception to Oct. 2004.  We included trials using melatonin as either sole treatment or as adjunct treatment.  Prespecified criteria guided our assessment of trial quality.  We conducted a meta-anal. using a random effects model.  We included 10 RCTs published between 1992 and 2003 and included 643 patients.  All trials included solid tumor cancers.  All trials were conducted at the same hospital network, and were unblinded.  Melatonin reduced the risk of death at 1 yr (relative risk: 0.66, 95% confidence interval: 0.59 - 0.73, I2 = 0%, heterogeneity P ≤ 0.56).  Effects were consistent across melatonin dose, and type of cancer.  No severe adverse events were reported.  The substantial redn. in risk of death, low adverse events reported and low costs related to this intervention suggest great potential for melatonin in treating cancer.  Confirming the efficacy and safety of melatonin in cancer treatment will require completion of blinded, independently conducted RCTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIJjwBw40vULVg90H21EOLACvtfcHk0lh8piLgGDW-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGqurvJ&md5=bb67876885e97add7c9618f7e6de5c99</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-079X.2005.00258.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-079X.2005.00258.x%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DSeely%26aufirst%3DD.%26aulast%3DGuyatt%26aufirst%3DG.%26atitle%3DMelatonin%2520in%2520the%2520treatment%2520of%2520cancer%253A%2520A%2520systematic%2520review%2520of%2520randomized%2520controlled%2520trials%2520and%2520meta-analysis%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2005%26volume%3D39%26spage%3D360%26epage%3D366%26doi%3D10.1111%2Fj.1600-079X.2005.00258.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, C. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, P. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhães, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lourdes Seabra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, V. M. S.</span></span> <span> </span><span class="NLM_article-title">Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease</span>. <i>J. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1007/s00415-006-0390-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1007%2Fs00415-006-0390-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=17404779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvF2isrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=459-464&author=C.+A.+M.+Medeirosauthor=P.+F.+C.+de+Bruinauthor=L.+A.+Lopesauthor=M.+C.+Magalh%C3%A3esauthor=M.+de+Lourdes+Seabraauthor=V.+M.+S.+de+Bruin&title=Effect+of+exogenous+melatonin+on+sleep+and+motor+dysfunction+in+Parkinson%E2%80%99s+disease&doi=10.1007%2Fs00415-006-0390-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study</span></div><div class="casAuthors">Medeiros, Camila Andrade Mendes; Carvalhedo de Bruin, Pedro Felipe; Lopes, Livia Ariane; Magalhaes, Maria Cecilia; Seabra, Maria de Lourdes; Sales de Bruin, Veralice Meireles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">459-464</span>CODEN:
                <span class="NLM_cas:coden">JNRYA9</span>;
        ISSN:<span class="NLM_cas:issn">0340-5354</span>.
    
            (<span class="NLM_cas:orgname">Steinkopff Verlag</span>)
        </div><div class="casAbstract">Insomnia, sleep fragmentation and excessive daytime sleepiness are common in Parkinson's disease (PD) and may contribute to the redn. of cognition and alertness in those patients.  Melatonin has been shown to improve sleep in several conditions.  In exptl. models of PD, melatonin can ameliorate motor symptoms.  To evaluate the effect of melatonin on sleep and motor dysfunction in PD, we studied 18 patients (Hoehn & Yahr I to III) from a PD clinic.  Prior to treatment, motor dysfunction was assessed by UP-DRS II, III and IV.  Subjective sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI) and daytime somnolence by the Epworth Sleepiness Scale (ESS).  Full polysomnog. (PSG) was performed in all subjects.  Patients were then randomized to receive melatonin (3mg) or placebo one hour before bedtime for four weeks.  All measures were repeated at the end of treatment.  On initial assessment, 14 patients (70%) showed poor quality sleep (PSQI > 6) and eight (40%) excessive daytime sleepiness (ESS > 10).  Increased sleep latency (50%), REM sleep without atonia (66%), and reduced sleep efficiency (72%) were found on PSG.  Eight patients had an apnea/hypopnea index greater than 15 but no severe oxygen desatn. was obsd.  Sleep fragmentation tended to be more severe in patients on lower doses of levodopa (p = 0.07).  Although melatonin significantly improved subjective quality of sleep (p = 0.03) as evaluated by the PSQI index, PSG abnormalities were not changed.  Motor dysfunction was not improved by the use of melatonin.  Undetected differences in motor scores and PSG findings may have been due to a small sample size and a type II error.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-GCJCXVMF-rVg90H21EOLACvtfcHk0lh8piLgGDW-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvF2isrw%253D&md5=570de6357c99a70299fb13bd9f8eed51</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00415-006-0390-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00415-006-0390-x%26sid%3Dliteratum%253Aachs%26aulast%3DMedeiros%26aufirst%3DC.%2BA.%2BM.%26aulast%3Dde%2BBruin%26aufirst%3DP.%2BF.%2BC.%26aulast%3DLopes%26aufirst%3DL.%2BA.%26aulast%3DMagalh%25C3%25A3es%26aufirst%3DM.%2BC.%26aulast%3Dde%2BLourdes%2BSeabra%26aufirst%3DM.%26aulast%3Dde%2BBruin%26aufirst%3DV.%2BM.%2BS.%26atitle%3DEffect%2520of%2520exogenous%2520melatonin%2520on%2520sleep%2520and%2520motor%2520dysfunction%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2007%26volume%3D254%26spage%3D459%26epage%3D464%26doi%3D10.1007%2Fs00415-006-0390-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waldhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldhauser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtman, R. J.</span></span> <span> </span><span class="NLM_article-title">Bioavailability of oral melatonin in humans</span>. <i>Neuroendocrinology</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1159/000123997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1159%2F000123997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=6493445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaL2MXht1aktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1984&pages=307-313&author=F.+Waldhauserauthor=M.+Waldhauserauthor=H.+R.+Liebermanauthor=M.-H.+Dengauthor=H.+J.+Lynchauthor=R.+J.+Wurtman&title=Bioavailability+of+oral+melatonin+in+humans&doi=10.1159%2F000123997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bioavailability of oral melatonin in humans</span></div><div class="casAuthors">Waldhauser, Franz; Waldhauser, Maria; Lieberman, Harris R.; Deng, Mei Hua; Lynch, Harry J.; Wurtman, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroendocrinology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-13</span>CODEN:
                <span class="NLM_cas:coden">NUNDAJ</span>;
        ISSN:<span class="NLM_cas:issn">0028-3835</span>.
    </div><div class="casAbstract">Cryst. melatonin (I)  [73-31-4] (80 mg) in gelatin capsules was administered to 5 young male volunteers and serum and urinary I levels was measured at intervals.  Changes in serum I levels were best described by a biexponential equation with an absorption const. (ka) of 1.72 h-1 (half-life = 0.40 h) and an elimination const. (kel) of 0.87 h-1 (half-life = 0.80 h).  Peak serum I levels, ranging from 350 to 10,000 times those occurring physiol. at nighttime, were obsd. 60-150 min after its administration, remaining stable for approx. 1.5 h.  The fraction of ingested I that was absorbed, estd. from the area under the curve describing serum I concns. as a function of time after I administration (the concn.-time curve), varied by 25-fold among subjects.  3 Addnl. volunteers received 3 I-contg. capsules (80 mg each) at 60-min intervals.  This regimen extended the duration of elevated serum I levels to 4-6 h.  I excretion closely paralleled serum I levels until 9 h after the hormone's administration, after which urinary levels tended to be higher than those predicted from serum levels.  However, the area under the concn.-time curve for serum I correlated well with the cumulative I excretion during the initial 15 h after I administration, indicating that either approach can be used to est. the absorption of orally administered I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPRh-h4FOJM7Vg90H21EOLACvtfcHk0lhpHvXATPPTXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXht1aktA%253D%253D&md5=2c24563e18c01d6b418d60041f31327e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1159%2F000123997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000123997%26sid%3Dliteratum%253Aachs%26aulast%3DWaldhauser%26aufirst%3DF.%26aulast%3DWaldhauser%26aufirst%3DM.%26aulast%3DLieberman%26aufirst%3DH.%2BR.%26aulast%3DDeng%26aufirst%3DM.-H.%26aulast%3DLynch%26aufirst%3DH.%2BJ.%26aulast%3DWurtman%26aufirst%3DR.%2BJ.%26atitle%3DBioavailability%2520of%2520oral%2520melatonin%2520in%2520humans%26jtitle%3DNeuroendocrinology%26date%3D1984%26volume%3D39%26spage%3D307%26epage%3D313%26doi%3D10.1159%2F000123997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeMuro, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nafziger, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blask, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menhinick, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertino, J. S.,  Jr.</span></span> <span> </span><span class="NLM_article-title">The absolute bioavailability of oral melatonin</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1177/00912700022009422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1177%2F00912700022009422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10883420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksFWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2000&pages=781-784&author=R.+L.+DeMuroauthor=A.+N.+Nafzigerauthor=D.+E.+Blaskauthor=A.+M.+Menhinickauthor=J.+S.+Bertino&title=The+absolute+bioavailability+of+oral+melatonin&doi=10.1177%2F00912700022009422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The absolute bioavailability of oral melatonin</span></div><div class="casAuthors">DeMuro, Rob L.; Nafziger, Anne N.; Blask, David E.; Menhinick, Anne M.; Bertino, Joseph S., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">781-784</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The abs. bioavailability of oral melatonin tablets was studied in 12 normal healthy volunteers.  Subjects were administered, in a randomized crossover fashion, melatonin 2 mg i.v. and 2 and 4 mg orally.  Both the 2 and the 4 mg oral dosages showed an abs. bioavailability of approx. 15%.  No difference in serum half-life was seen in any of the study phases.  Oral melatonin tablets in dosages of 2 and 4 mg had poor abs. bioavailability, either due to poor oral absorption, large first-pass metab., or a combination of both.  Further studies examg. larger doses, in an attempt to sat. first-pass metab. if it occurs, may be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-4IvXfCxd5bVg90H21EOLACvtfcHk0lhpHvXATPPTXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksFWrtbc%253D&md5=f38ac768cc72222a521a04d11dc0d3ee</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F00912700022009422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F00912700022009422%26sid%3Dliteratum%253Aachs%26aulast%3DDeMuro%26aufirst%3DR.%2BL.%26aulast%3DNafziger%26aufirst%3DA.%2BN.%26aulast%3DBlask%26aufirst%3DD.%2BE.%26aulast%3DMenhinick%26aufirst%3DA.%2BM.%26aulast%3DBertino%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520absolute%2520bioavailability%2520of%2520oral%2520melatonin%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D40%26spage%3D781%26epage%3D784%26doi%3D10.1177%2F00912700022009422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jockers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delagrange, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubocovich, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markus, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renault, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotos, D. P.</span></span> <span> </span><span class="NLM_article-title">Update on melatonin receptors: IUPHAR Review 20</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">2702</span>– <span class="NLM_lpage">2725</span>, <span class="refDoi"> DOI: 10.1111/bph.13536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1111%2Fbph.13536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=27314810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12ksbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=2702-2725&author=R.+Jockersauthor=P.+Delagrangeauthor=M.+L.+Dubocovichauthor=R.+P.+Markusauthor=N.+Renaultauthor=G.+Tosiniauthor=E.+Ceconauthor=D.+P.+Zlotos&title=Update+on+melatonin+receptors%3A+IUPHAR+Review+20&doi=10.1111%2Fbph.13536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Update on melatonin receptors: IUPHAR Review 20</span></div><div class="casAuthors">Jockers, Ralf; Delagrange, Philippe; Dubocovich, Margarita L.; Markus, Regina P.; Renault, Nicolas; Tosini, Gianluca; Cecon, Erika; Zlotos, Darius P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2702-2725</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Melatonin receptors are seven transmembrane-spanning proteins belonging to the GPCR superfamily.  In mammals, two melatonin receptor subtypes exist - MT1 and MT2 - encoded by the MTNR1A and MTNR1B genes resp.  The current review provides an update on melatonin receptors by the corresponding subcommittee of the International Union of Basic and Clin. Pharmacol.  We will highlight recent developments of melatonin receptor ligands, including radioligands, and give an update on the latest phenotyping results of melatonin receptor knockout mice.  The current status and perspectives of the structure of melatonin receptor will be summarized.  The physiol. importance of melatonin receptor dimers and biol. important and type 2 diabetes-assocd. genetic variants of melatonin receptors will be discussed.  The role of melatonin receptors in physiol. and disease will be further exemplified by their functions in the immune system and the CNS.  Finally, antioxidant and free radical scavenger properties of melatonin and its relation to melatonin receptors will be critically addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKhV4YSnAj7Vg90H21EOLACvtfcHk0lhpHvXATPPTXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12ksbrM&md5=91a1f7bc33cdd02656ffc6a2363dffb3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fbph.13536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13536%26sid%3Dliteratum%253Aachs%26aulast%3DJockers%26aufirst%3DR.%26aulast%3DDelagrange%26aufirst%3DP.%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26aulast%3DMarkus%26aufirst%3DR.%2BP.%26aulast%3DRenault%26aufirst%3DN.%26aulast%3DTosini%26aufirst%3DG.%26aulast%3DCecon%26aufirst%3DE.%26aulast%3DZlotos%26aufirst%3DD.%2BP.%26atitle%3DUpdate%2520on%2520melatonin%2520receptors%253A%2520IUPHAR%2520Review%252020%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D2702%26epage%3D2725%26doi%3D10.1111%2Fbph.13536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunoh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkawa, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4222</span>– <span class="NLM_lpage">4239</span>, <span class="refDoi"> DOI: 10.1021/jm0201159</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0201159" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVymsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4222-4239&author=O.+Uchikawaauthor=K.+Fukatsuauthor=R.+Tokunohauthor=M.+Kawadaauthor=K.+Matsumotoauthor=Y.+Imaiauthor=S.+Hinumaauthor=K.+Katoauthor=H.+Nishikawaauthor=K.+Hiraiauthor=M.+Miyamotoauthor=S.+Ohkawa&title=Synthesis+of+a+novel+series+of+tricyclic+indan+derivatives+as+melatonin+receptor+agonists&doi=10.1021%2Fjm0201159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists</span></div><div class="casAuthors">Uchikawa, Osamu; Fukatsu, Kohji; Tokunoh, Ryosuke; Kawada, Mitsuru; Matsumoto, Kiyoharu; Imai, Yumi; Hinuma, Shuji; Kato, Koki; Nishikawa, Hisao; Hirai, Keisuke; Miyamoto, Masaomi; Ohkawa, Shigenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4222-4239</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of tricyclic indan derivs. were prepd. as potential therapeutic agents for sleep disorders and evaluated for their binding affinity to melatonin receptors.  Previously, a conformation of the methoxy group of melatonin (I) resulting in optimal binding of the MT1 receptor had been proposed.  To fix the methoxy group in an active conformation, we decided to synthesize conformationally restricted tricyclic indan analogs with the oxygen atom in the 6-position incorporated into a furan, 1,3-dioxane, oxazole, pyran, morpholine, or 1,4-dioxane ring system.  Among these compds., indeno[5,4-b]furan analogs II (R = Me, Et, n-Pr) were found to be the most potent and selective MT1 receptor ligands and to have superior metabolic stability.  The optimization of substituents led to (S)-II [R = Et (III)], which showed very strong affinity for human MT1 (Ki = 0.014 nM), but no significant affinity for hamster MT3 (Ki = 2600 nM) or other neurotransmitter receptors.  The pharmacol. effects of III were studied in exptl. animals, and it was found that a dose of 0.1 mg/kg, po promoted a sleep in freely moving cats, as demonstrated by a decrease in wakefulness and increases in slow wave sleep and rapid eye movement sleep, which lasted for 6 h after administration.  I (1 mg/kg, po) also had a sleep-promoting effect, though it lasted only 2 h.  A new chiral method for the synthesis of III starting from IV, which was prepd. from V employing asym. hydrogenation with the (S)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl-Ru complex, was developed.  III (TAK-375) is currently in clin. trials for the treatment of insomnia and circadian rhythm disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-sBC1iSUoY7Vg90H21EOLACvtfcHk0lh3IJl6HLlSmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVymsrk%253D&md5=3ad626e9e7e94fa016758a8886ab3724</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0201159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0201159%26sid%3Dliteratum%253Aachs%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DFukatsu%26aufirst%3DK.%26aulast%3DTokunoh%26aufirst%3DR.%26aulast%3DKawada%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DOhkawa%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520series%2520of%2520tricyclic%2520indan%2520derivatives%2520as%2520melatonin%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4222%26epage%3D4239%26doi%3D10.1021%2Fjm0201159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span> <span> </span><span class="NLM_article-title">Neurochemical propertie of ramelteon (TAK-375), a selective MT<sub>1</sub>/MT<sub>2</sub> receptor agonist</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.neuropharm.2004.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15695169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=301-310&author=K.+Katoauthor=K.+Hiraiauthor=K.+Nishiyamaauthor=O.+Uchikawaauthor=K.+Fukatsuauthor=S.+Ohkawaauthor=Y.+Kawamataauthor=S.+Hinumaauthor=M.+Miyamoto&title=Neurochemical+propertie+of+ramelteon+%28TAK-375%29%2C+a+selective+MT1%2FMT2+receptor+agonist&doi=10.1016%2Fj.neuropharm.2004.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist</span></div><div class="casAuthors">Kato, Koki; Hirai, Keisuke; Nishiyama, Keiji; Uchikawa, Osamu; Fukatsu, Kohji; Ohkawa, Shigenori; Kawamata, Yuji; Hinuma, Shuji; Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-310</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ramelteon (TAK-375) is a novel melatonin receptor agonist currently under investigation for the treatment of insomnia.  This study describes the neurochem. and receptor binding characteristics of ramelteon in vitro.  Ramelteon showed very high affinity for human MT1 (Mel1a) and MT2 (Mel1b) receptors (expressed in Chinese hamster ovary [CHO] cells), and chick forebrain melatonin receptors (consisting of Mel1a and Mel1c receptors) with K i values of 14.0, 112, and 23.1 pM, resp., making the affinities of ramelteon for these receptors 3 - 16 times higher than those of melatonin.  The affinity of ramelteon for hamster brain MT3 binding sites was extremely weak (K i: 2.65 μM) compared to melatonin's affinity for the MT3 binding site (K i: 24.1 nM).  In addn., ramelteon showed no measurable affinity for a large no. of ligand binding sites (including benzodiazepine receptors, dopamine receptors, opiate receptors, ion channels, and transporters) and no effect on the activity of various enzymes.  Ramelteon inhibited forskolin-stimulated cAMP prodn. in the CHO cells that express the human MT1 or MT2 receptors.  Taken together, these results indicate that ramelteon is a potent and highly selective agonist of MT1/MT2 melatonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom8AZjargfI7Vg90H21EOLACvtfcHk0lh3IJl6HLlSmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOksLk%253D&md5=3b21530d660512328ab64d5cbab3d734</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DNishiyama%26aufirst%3DK.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DFukatsu%26aufirst%3DK.%26aulast%3DOhkawa%26aufirst%3DS.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DNeurochemical%2520propertie%2520of%2520ramelteon%2520%2528TAK-375%2529%252C%2520a%2520selective%2520MT1%252FMT2%2520receptor%2520agonist%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D48%26spage%3D301%26epage%3D310%26doi%3D10.1016%2Fj.neuropharm.2004.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of ramelteon, a selective MT<sub>1</sub>/MT<sub>2</sub> receptor agonist: a novel therapeutic drug for sleep disorders</span>. <i>CNS Neurosci. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1111/j.1755-5949.2008.00066.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1111%2Fj.1755-5949.2008.00066.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=19228178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=32-51&author=M.+Miyamoto&title=Pharmacology+of+ramelteon%2C+a+selective+MT1%2FMT2+receptor+agonist%3A+a+novel+therapeutic+drug+for+sleep+disorders&doi=10.1111%2Fj.1755-5949.2008.00066.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders</span></div><div class="casAuthors">Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-51</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  An estd. one-third of the general population is affected by insomnia, and this no. is increasing due to more stressful working conditions and the progressive aging of society.  However, current treatment of insomnia with hypnotics, gamma-aminobutyric acid A (GABAA) receptor modulators, induces various side effects, including cognitive impairment, motor disturbance, dependence, tolerance, hangover, and rebound insomnia.  Ramelteon (Rozerem; Takeda Pharmaceutical Company Limited, Osaka, Japan) is an orally active, highly selective melatonin MT1/MT2 receptor agonist.  Unlike the sedative hypnotics that target GABAA receptor complexes, ramelteon is a chronohypnotic that acts on the melatonin MT1 and MT2 receptors, which are primarily located in the suprachiasmatic nucleus, the body's "master clock.".  As such, ramelteon possesses the first new therapeutic mechanism of action for a prescription insomnia medication in over three decades.  Ramelteon has demonstrated sleep-promoting effects in clin. trials, and coupled with its favorable safety profile and lack of abuse potential or dependence, this chronohypnotic provides an important treatment option for insomnia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaq1w47EuISbVg90H21EOLACvtfcHk0lh3IJl6HLlSmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnsbw%253D&md5=323034d6dc75770fbe7d8f3f3d925ab5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2008.00066.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2008.00066.x%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DPharmacology%2520of%2520ramelteon%252C%2520a%2520selective%2520MT1%252FMT2%2520receptor%2520agonist%253A%2520a%2520novel%2520therapeutic%2520drug%2520for%2520sleep%2520disorders%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2009%26volume%3D15%26spage%3D32%26epage%3D51%26doi%3D10.1111%2Fj.1755-5949.2008.00066.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolbert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span> <span> </span><span class="NLM_article-title">Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT<sub>1</sub> and MT<sub>2</sub> melatonin receptor agonist indicated for treatment of insomnia</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1177/0091270005283461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1177%2F0091270005283461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=16432265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFejs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=140-148&author=A.+Karimauthor=D.+Tolbertauthor=C.+Cao&title=Disposition+kinetics+and+tolerance+of+escalating+single+doses+of+ramelteon%2C+a+high-affinity+MT1+and+MT2+melatonin+receptor+agonist+indicated+for+treatment+of+insomnia&doi=10.1177%2F0091270005283461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia</span></div><div class="casAuthors">Karim, Aziz; Tolbert, Dwain; Cao, Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Ramelteon is a selective MT1/MT2 receptor agonist, indicated for insomnia treatment.  Safety, tolerance, pharmacokinetics, and cognitive performance were evaluated following increasing ramelteon doses.  Healthy adults (35-65 years) were randomly assigned to receive 1 of 5 oral ramelteon doses (4, 8, 16, 32, or 64 mg; n = 8 per group) or placebo (n = 20).  Cmax and AUC∞ (mean [%CV]) increased with each dose: Cmax = 1.15 (109), 5.73 (97), 6.92 (77), 17.4 (76), and 25.9 (77) ng/mL, resp., and AUC∞ = 1.71 (114), 6.95 (108), 9.88 (78), 22.5 (80), and 36.1 (71 ng•h/mL), resp.  Mean Tmax values of 0.75 to 0.94 h and mean elimination half-life of 0.83 to 1.90 h remained relatively const.  Ramelteon was extensively metabolized.  Besides ramelteon, 4 metabolites, M-I, M-II, M-III, and M-IV, were measured in serum.  Metabolite M-II, which has shown weak ramelteon-like activity in vitro, was the major metabolite in serum.  Digit Symbol Substitution Test and visual analog scale alertness scores were similar across all dose groups and did not differ from placebo.  All adverse events were mild or moderate and resolved before study completion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQKT7xinirK7Vg90H21EOLACvtfcHk0lgm5ktt21c_7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFejs7c%253D&md5=2d241de7296dcff0d4d1fa6cfa847bd7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1177%2F0091270005283461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270005283461%26sid%3Dliteratum%253Aachs%26aulast%3DKarim%26aufirst%3DA.%26aulast%3DTolbert%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DC.%26atitle%3DDisposition%2520kinetics%2520and%2520tolerance%2520of%2520escalating%2520single%2520doses%2520of%2520ramelteon%252C%2520a%2520high-affinity%2520MT1%2520and%2520MT2%2520melatonin%2520receptor%2520agonist%2520indicated%2520for%2520treatment%2520of%2520insomnia%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D140%26epage%3D148%26doi%3D10.1177%2F0091270005283461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, A.-E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarimont, C.</span></span> <span> </span><span class="NLM_article-title">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2FS1359-6446%2804%2903280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15574318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1020-1028&author=A.-E.+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+decision-making+process+in+the+structural+modification+of+drug+candidates%3A+enhancing+metabolic+stability&doi=10.1016%2FS1359-6446%2804%2903280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Kamel, Amin M.; Clarimont, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1020-1028</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.  The activity-exposure-toxicity relationship, which can be described as the rule of three', presents the single most difficult challenge in the design of drug candidates and their subsequent advancement to the development stage.  ADME studies are widely used in drug discovery to optimize the balance of properties necessary to convert lead candidates into drugs that are safe and effective for humans.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokn5ucRSES-rVg90H21EOLACvtfcHk0lgm5ktt21c_7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL&md5=67a85a167b62f0ea4e9f43d25f3e0866</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903280-5%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.-E.%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520decision-making%2520process%2520in%2520the%2520structural%2520modification%2520of%2520drug%2520candidates%253A%2520enhancing%2520metabolic%2520stability%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1020%26epage%3D1028%26doi%3D10.1016%2FS1359-6446%2804%2903280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4-aza analog of ramelteon: a novel tricyclic 1,6,7,8-tetrahydro-2<i>H</i>-cyclopenta[<i>d</i>]furo[2,3-<i>b</i>]pyridine derivative as melatonin receptor ligand</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3009</span>– <span class="NLM_lpage">3011</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.03.147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.tetlet.2011.03.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=3009-3011&author=T.+Koikeauthor=Y.+Hoashiauthor=T.+Takaiauthor=O.+Uchikawa&title=Synthesis+of+4-aza+analog+of+ramelteon%3A+a+novel+tricyclic+1%2C6%2C7%2C8-tetrahydro-2H-cyclopenta%5Bd%5Dfuro%5B2%2C3-b%5Dpyridine+derivative+as+melatonin+receptor+ligand&doi=10.1016%2Fj.tetlet.2011.03.147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4-aza analog of ramelteon: a novel tricyclic 1,6,7,8-tetrahydro-2H-cyclopenta[d]furo[2,3-b]pyridine derivative as melatonin receptor ligand</span></div><div class="casAuthors">Koike, Tatsuki; Hoashi, Yasutaka; Takai, Takafumi; Uchikawa, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3009-3011</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The 4-aza analog of ramelteon (-)-I, a novel tricyclic 1,6,7,8-tetrahydro-2H-cyclopenta[d]furo[2,3-b]pyridine deriv., was synthesized via the intramol. inverse electron demand Diels-Alder reaction followed by fluoride-induced desilylation-cyclization.  (-)-I was shown to exhibit potent binding affinities for melatonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4ahHll0X4kLVg90H21EOLACvtfcHk0lgm5ktt21c_7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWntbo%253D&md5=e8e4acb32517063506f3095001ddb75b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.03.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.03.147%26sid%3Dliteratum%253Aachs%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DUchikawa%26aufirst%3DO.%26atitle%3DSynthesis%2520of%25204-aza%2520analog%2520of%2520ramelteon%253A%2520a%2520novel%2520tricyclic%25201%252C6%252C7%252C8-tetrahydro-2H-cyclopenta%255Bd%255Dfuro%255B2%252C3-b%255Dpyridine%2520derivative%2520as%2520melatonin%2520receptor%2520ligand%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D3009%26epage%3D3011%26doi%3D10.1016%2Fj.tetlet.2011.03.147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a novel tricyclic 1,6,7,8-tetrahydro-2<i>H</i>-cyclopenta[<i>b</i>]furo[3,2-<i>d</i>]pyridine derivative, the 5-aza analog of ramelteon</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4014</span>– <span class="NLM_lpage">4016</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.05.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.tetlet.2014.05.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsl2js7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=4014-4016&author=Y.+Hoashiauthor=T.+Takaiauthor=T.+Koikeauthor=O.+Uchikawa&title=Synthesis+of+a+novel+tricyclic+1%2C6%2C7%2C8-tetrahydro-2H-cyclopenta%5Bb%5Dfuro%5B3%2C2-d%5Dpyridine+derivative%2C+the+5-aza+analog+of+ramelteon&doi=10.1016%2Fj.tetlet.2014.05.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a novel tricyclic 1,6,7,8-tetrahydro-2H-cyclopenta[b]furo[3,2-d]pyridine derivative, the 5-aza analog of ramelteon</span></div><div class="casAuthors">Hoashi, Yasutaka; Takai, Takafumi; Koike, Tatsuki; Uchikawa, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">4014-4016</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The 5-aza analog of ramelteon I, a novel tricyclic 1,6,7,8-tetrahydro-2H-cyclopenta[b]furo[3,2-d]pyridine deriv., was synthesized by hetero-Diels-Alder reaction and chemoselective Dieckmann condensation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0pNY2EeE4fbVg90H21EOLACvtfcHk0lgTXjyaEHt9eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsl2js7g%253D&md5=ac41b03904574c5e88b66c46e99367a8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DUchikawa%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520tricyclic%25201%252C6%252C7%252C8-tetrahydro-2H-cyclopenta%255Bb%255Dfuro%255B3%252C2-d%255Dpyridine%2520derivative%252C%2520the%25205-aza%2520analog%2520of%2520ramelteon%26jtitle%3DTetrahedron%2520Lett.%26date%3D2014%26volume%3D55%26spage%3D4014%26epage%3D4016%26doi%3D10.1016%2Fj.tetlet.2014.05.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-<i>c</i>]pyrazolo[1,5-<i>a</i>]pyridines as melatonin receptor (MT<sub>1</sub>/MT<sub>2</sub>) ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4207</span>– <span class="NLM_lpage">4218</span>, <span class="refDoi"> DOI: 10.1021/jm200385u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200385u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFymtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4207-4218&author=T.+Koikeauthor=T.+Takaiauthor=Y.+Hoashiauthor=M.+Nakayamaauthor=Y.+Kosugiauthor=M.+Nakashimaauthor=S.+Yoshikuboauthor=K.+Hiraiauthor=O.+Uchikawa&title=Synthesis+of+a+novel+series+of+tricyclic+dihydrofuran+derivatives%3A+discovery+of+8%2C9-dihydrofuro%5B3%2C2-c%5Dpyrazolo%5B1%2C5-a%5Dpyridines+as+melatonin+receptor+%28MT1%2FMT2%29+ligands&doi=10.1021%2Fjm200385u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Novel Series of Tricyclic Dihydrofuran Derivatives: Discovery of 8,9-Dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as Melatonin Receptor (MT1/MT2) Ligands</span></div><div class="casAuthors">Koike, Tatsuki; Takai, Takafumi; Hoashi, Yasutaka; Nakayama, Masaharu; Kosugi, Yohei; Nakashima, Masato; Yoshikubo, Shin-ichi; Hirai, Keisuke; Uchikawa, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4207-4218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel tricyclic dihydrofuran derivs. were designed, synthesized, and evaluated as melatonin receptor (MT1/MT2) ligands based on the previously reported 1,6-dihydro-2H-indeno[5,4-b]furan I.  By screening the central tricyclic cores, 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridine was identified as a potent scaffold with a high ligand-lipophilicity efficiency (LLE) value.  Subsequent optimization of the side chains led to identification of the potent MT1/MT2 agonist II (MT1, Ki = 0.062 nM; MT2, Ki = 0.420 nM) with good oral absorption and blood-brain barrier (BBB) penetration in rats.  The oral administration of compd. II exhibited a sleep-promoting action in freely moving cats at 0.1 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjmbUJVsQKUrVg90H21EOLACvtfcHk0lhllcil4vVSQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFymtLw%253D&md5=6e698973df776694731852f6c5215aa7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm200385u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200385u%26sid%3Dliteratum%253Aachs%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DTakai%26aufirst%3DT.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DKosugi%26aufirst%3DY.%26aulast%3DNakashima%26aufirst%3DM.%26aulast%3DYoshikubo%26aufirst%3DS.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DUchikawa%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520series%2520of%2520tricyclic%2520dihydrofuran%2520derivatives%253A%2520discovery%2520of%25208%252C9-dihydrofuro%255B3%252C2-c%255Dpyrazolo%255B1%252C5-a%255Dpyridines%2520as%2520melatonin%2520receptor%2520%2528MT1%252FMT2%2529%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4207%26epage%3D4218%26doi%3D10.1021%2Fjm200385u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stauch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slocum, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brehm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiriaeva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, R. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tribo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weierstall, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span> <span> </span><span class="NLM_article-title">Structural basis of ligand recognition at the human MT<sub>1</sub> melatonin receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>569</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1141-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1038%2Fs41586-019-1141-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=31019306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosVSkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=569&publication_year=2019&pages=284-288&author=B.+Stauchauthor=L.+C.+Johanssonauthor=J.+D.+McCorvyauthor=N.+Patelauthor=G.+W.+Hanauthor=X.+P.+Huangauthor=C.+Gatiauthor=A.+Batyukauthor=S.+T.+Slocumauthor=A.+Ishchenkoauthor=W.+Brehmauthor=T.+A.+Whiteauthor=N.+Michaelianauthor=C.+Madsenauthor=L.+Zhuauthor=T.+D.+Grantauthor=J.+M.+Grandnerauthor=A.+Shiriaevaauthor=R.+H.+J.+Olsenauthor=A.+R.+Triboauthor=S.+Yousauthor=R.+C.+Stevensauthor=U.+Weierstallauthor=V.+Katritchauthor=B.+L.+Rothauthor=W.+Liuauthor=V.+Cherezov&title=Structural+basis+of+ligand+recognition+at+the+human+MT1+melatonin+receptor&doi=10.1038%2Fs41586-019-1141-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of ligand recognition at the human MT1 melatonin receptor</span></div><div class="casAuthors">Stauch, Benjamin; Johansson, Linda C.; McCorvy, John D.; Patel, Nilkanth; Han, Gye Won; Huang, Xi-Ping; Gati, Cornelius; Batyuk, Alexander; Slocum, Samuel T.; Ishchenko, Andrii; Brehm, Wolfgang; White, Thomas A.; Michaelian, Nairie; Madsen, Caleb; Zhu, Lan; Grant, Thomas D.; Grandner, Jessica M.; Shiriaeva, Anna; Olsen, Reid H. J.; Tribo, Alexandra R.; Yous, Said; Stevens, Raymond C.; Weierstall, Uwe; Katritch, Vsevolod; Roth, Bryan L.; Liu, Wei; Cherezov, Vadim</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">569</span>
        (<span class="NLM_cas:issue">7755</span>),
    <span class="NLM_cas:pages">284-288</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone that maintains circadian rhythms by synchronization to environmental cues and is involved in diverse physiol. processes such as the regulation of blood pressure and core body temp., oncogenesis, and immune function.  Melatonin is formed in the pineal gland in a light-regulated manner by enzymic conversion from 5-hydroxytryptamine (5-HT or serotonin), and modulates sleep and wakefulness by activating two high-affinity G-protein-coupled receptors, type 1A (MT1) and type 1B (MT2).  Shift work, travel, and ubiquitous artificial lighting can disrupt natural circadian rhythms; as a result, sleep disorders affect a substantial population in modern society and pose a considerable economic burden.  Over-the-counter melatonin is widely used to alleviate jet lag and as a safer alternative to benzodiazepines and other sleeping aids, and is one of the most popular supplements in the United States.  Here, we present high-resoln. room-temp. X-ray free electron laser (XFEL) structures of MT1 in complex with four agonists: the insomnia drug ramelteon, two melatonin analogs, and the mixed melatonin-serotonin antidepressant agomelatine.  The structure of MT2 is described in an accompanying paper.  Although the MT1 and 5-HT receptors have similar endogenous ligands, and agomelatine acts on both receptors, the receptors differ markedly in the structure and compn. of their ligand pockets; in MT1, access to the ligand pocket is tightly sealed from solvent by extracellular loop 2, leaving only a narrow channel between transmembrane helixes IV and V that connects it to the lipid bilayer.  The binding site is extremely compact, and ligands interact with MT1 mainly by strong arom. stacking with Phe179 and auxiliary hydrogen bonds with Asn162 and Gln181.  Our structures provide an unexpected example of atypical ligand entry for a non-lipid receptor, lay the mol. foundation of ligand recognition by melatonin receptors, and will facilitate the design of future tool compds. and therapeutic agents, while their comparison to 5-HT receptors yields insights into the evolution and polypharmacol. of G-protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplFhqB4FkpoLVg90H21EOLACvtfcHk0lhllcil4vVSQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosVSkur0%253D&md5=61cecfc7a75118449d015c5b695d2f8f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1141-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1141-3%26sid%3Dliteratum%253Aachs%26aulast%3DStauch%26aufirst%3DB.%26aulast%3DJohansson%26aufirst%3DL.%2BC.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DSlocum%26aufirst%3DS.%2BT.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DBrehm%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DMichaelian%26aufirst%3DN.%26aulast%3DMadsen%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DGrant%26aufirst%3DT.%2BD.%26aulast%3DGrandner%26aufirst%3DJ.%2BM.%26aulast%3DShiriaeva%26aufirst%3DA.%26aulast%3DOlsen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DTribo%26aufirst%3DA.%2BR.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DStructural%2520basis%2520of%2520ligand%2520recognition%2520at%2520the%2520human%2520MT1%2520melatonin%2520receptor%26jtitle%3DNature%26date%3D2019%26volume%3D569%26spage%3D284%26epage%3D288%26doi%3D10.1038%2Fs41586-019-1141-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slocum, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, R. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tribo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatsepin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weierstall, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span> <span> </span><span class="NLM_article-title">XFEL structures of the human MT<sub>2</sub> melatonin receptor reveal the basis of subtype selectivity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>569</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1144-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1038%2Fs41586-019-1144-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=31019305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosVSkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=569&publication_year=2019&pages=289-292&author=L.+C.+Johanssonauthor=B.+Stauchauthor=J.+D.+McCorvyauthor=G.+W.+Hanauthor=N.+Patelauthor=X.-P.+Huangauthor=A.+Batyukauthor=C.+Gatiauthor=S.+T.+Slocumauthor=C.+Liauthor=J.+M.+Grandnerauthor=S.+Haoauthor=R.+H.+J.+Olsenauthor=A.+R.+Triboauthor=S.+Zaareauthor=L.+Zhuauthor=N.+A.+Zatsepinauthor=U.+Weierstallauthor=S.+Yousauthor=R.+C.+Stevensauthor=W.+Liuauthor=B.+L.+Rothauthor=V.+Katritchauthor=V.+Cherezov&title=XFEL+structures+of+the+human+MT2+melatonin+receptor+reveal+the+basis+of+subtype+selectivity&doi=10.1038%2Fs41586-019-1144-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity</span></div><div class="casAuthors">Johansson, Linda C.; Stauch, Benjamin; McCorvy, John D.; Han, Gye Won; Patel, Nilkanth; Huang, Xi-Ping; Batyuk, Alexander; Gati, Cornelius; Slocum, Samuel T.; Li, Chufeng; Grandner, Jessica M.; Hao, Shuming; Olsen, Reid H. J.; Tribo, Alexandra R.; Zaare, Sahba; Zhu, Lan; Zatsepin, Nadia A.; Weierstall, Uwe; Yous, Said; Stevens, Raymond C.; Liu, Wei; Roth, Bryan L.; Katritch, Vsevolod; Cherezov, Vadim</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">569</span>
        (<span class="NLM_cas:issue">7755</span>),
    <span class="NLM_cas:pages">289-292</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The human MT1 and MT2 melatonin receptors1,2 are G-protein-coupled receptors (GPCRs) that help to regulate circadian rhythm and sleep patterns3.  Drug development efforts have targeted both receptors for the treatment of insomnia, circadian rhythm and mood disorders, and cancer3, and MT2 has also been implicated in type 2 diabetes4,5.  Here we report X-ray free electron laser (XFEL) structures of the human MT2 receptor in complex with the agonists 2-phenylmelatonin (2-PMT) and ramelteon6 at resolns. of 2.8 Å and 3.3 Å, resp., along with two structures of function-related mutants: H2085.46A (superscripts represent the Ballesteros-Weinstein residue numbering nomenclature7) and N862.50D, obtained in complex with 2-PMT.  Comparison of the structures of MT2 with a published structure8 of MT1 reveals that, despite conservation of the orthosteric ligand-binding site residues, there are notable conformational variations as well as differences in [3H]melatonin dissocn. kinetics that provide insights into the selectivity between melatonin receptor subtypes.  A membrane-buried lateral ligand entry channel is obsd. in both MT1 and MT2, but in addn. the MT2 structures reveal a narrow opening towards the solvent in the extracellular part of the receptor.  We provide functional and kinetic data that support a prominent role for intramembrane ligand entry in both receptors, and suggest that there might also be an extracellular entry path in MT2.  Our findings contribute to a mol. understanding of melatonin receptor subtype selectivity and ligand access modes, which are essential for the design of highly selective melatonin tool compds. and therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrePfxnJ1rXDbVg90H21EOLACvtfcHk0lg9PN3TpEP2uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosVSkuro%253D&md5=6627fc1e26c873f6a14a7a4d4bf3a346</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1144-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1144-0%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DL.%2BC.%26aulast%3DStauch%26aufirst%3DB.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DSlocum%26aufirst%3DS.%2BT.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DGrandner%26aufirst%3DJ.%2BM.%26aulast%3DHao%26aufirst%3DS.%26aulast%3DOlsen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DTribo%26aufirst%3DA.%2BR.%26aulast%3DZaare%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZatsepin%26aufirst%3DN.%2BA.%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DXFEL%2520structures%2520of%2520the%2520human%2520MT2%2520melatonin%2520receptor%2520reveal%2520the%2520basis%2520of%2520subtype%2520selectivity%26jtitle%3DNature%26date%3D2019%26volume%3D569%26spage%3D289%26epage%3D292%26doi%3D10.1038%2Fs41586-019-1144-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iben, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1197</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.bmcl.2003.12.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=14980664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1197-1200&author=L.-Q.+Sunauthor=J.+Chenauthor=K.+Takakiauthor=G.+Johnsonauthor=L.+Ibenauthor=C.+D.+Mahleauthor=E.+Ryanauthor=C.+Xu&title=Design+and+synthesis+of+benzoxazole+derivatives+as+novel+melatoninergic+ligands&doi=10.1016%2Fj.bmcl.2003.12.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands</span></div><div class="casAuthors">Sun, Li-Qiang; Chen, Jie; Takaki, Katherine; Johnson, Graham; Iben, Lawrence; Mahle, Cathy D.; Ryan, Elaine; Xu, Cen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1197-1200</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A novel series of benzoxazole derivs. was synthesized and evaluated as melatoninergic ligands.  The binding affinity of these compds. for human MT1 and MT2 receptors was detd. using 2-[125I]-iodomelatonin as the radioligand.  The benzoxazole I exhibited better MT1 and MT2 receptor affinities than melatonin itself.  This work also established the benzoxazole nucleus as a melatoninergic pharmacophore, which served as an isosteric replacement to the previously established alkoxyaryl core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocaz6w4FAKT7Vg90H21EOLACvtfcHk0lg9PN3TpEP2uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFemur4%253D&md5=68b709c6e89526b54d3296ffe8577611</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTakaki%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DG.%26aulast%3DIben%26aufirst%3DL.%26aulast%3DMahle%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520benzoxazole%2520derivatives%2520as%2520novel%2520melatoninergic%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1197%26epage%3D1200%26doi%3D10.1016%2Fj.bmcl.2003.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deskus, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epperson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iben, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship of novel benzoxazole derivatives as melatonin receptor agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3799</span>– <span class="NLM_lpage">3802</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1016%2Fj.bmcl.2004.04.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15203165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFymurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3799-3802&author=L.-Q.+Sunauthor=J.+Chenauthor=M.+Bruceauthor=J.+A.+Deskusauthor=J.+R.+Eppersonauthor=K.+Takakiauthor=G.+Johnsonauthor=L.+Ibenauthor=C.+D.+Mahleauthor=E.+Ryanauthor=C.+Xu&title=Synthesis+and+structure%E2%80%93activity+relationship+of+novel+benzoxazole+derivatives+as+melatonin+receptor+agonists&doi=10.1016%2Fj.bmcl.2004.04.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists</span></div><div class="casAuthors">Sun, Li-Qiang; Chen, Jie; Bruce, Marc; Deskus, Jeffrey A.; Epperson, James R.; Takaki, Katherine; Johnson, Graham; Iben, Lawrence; Mahle, Cathy D.; Ryan, Elaine; Xu, Cen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3799-3802</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A series of benzoxazoles I [R1 = H, Me, Et, n-Pr, Me2CH, Ph, Ph(CH2)4; R2 = Me, Et, n-Pr, Me2CH, cyclopropyl, EtNH] was synthesized and evaluated as melatoninergic ligands.  The binding affinity of these compds. for human MT1 and MT2 receptors was detd. using 2-[125I]-iodomelatonin as the radioligand.  From this series of benzoxazole derivs., I (R1 = Me; R2 = Et, cyclopropyl) were identified as melatonin receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8oFAqTptsrrVg90H21EOLACvtfcHk0lg9PN3TpEP2uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFymurk%253D&md5=c93a2a49b441778615f5c1fb20fd9ee1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.082%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBruce%26aufirst%3DM.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DEpperson%26aufirst%3DJ.%2BR.%26aulast%3DTakaki%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DG.%26aulast%3DIben%26aufirst%3DL.%26aulast%3DMahle%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520novel%2520benzoxazole%2520derivatives%2520as%2520melatonin%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3799%26epage%3D3802%26doi%3D10.1016%2Fj.bmcl.2004.04.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">Values for cLogP were calculated by the software of Daylight Chemical Information Systems, Inc.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muckensturm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diyani, F.</span></span> <span> </span><span class="NLM_article-title">An improved preparation of 7-hydroxyindan-1-ones</span>. <i>J. Chem. Res. Miniprint</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2544</span>– <span class="NLM_lpage">2556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1995&pages=2544-2556&author=B.+Muckensturmauthor=F.+Diyani&title=An+improved+preparation+of+7-hydroxyindan-1-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuckensturm%26aufirst%3DB.%26aulast%3DDiyani%26aufirst%3DF.%26atitle%3DAn%2520improved%2520preparation%2520of%25207-hydroxyindan-1-ones%26jtitle%3DJ.%2520Chem.%2520Res.%2520Miniprint%26date%3D1995%26volume%3D11%26spage%3D2544%26epage%3D2556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musso, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selph, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigdon, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styles, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, W. R.</span></span> <span> </span><span class="NLM_article-title">Indanylidenes. 1. Design and synthesis of (<i>E</i>)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1021/jm020067s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020067s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD38XpvVantL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=399-408&author=D.+L.+Mussoauthor=F.+R.+Cochranauthor=J.+L.+Kelleyauthor=E.+W.+McLeanauthor=J.+L.+Selphauthor=G.+C.+Rigdonauthor=G.+F.+Orrauthor=R.+G.+Davisauthor=B.+R.+Cooperauthor=V.+L.+Stylesauthor=J.+B.+Thompsonauthor=W.+R.+Hall&title=Indanylidenes.+1.+Design+and+synthesis+of+%28E%29-2-%284%2C6-difluoro-1-indanylidene%29acetamide%2C+a+potent%2C+centrally+acting+muscle+relaxant+with+antiinflammatory+and+analgesic+activity&doi=10.1021%2Fjm020067s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Indanylidenes. 1. Design and Synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a Potent, Centrally Acting Muscle Relaxant with Antiinflammatory and Analgesic Activity</span></div><div class="casAuthors">Musso, David L.; Cochran, Felicia R.; Kelley, James L.; McLean, Ed W.; Selph, Jeffrey L.; Rigdon, Greg C.; Orr, G. Faye; Davis, Ronda G.; Cooper, Barrett R.; Styles, Virgil L.; Thompson, James B.; Hall, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-408</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design of rigid cyclic analogs derived from (E)-N-cyclopropyl-3-(3-fluorophenyl)prop-2-enamide and (E)-N-cyclopropyl-3-(3-fluorophenyl)but-2-enamide has led to the discovery of the potent, centrally acting muscle relaxant (E)-2-(4,6-difluoro-1-indanylidene)acetamide (I).  I also possesses potent antiinflammatory and analgesic activity.  The synthesis and the muscle relaxant, antiinflammatory, and analgesic structure-activity relationships of I and 67 of its analogs is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoY3cTrqnfTLVg90H21EOLACvtfcHk0li94Q-cW68nqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpvVantL4%253D&md5=6b62635649508e1700ac4adea68efdb3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm020067s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020067s%26sid%3Dliteratum%253Aachs%26aulast%3DMusso%26aufirst%3DD.%2BL.%26aulast%3DCochran%26aufirst%3DF.%2BR.%26aulast%3DKelley%26aufirst%3DJ.%2BL.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DSelph%26aufirst%3DJ.%2BL.%26aulast%3DRigdon%26aufirst%3DG.%2BC.%26aulast%3DOrr%26aufirst%3DG.%2BF.%26aulast%3DDavis%26aufirst%3DR.%2BG.%26aulast%3DCooper%26aufirst%3DB.%2BR.%26aulast%3DStyles%26aufirst%3DV.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DHall%26aufirst%3DW.%2BR.%26atitle%3DIndanylidenes.%25201.%2520Design%2520and%2520synthesis%2520of%2520%2528E%2529-2-%25284%252C6-difluoro-1-indanylidene%2529acetamide%252C%2520a%2520potent%252C%2520centrally%2520acting%2520muscle%2520relaxant%2520with%2520antiinflammatory%2520and%2520analgesic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D399%26epage%3D408%26doi%3D10.1021%2Fjm020067s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwachido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayama, N.</span></span> <span> </span><span class="NLM_article-title">Palladium(0)-catalyzed synthesis of 2-alkylbenzothiazoles by a novel thiation of 1-amino-2-iodoarenes with thioamides</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1246/cl.1987.839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1246%2Fcl.1987.839" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1987&pages=839-840&author=K.+Takagiauthor=T.+Iwachidoauthor=N.+Hayama&title=Palladium%280%29-catalyzed+synthesis+of+2-alkylbenzothiazoles+by+a+novel+thiation+of+1-amino-2-iodoarenes+with+thioamides&doi=10.1246%2Fcl.1987.839"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1246%2Fcl.1987.839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.1987.839%26sid%3Dliteratum%253Aachs%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DIwachido%26aufirst%3DT.%26aulast%3DHayama%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520synthesis%2520of%25202-alkylbenzothiazoles%2520by%2520a%2520novel%2520thiation%2520of%25201-amino-2-iodoarenes%2520with%2520thioamides%26jtitle%3DChem.%2520Lett.%26date%3D1987%26volume%3D16%26spage%3D839%26epage%3D840%26doi%3D10.1246%2Fcl.1987.839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiao, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-C.</span></span> <span> </span><span class="NLM_article-title">Facile synthesis of two pyridine alkaloids via functionalized 3,4-dialkylpyridines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3162</span>– <span class="NLM_lpage">3164</span>, <span class="refDoi"> DOI: 10.1021/jo00063a043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00063a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1ynsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=3162-3164&author=M.-J.+Shiaoauthor=W.-L.+Chiaauthor=C.-J.+Pengauthor=C.-C.+Shen&title=Facile+synthesis+of+two+pyridine+alkaloids+via+functionalized+3%2C4-dialkylpyridines&doi=10.1021%2Fjo00063a043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Facile synthesis of two pyridine alkaloids via functionalized 3,4-dialkylpyridines</span></div><div class="casAuthors">Shiao, Min Jen; Chia, Win Long; Peng, Chin Jen; Shen, Chien Chang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3162-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">3-Substituted 4-alkylpyridines, e.g. I (R = H, R1 = Me; R = Me, R1 = H), were obtained in good yields (27-88%) by reaction of mixed copper zinc alkyl organometallics with 3-substituted 1-(ethoxycarbonyl)pyridinium chlorides followed by sulfur oxidn. in boiling xylene.  Compds. I (R = H, R1 = Me; R = Me, R1 = H) were further cyclized and then decarboxylated to give 3,4-annulated pyridines II.  II are important precursors which can be used for the synthesis of two pyridine alkaloids 3,6,6-trimethyl-5,6-dihydro-2-pyrindin-7-one (III) and (±)-actinidine (IV) in 1 and 2 steps, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa7tR9PhcQXLVg90H21EOLACvtfcHk0li94Q-cW68nqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1ynsr4%253D&md5=ad474a95ef1e2cfd41a3d5956deff1e2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo00063a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00063a043%26sid%3Dliteratum%253Aachs%26aulast%3DShiao%26aufirst%3DM.-J.%26aulast%3DChia%26aufirst%3DW.-L.%26aulast%3DPeng%26aufirst%3DC.-J.%26aulast%3DShen%26aufirst%3DC.-C.%26atitle%3DFacile%2520synthesis%2520of%2520two%2520pyridine%2520alkaloids%2520via%2520functionalized%25203%252C4-dialkylpyridines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D3162%26epage%3D3164%26doi%3D10.1021%2Fjo00063a043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boekelheide, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedoruk, N. A.</span></span> <span> </span><span class="NLM_article-title">Syntheses of fused aromatic heterocycles by 1,3-dipolar addition reactions. 3-Azapyrrocolines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2062</span>– <span class="NLM_lpage">2064</span>, <span class="refDoi"> DOI: 10.1021/jo01269a075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01269a075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADyaF1cXktVaqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1968&pages=2062-2064&author=V.+Boekelheideauthor=N.+A.+Fedoruk&title=Syntheses+of+fused+aromatic+heterocycles+by+1%2C3-dipolar+addition+reactions.+3-Azapyrrocolines&doi=10.1021%2Fjo01269a075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of fused aromatic heterocycles by 1,3-dipolar addition reactions.  3-Azapyrrocolines</span></div><div class="casAuthors">Boekelheide, Virgil; Fedoruk, N. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2062-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The reaction of pyridine-N-imines with Et propiolate is a convenient method for prepg. 3-azapyrrocolines.  However, attempts to convert 3,5-trimethylene-3-azapyrrocolinium iodide (I) into 10-azacycl[3.3.2]azine (II) were unsuccessful.  20 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpowSVSuQ1qX7Vg90H21EOLACvtfcHk0lgpbmge1F1CVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXktVaqsLk%253D&md5=ca79bd74abd9bed30639eeef0b40b169</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo01269a075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01269a075%26sid%3Dliteratum%253Aachs%26aulast%3DBoekelheide%26aufirst%3DV.%26aulast%3DFedoruk%26aufirst%3DN.%2BA.%26atitle%3DSyntheses%2520of%2520fused%2520aromatic%2520heterocycles%2520by%25201%252C3-dipolar%2520addition%2520reactions.%25203-Azapyrrocolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1968%26volume%3D33%26spage%3D2062%26epage%3D2064%26doi%3D10.1021%2Fjo01269a075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Legault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charette, A. B.</span></span> <span> </span><span class="NLM_article-title">Highly efficient synthesis of O-(2,4-dinitrophenyl)hydroxylamine. Application to the synthesis of substituted N-benzoyliminopyridinium ylides</span>. <i>J. Org. Chem..</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">7119</span>– <span class="NLM_lpage">7122</span>, <span class="refDoi"> DOI: 10.1021/jo034456l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo034456l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFOlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=7119-7122&author=C.+Legaultauthor=A.+B.+Charette&title=Highly+efficient+synthesis+of+O-%282%2C4-dinitrophenyl%29hydroxylamine.+Application+to+the+synthesis+of+substituted+N-benzoyliminopyridinium+ylides&doi=10.1021%2Fjo034456l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Efficient Synthesis of O-(2,4-Dinitrophenyl)hydroxylamine. Application to the Synthesis of Substituted N-Benzoyliminopyridinium Ylides</span></div><div class="casAuthors">Legault, Claude; Charette, Andre B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7119-7122</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient two-step synthesis of O-(2,4-dinitrophenyl)hydroxylamine is described along with a comparison of its aminating efficiency with O-mesitylenesulfonylhydroxylamine (MSH).  It was used in an expedient N-amination/benzoylation procedure involving various substituted pyridines, leading to polysubstituted N-benzoyliminopyridinium ylides, and the scope of its amination power was studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro9rq3O_nxx7Vg90H21EOLACvtfcHk0lgpbmge1F1CVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFOlsLk%253D&md5=78ca7ceaa59fe3a687604f891c9e5685</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo034456l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034456l%26sid%3Dliteratum%253Aachs%26aulast%3DLegault%26aufirst%3DC.%26aulast%3DCharette%26aufirst%3DA.%2BB.%26atitle%3DHighly%2520efficient%2520synthesis%2520of%2520O-%25282%252C4-dinitrophenyl%2529hydroxylamine.%2520Application%2520to%2520the%2520synthesis%2520of%2520substituted%2520N-benzoyliminopyridinium%2520ylides%26jtitle%3DJ.%2520Org.%2520Chem..%26date%3D2003%26volume%3D68%26spage%3D7119%26epage%3D7122%26doi%3D10.1021%2Fjo034456l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boloor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span> <span> </span><span class="NLM_article-title">Efficient and regioselective synthesis of 2-alkyl-2<i>H</i>-indazoles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">4093</span>– <span class="NLM_lpage">4095</span>, <span class="refDoi"> DOI: 10.1021/jo0265434</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0265434" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=4093-4095&author=M.+Cheungauthor=A.+Boloorauthor=J.+A.+Stafford&title=Efficient+and+regioselective+synthesis+of+2-alkyl-2H-indazoles&doi=10.1021%2Fjo0265434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Regioselective Synthesis of 2-Alkyl-2H-indazoles</span></div><div class="casAuthors">Cheung, Mui; Boloor, Amogh; Stafford, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4093-4095</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-Methyl-2H-indazoles and 2-ethyl-2H-indazoles are prepd. regioselectively in 82-96% yields by treatment of 1H-indazoles with either trimethyloxonium tetrafluoroborate or triethyloxonium hexafluorophosphate in Et acetate.  Methoxy, chloro, and nitro-substituted indazoles are regioselectively alkylated under the reaction conditions.  Et acetate is the most effective solvent for the methylation or ethylation reactions; ethylation of 6-nitro-1H-indazole in methylene chloride gives the desired 2-Me indazole in only 50% yield, while in Et acetate ethylation under similar conditions gives the 2-Me indazole in 90% yield.  The regioselectivity and chemoselectivity of methylation of 6-nitro-1H-indazole is strongly dependent upon the methylating agent used; the use of diazomethane in the presence of boron trifluoride etherate gives 1-Me-6-nitro-1H-indazole in 75% yield, Me tosylate gives 2-Me-6-nitro-2H-indazole in 50% yield, and Me iodide gives mixts. contg. both 1-Me and 2-Me indazoles in addn. to 1,2-dimethyl-6-nitro-1H-indazolium iodide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgDXjoXLAPJbVg90H21EOLACvtfcHk0lgpbmge1F1CVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFansb8%253D&md5=6a94eacdbb4247e83c7df66e963ae1f7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo0265434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0265434%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DM.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26atitle%3DEfficient%2520and%2520regioselective%2520synthesis%2520of%25202-alkyl-2H-indazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D4093%26epage%3D4095%26doi%3D10.1021%2Fjo0265434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doken, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkawa, S.</span></span> <span> </span><span class="NLM_article-title">The sleep-promoting action of ramelteon (TAK-375) in freely moving cats</span>. <i>Sleep</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1319</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1093/sleep/27.7.1319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=10.1093%2Fsleep%2F27.7.1319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=15586784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;key=1%3ACAS%3A280%3ADC%252BD2cnhsVSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1319-1325&author=M.+Miyamotoauthor=H.+Nishikawaauthor=Y.+Dokenauthor=K.+Hiraiauthor=O.+Uchikawaauthor=S.+Ohkawa&title=The+sleep-promoting+action+of+ramelteon+%28TAK-375%29+in+freely+moving+cats&doi=10.1093%2Fsleep%2F27.7.1319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The sleep-promoting action of ramelteon (TAK-375) in freely moving cats</span></div><div class="casAuthors">Miyamoto Masaomi; Nishikawa Hisao; Doken Yayoi; Hirai Keisuke; Uchikawa Osamu; Ohkawa Shigenori</div><div class="citationInfo"><span class="NLM_cas:title">Sleep</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1319-25</span>
        ISSN:<span class="NLM_cas:issn">0161-8105</span>.
    </div><div class="casAbstract">INTRODUCTION:  Ramelteon (TAK-375) is an MT1/MT2 receptor agonist being studied for the treatment of insomnia and circadian rhythm sleep disorders.  We compared the behavioral effects of ramelteon and exogenous melatonin in freely moving cats.  METHODS:  Ramelteon and melatonin were each suspended in a 0.5% (weight per volume) methylcellulose solution and administered orally to freely moving cats.  In the control trial, each cat was given vehicle.  Each dose of ramelteon or melatonin was compared with the vehicle control in a crossover design.  Electroencephalogram, electromyogram, and electrooculogram recordings were assessed.  RESULTS:  Ramelteon significantly decreased wakefulness at doses of 0.001,0.01, and 0.1 mg/kg, increased slow-wave sleep at doses of 0.001, 0.01, and 0.1 mg/kg, and increased rapid eye movement sleep at a dose of 0.1 mg/kg, compared with the vehicle controls, as assessed by analysis of variance.  The effects of ramelteon lasted for up to 6 hours when evaluated by reduction of wakefulness.  Exogenous melatonin (0.01-1 mg/kg) significantly increased slow-wave sleep, but the effect was weaker than that of ramelteon and lasted for only 2 hours.  The lowest doses of ramelteon (0.0001 mg/kg) and melatonin (0.001 mg/kg) had no significant effect on sleep-wakefulness stage.  CONCLUSIONS:  Ramelteon was more effective than exogenous melatonin in promoting and maintaining sleep in freely moving cats.  Based on its unique mechanism of action, ramelteon should be studied further to evaluate its potential for the treatment of sleep disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpxhu-p8KJDzAEfvC7EH1LfW6udTcc2eZbX_tIpBX_W7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnhsVSltA%253D%253D&md5=9ae5a4c001b4aad4ff0b66a114d95fde</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fsleep%2F27.7.1319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fsleep%252F27.7.1319%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DDoken%26aufirst%3DY.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DOhkawa%26aufirst%3DS.%26atitle%3DThe%2520sleep-promoting%2520action%2520of%2520ramelteon%2520%2528TAK-375%2529%2520in%2520freely%2520moving%2520cats%26jtitle%3DSleep%26date%3D2004%26volume%3D27%26spage%3D1319%26epage%3D1325%26doi%3D10.1093%2Fsleep%2F27.7.1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01836">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21067"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01836?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01836</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR charts of (<i>S</i>)-<b>3b</b>, determination of the absolute configuration of (<i>S</i>)-<b>3b</b>, HPLC analysis of <b>3f</b>, functional analysis of the other tricyclic series than indeno[5,4-<i>d</i>][1,3]oxazole, and brain and plasma concentrations of (<i>S</i>)-<b>3b</b> in individual rats (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all reported final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_001.pdf">jm0c01836_si_001.pdf (458.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01836/suppl_file/jm0c01836_si_002.csv">jm0c01836_si_002.csv (1.12 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01836&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-6%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01836%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01836" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b0e6ce083c70","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
